<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://librepathology.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Michael</id>
	<title>Libre Pathology - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://librepathology.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Michael"/>
	<link rel="alternate" type="text/html" href="https://librepathology.org/wiki/Special:Contributions/Michael"/>
	<updated>2026-06-06T06:04:33Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.36.3</generator>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Pneumatosis_intestinalis&amp;diff=53806</id>
		<title>Pneumatosis intestinalis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Pneumatosis_intestinalis&amp;diff=53806"/>
		<updated>2026-06-05T14:10:40Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Pneumatosis intestinalis''' is presence of air in the wall of the intestine. May be referred to as '''pseudolipomatosis'''.&amp;lt;ref name=pmid14669349&amp;gt;{{cite journal |authors=Alper M, Akcan Y, Belenli OK, Cukur S, Aksoy KA, Suna M |title=Gastric pseudolipomatosis, usual or unusual? Re-evaluation of 909 endoscopic gastric biopsies |journal=World J Gastroenterol |volume=9 |issue=12 |pages=2846–8 |date=December 2003 |pmid=14669349 |pmc=4612068 |doi=10.3748/wjg.v9.i12.2846 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
''Pseudolipomatosis coli'' directs here. ''Microvesicular pneumatosis'' redirects here.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Bad prognosis - esp. if diffuse.&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Small bubbles in the intestinal wall.&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&lt;br /&gt;
*+/-Large submucosal pseudocysts - see ''[[pneumatosis cystoides intestinalis]]''.&lt;br /&gt;
*+/-Vacuolation of the mucosa - fat-like spaces 30-250 micrometres in diameter.&amp;lt;ref name=pmid14669349&amp;gt;{{cite journal |authors=Alper M, Akcan Y, Belenli OK, Cukur S, Aksoy KA, Suna M |title=Gastric pseudolipomatosis, usual or unusual? Re-evaluation of 909 endoscopic gastric biopsies |journal=World J Gastroenterol |volume=9 |issue=12 |pages=2846–8 |date=December 2003 |pmid=14669349 |pmc=4612068 |doi=10.3748/wjg.v9.i12.2846 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Notes:&lt;br /&gt;
*A microvesicular pattern is described - where the voids are 20-200 micrometres.&amp;lt;ref name=pmid14658539&amp;gt;{{cite journal |authors=Belenli OK, Akcan Y, Alper M |title=Micropneumatosis coexistent with Helicobacter pylori and its improvement |journal=Indian J Gastroenterol |volume=22 |issue=5 |pages=191–2 |date=2003 |pmid=14658539 |doi= |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Image:&lt;br /&gt;
*[http://www.wjes.org/content/6/1/15/figure/F4?highres=y Pneumatosis cystoides intestinalis (wjes.org)].&amp;lt;ref name=pmid21548980&amp;gt;{{Cite journal  | last1 = Takami | first1 = Y. | last2 = Koh | first2 = T. | last3 = Nishio | first3 = M. | last4 = Nakagawa | first4 = N. | title = Pneumatosis intestinalis leading to perioperative hypovolemic shock: Case report. | journal = World J Emerg Surg | volume = 6 | issue =  | pages = 15 | month =  | year = 2011 | doi = 10.1186/1749-7922-6-15 | PMID = 21548980 |PMC = PMC3108289}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[https://pmc.ncbi.nlm.nih.gov/articles/PMC6172536/ Pseudolipomatosis (nih.gov)].&amp;lt;ref name=pmid29709952&amp;gt;{{cite journal |authors=Iwamuro M, Tanaka T, Kawabata T, Sugihara Y, Harada K, Hiraoka S, Okada H |title=Pseudolipomatosis of the Colon and Cecum Followed by Pneumatosis Intestinalis |journal=Intern Med |volume=57 |issue=17 |pages=2501–2504 |date=September 2018 |pmid=29709952 |pmc=6172536 |doi=10.2169/internalmedicine.0730-17 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Gastrointestinal pathology]].&lt;br /&gt;
*[[Pneumatosis cystoides intestinalis]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;br /&gt;
[[Category:Gastrointestinal pathology]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Pneumatosis_intestinalis&amp;diff=53805</id>
		<title>Pneumatosis intestinalis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Pneumatosis_intestinalis&amp;diff=53805"/>
		<updated>2026-06-05T14:00:47Z</updated>

		<summary type="html">&lt;p&gt;Michael: rm broken link&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Pneumatosis intestinalis''' is presence of air in the wall of the intestine. May be referred to as '''pseudolipomatosis'''.&amp;lt;ref name=pmid14669349&amp;gt;{{cite journal |authors=Alper M, Akcan Y, Belenli OK, Cukur S, Aksoy KA, Suna M |title=Gastric pseudolipomatosis, usual or unusual? Re-evaluation of 909 endoscopic gastric biopsies |journal=World J Gastroenterol |volume=9 |issue=12 |pages=2846–8 |date=December 2003 |pmid=14669349 |pmc=4612068 |doi=10.3748/wjg.v9.i12.2846 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
''Pseudolipomatosis coli'' directs here. ''Microvesicular pneumatosis'' redirects here.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Bad prognosis - esp. if diffuse.&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Small bubbles in the intestinal wall.&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&lt;br /&gt;
*+/-Large submucosal pseudocysts - see ''[[pneumatosis cystoides intestinalis]]''.&lt;br /&gt;
*+/-Vacuolation of the mucosa - fat-like spaces 30-250 micrometres in diameter.&amp;lt;ref name=pmid14669349&amp;gt;{{cite journal |authors=Alper M, Akcan Y, Belenli OK, Cukur S, Aksoy KA, Suna M |title=Gastric pseudolipomatosis, usual or unusual? Re-evaluation of 909 endoscopic gastric biopsies |journal=World J Gastroenterol |volume=9 |issue=12 |pages=2846–8 |date=December 2003 |pmid=14669349 |pmc=4612068 |doi=10.3748/wjg.v9.i12.2846 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Notes:&lt;br /&gt;
*A microvesicular pattern is described - where the voids are 20-200 micrometres.&amp;lt;ref name=pmid14658539&amp;gt;{{cite journal |authors=Belenli OK, Akcan Y, Alper M |title=Micropneumatosis coexistent with Helicobacter pylori and its improvement |journal=Indian J Gastroenterol |volume=22 |issue=5 |pages=191–2 |date=2003 |pmid=14658539 |doi= |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Image:&lt;br /&gt;
*[http://www.wjes.org/content/6/1/15/figure/F4?highres=y Pneumatosis cystoides intestinalis (wjes.org)].&amp;lt;ref name=pmid21548980&amp;gt;{{Cite journal  | last1 = Takami | first1 = Y. | last2 = Koh | first2 = T. | last3 = Nishio | first3 = M. | last4 = Nakagawa | first4 = N. | title = Pneumatosis intestinalis leading to perioperative hypovolemic shock: Case report. | journal = World J Emerg Surg | volume = 6 | issue =  | pages = 15 | month =  | year = 2011 | doi = 10.1186/1749-7922-6-15 | PMID = 21548980 |PMC = PMC3108289}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Gastrointestinal pathology]].&lt;br /&gt;
*[[Pneumatosis cystoides intestinalis]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;br /&gt;
[[Category:Gastrointestinal pathology]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Pneumatosis_cystoides_intestinalis&amp;diff=53804</id>
		<title>Pneumatosis cystoides intestinalis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Pneumatosis_cystoides_intestinalis&amp;diff=53804"/>
		<updated>2026-06-05T13:59:44Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Gross */ +rm broken link&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Pneumatosis cystoides intestinalis''' is an uncommon intestinal pathology characterized by pseudocysts filled with air.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Benign, generally asymptomatic subset of [[pneumatosis intestinalis]].&amp;lt;ref&amp;gt;URL: [http://emedicine.medscape.com/article/371955-overview http://emedicine.medscape.com/article/371955-overview]. Accessed on: 24 January 2012.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Small or large bowel.&amp;lt;ref&amp;gt;{{Cite journal  | last1 = Micklefield | first1 = GH. | last2 = Kuntz | first2 = HD. | last3 = May | first3 = B. | title = Pneumatosis cystoides intestinalis: case reports and review of the literature. | journal = Mater Med Pol | volume = 22 | issue = 2 | pages = 70-2 | month =  | year =  | doi =  | PMID = 2102980 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Possible etiologies:&amp;lt;ref name=pmid21864163&amp;gt;{{Cite journal  | last1 = Wu | first1 = SS. | last2 = Yen | first2 = HH. | title = Images in clinical medicine. Pneumatosis cystoides intestinalis. | journal = N Engl J Med | volume = 365 | issue = 8 | pages = e16 | month = Aug | year = 2011 | doi = 10.1056/NEJMicm1013439 | PMID = 21864163 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[IBD]].&lt;br /&gt;
*Infection.&lt;br /&gt;
*Bowel necrosis.&lt;br /&gt;
*Malignancy.&lt;br /&gt;
*Drugs, e.g. alpha-glucosidase inhibitors.&lt;br /&gt;
*Idiopathic.&lt;br /&gt;
&lt;br /&gt;
Others:&lt;br /&gt;
*[[Necrotizing enterocolitis]]. (???)&lt;br /&gt;
*[[Cystic fibrosis]]. (???)&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Polypoid lesions.&lt;br /&gt;
&lt;br /&gt;
Images:&lt;br /&gt;
*www:&lt;br /&gt;
**[http://biblioteca.colmed5.org.ar/consultas/pneumatosis.htm Pneumatosis cystoides intestinalis - endoscopic image (colmed5.org.ar)].&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&lt;br /&gt;
*Large submucosal pseudocysts lined by macrophages and multi-nucleated giant cells.&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
*www:&lt;br /&gt;
**[http://www.wjes.org/content/6/1/15/figure/F4?highres=y Pneumatosis cystoides intestinalis (wjes.org)].&amp;lt;ref name=pmid21548980&amp;gt;{{Cite journal  | last1 = Takami | first1 = Y. | last2 = Koh | first2 = T. | last3 = Nishio | first3 = M. | last4 = Nakagawa | first4 = N. | title = Pneumatosis intestinalis leading to perioperative hypovolemic shock: Case report. | journal = World J Emerg Surg | volume = 6 | issue =  | pages = 15 | month =  | year = 2011 | doi = 10.1186/1749-7922-6-15 | PMID = 21548980 |PMC = PMC3108289}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Pneumatosis_cystoides_intestinalis_-_low_mag.jpg | Pneumatosis cystoides intestinalis - low mag. (WC)&lt;br /&gt;
Image:Pneumatosis_cystoides_intestinalis_-_intermed_mag.jpg | Pneumatosis cystoides intestinalis - intermed. mag. (WC)&lt;br /&gt;
Image:Pneumatosis_cystoides_intestinalis_-_high_mag.jpg | Pneumatosis cystoides intestinalis - high mag. (WC)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Gastrointestinal pathology]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;br /&gt;
[[Category:Gastrointestinal pathology]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Clear_cell_papillary_renal_cell_tumour&amp;diff=53803</id>
		<title>Clear cell papillary renal cell tumour</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Clear_cell_papillary_renal_cell_tumour&amp;diff=53803"/>
		<updated>2026-06-03T15:46:04Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Clear_cell_papillary_renal_cell_carcinoma_-_very_high_mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Clear cell papillary renal cell tumour. [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   = previously known as ''clear cell tubulopapillary renal cell carcinoma'' and ''clear cell papillary renal cell carcinoma''&lt;br /&gt;
| Micro      = low ([[ISUP nucleolar grade|ISUP nucleolar]]) grade apical nuclei (reverse polarized), clear cells, pseudopapillae, cystic and/or tubular architectures&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[clear cell renal cell carcinoma]], [[papillary renal cell carcinoma]], [[Xp11.2 translocation carcinoma]]&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        = CK7 +ve, GATA-3 +ve, MA903 +ve, CD10 -ve, AMACR -ve, TFE3 -ve&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   = [[total nephrectomy for tumour grossing]], [[partial nephrectomy grossing]]&lt;br /&gt;
| Staging    = [[kidney cancer staging]]&lt;br /&gt;
| Site       = [[kidney]] - see [[renal tumours]]&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = uncommon&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = good&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = other [[renal tumours]]&lt;br /&gt;
}}&lt;br /&gt;
'''Clear cell papillary renal cell tumour''', abbreviated '''CCPRCT''', is a relatively common benign renal tumour. &lt;br /&gt;
&lt;br /&gt;
It was previously known as '''clear cell papillary renal cell carcinoma''', abbreviated '''CCPRCC'''&lt;br /&gt;
&lt;br /&gt;
It was also previously known as '''clear cell tubulopapillary renal cell carcinoma''',&amp;lt;ref name=pmid21602815&amp;gt;{{Cite journal  | last1 = Rohan | first1 = SM. | last2 = Xiao | first2 = Y. | last3 = Liang | first3 = Y. | last4 = Dudas | first4 = ME. | last5 = Al-Ahmadie | first5 = HA. | last6 = Fine | first6 = SW. | last7 = Gopalan | first7 = A. | last8 = Reuter | first8 = VE. | last9 = Rosenblum | first9 = MK. | title = Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. | journal = Mod Pathol | volume = 24 | issue = 9 | pages = 1207-20 | month = Sep | year = 2011 | doi = 10.1038/modpathol.2011.80 | PMID = 21602815 }}&amp;lt;/ref&amp;gt; abbreviated '''CCTPRCC'''.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Relatively new entity.&lt;br /&gt;
**Not in the (original) 2004 [[WHO]] classification of renal tumours.&amp;lt;ref name=pmid21602815&amp;gt;{{Cite journal  | last1 = Rohan | first1 = SM. | last2 = Xiao | first2 = Y. | last3 = Liang | first3 = Y. | last4 = Dudas | first4 = ME. | last5 = Al-Ahmadie | first5 = HA. | last6 = Fine | first6 = SW. | last7 = Gopalan | first7 = A. | last8 = Reuter | first8 = VE. | last9 = Rosenblum | first9 = MK. | title = Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. | journal = Mod Pathol | volume = 24 | issue = 9 | pages = 1207-20 | month = Sep | year = 2011 | doi = 10.1038/modpathol.2011.80 | PMID = 21602815 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
***Added in ''[[Vancouver classification|The 2012 Vancouver modification of the WHO classification]]''.&amp;lt;ref name=pmid24025519&amp;gt;{{Cite journal  | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | last3 = Eble | first3 = JN. | last4 = Egevad | first4 = L. | last5 = Epstein | first5 = JI. | last6 = Grignon | first6 = D. | last7 = Hes | first7 = O. | last8 = Moch | first8 = H. | last9 = Montironi | first9 = R. | title = The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. | journal = Am J Surg Pathol | volume = 37 | issue = 10 | pages = 1469-89 | month = Oct | year = 2013 | doi = 10.1097/PAS.0b013e318299f2d1 | PMID = 24025519 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Shown to be distinct on a molecular basis.&amp;lt;ref&amp;gt;{{Cite journal  | last1 = Rohan | first1 = SM. | last2 = Xiao | first2 = Y. | last3 = Liang | first3 = Y. | last4 = Dudas | first4 = ME. | last5 = Al-Ahmadie | first5 = HA. | last6 = Fine | first6 = SW. | last7 = Gopalan | first7 = A. | last8 = Reuter | first8 = VE. | last9 = Rosenblum | first9 = MK. | title = Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. | journal = Mod Pathol | volume = 24 | issue = 9 | pages = 1207-20 | month = Sep | year = 2011 | doi = 10.1038/modpathol.2011.80 | PMID = 21602815 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**No [[vHL]] gene mutations,&amp;lt;ref name=pmid20924276&amp;gt;{{Cite journal  | last1 = Aydin | first1 = H. | last2 = Chen | first2 = L. | last3 = Cheng | first3 = L. | last4 = Vaziri | first4 = S. | last5 = He | first5 = H. | last6 = Ganapathi | first6 = R. | last7 = Delahunt | first7 = B. | last8 = Magi-Galluzzi | first8 = C. | last9 = Zhou | first9 = M. | title = Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. | journal = Am J Surg Pathol | volume = 34 | issue = 11 | pages = 1608-21 | month = Nov | year = 2010 | doi = 10.1097/PAS.0b013e3181f2ee0b | PMID = 20924276 }}&lt;br /&gt;
&amp;lt;/ref&amp;gt; seen in [[clear cell renal cell carcinoma]].&lt;br /&gt;
*Good prognosis.&lt;br /&gt;
*Previously classified as ''carcinoma''.&lt;br /&gt;
**On the basis of 268 cases: it has was suggested that ''clear cell papillary renal cell carcinoma'' be renamed ''clear cell papillary neoplasm of low malignant potential''.&amp;lt;ref name=pmid26426379&amp;gt;{{Cite journal  | last1 = Diolombi | first1 = ML. | last2 = Cheng | first2 = L. | last3 = Argani | first3 = P. | last4 = Epstein | first4 = JI. | title = Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential? | journal = Am J Surg Pathol | volume = 39 | issue = 12 | pages = 1621-34 | month = Dec | year = 2015 | doi = 10.1097/PAS.0000000000000513 | PMID = 26426379 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**The name ''clear cell papillary (cyst)adenoma'' was also proposed.&amp;lt;ref name=pmid33223139&amp;gt;{{cite journal |authors=Williamson SR |title=Clear cell papillary renal cell carcinoma: an update after 15 years |journal=Pathology |volume=53 |issue=1 |pages=109–119 |date=January 2021 |pmid=33223139 |doi=10.1016/j.pathol.2020.10.002 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Relatively common - if one considers it a RCC: it is the fourth most common type.&amp;lt;ref name=pmid24182559&amp;gt;{{Cite journal  | last1 = Zhou | first1 = H. | last2 = Zheng | first2 = S. | last3 = Truong | first3 = LD. | last4 = Ro | first4 = JY. | last5 = Ayala | first5 = AG. | last6 = Shen | first6 = SS. | title = Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. | journal = Hum Pathol | volume =  | issue =  | pages =  | month = Oct | year = 2013 | doi = 10.1016/j.humpath.2013.08.004 | PMID = 24182559 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Most common (in order): [[clear cell RCC]], [[papillary RCC]], [[chromophobe RCC]], clear cell papillary RCC.&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&amp;lt;ref name=pmid21602815/&amp;gt;&lt;br /&gt;
*Some features of both:&lt;br /&gt;
*#Clear cell RCC.&lt;br /&gt;
*#*Clear cells.&lt;br /&gt;
*#Papillary RCC.&lt;br /&gt;
*#*Pseudopapillae - often do not have true papillae.&lt;br /&gt;
*Apical nuclei - should be predominant ‡ - '''key feature'''.&amp;lt;ref name=bing&amp;gt;{{Cite journal  | last1 = Bing | first1 = Z. | last2 = Tomaszewski | first2 = JE. | title = Case Report: Clear Cell Papillary Renal Cell Carcinoma in the  Bilateral Native Kidneys after 2 Years of Renal Transplantation:  Report of a Case and Review of  the Literature. | journal = Case Reports in Transplantation | volume = 2011 | issue = | pages =  | month =  | year = 2011 | doi = 10.1155/2011/387645 | PMID =  | url = http://www.hindawi.com/crim/transplantation/2011/387645/cta/ }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**In most glandular structures the nuclei are usu. basally located, i.e. in the cytoplasm adjacent to the basement membrane.&lt;br /&gt;
*Tubular and/or cystic architecture.&lt;br /&gt;
&lt;br /&gt;
Notes: ‡&lt;br /&gt;
*Apical nuclei may be seen focally in [[clear cell renal cell carcinoma]].&lt;br /&gt;
*Nuclei should be low grade ([[ISUP nucleolar grade]] 1 or 2).&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Clear cell renal cell carcinoma]] - main DDx.&lt;br /&gt;
*[[Papillary renal cell carcinoma]].&lt;br /&gt;
*[[Xp11.2 translocation carcinoma]].&lt;br /&gt;
&lt;br /&gt;
Note:&lt;br /&gt;
*[[Renal angiomyoadenomatous tumour]] has been proposed as separate entity.&amp;lt;ref name=pmid23434146&amp;gt;{{Cite journal  | last1 = Petersson | first1 = F. | last2 = Grossmann | first2 = P. | last3 = Hora | first3 = M. | last4 = Sperga | first4 = M. | last5 = Montiel | first5 = DP. | last6 = Martinek | first6 = P. | last7 = Gutierrez | first7 = ME. | last8 = Bulimbasic | first8 = S. | last9 = Michal | first9 = M. | title = Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma. | journal = Hum Pathol | volume = 44 | issue = 7 | pages = 1412-20 | month = Jul | year = 2013 | doi = 10.1016/j.humpath.2012.11.019 | PMID = 23434146 }}&amp;lt;/ref&amp;gt; ''The Vancouver modification of the WHO classification'' does '''not''' consider it a separate entity; it lumps it with ''clear cell papillary renal cell carcinoma''.&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Clear_cell_papillary_renal_cell_carcinoma_-_high_mag.jpg | CCPRCT - high mag. (WC/Nephron)&lt;br /&gt;
Image:Clear_cell_papillary_renal_cell_carcinoma_-_very_high_mag.jpg | CCPRCT - very high mag. (WC/Nephron)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
www:&lt;br /&gt;
*[http://path.upmc.edu/cases/case682.html Clear cell papillary RCC - several images (upmc.edu)].&lt;br /&gt;
*[http://www.flickr.com/photos/40764007@N08/7177459461/ CCPRCC (flickr.com)].&lt;br /&gt;
&lt;br /&gt;
==IHC==&lt;br /&gt;
Features:&amp;lt;ref name=pmid21602815/&amp;gt;&lt;br /&gt;
*CK7 +ve - esp. diffuse.&amp;lt;ref name=pmid26457355&amp;gt;{{Cite journal  | last1 = Williamson | first1 = SR. | last2 = Gupta | first2 = NS. | last3 = Eble | first3 = JN. | last4 = Rogers | first4 = CG. | last5 = Michalowski | first5 = S. | last6 = Zhang | first6 = S. | last7 = Wang | first7 = M. | last8 = Grignon | first8 = DJ. | last9 = Cheng | first9 = L. | title = Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis. | journal = Am J Surg Pathol | volume = 39 | issue = 11 | pages = 1502-10 | month = Nov | year = 2015 | doi = 10.1097/PAS.0000000000000514 | PMID = 26457355 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Usually -ve (or patchy) in clear cell RCC.&lt;br /&gt;
*CD10 -ve (0 +ve/9 cases in one series&amp;lt;ref name=pmid21602815&amp;gt;{{Cite journal  | last1 = Rohan | first1 = SM. | last2 = Xiao | first2 = Y. | last3 = Liang | first3 = Y. | last4 = Dudas | first4 = ME. | last5 = Al-Ahmadie | first5 = HA. | last6 = Fine | first6 = SW. | last7 = Gopalan | first7 = A. | last8 = Reuter | first8 = VE. | last9 = Rosenblum | first9 = MK. | title = Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. | journal = Mod Pathol | volume = 24 | issue = 9 | pages = 1207-20 | month = Sep | year = 2011 | doi = 10.1038/modpathol.2011.80 | PMID = 21602815 }}&amp;lt;/ref&amp;gt;). &lt;br /&gt;
**Usually +ve in clear cell RCC.&lt;br /&gt;
**Positive in Xp11.2 translocation carcinoma.&amp;lt;ref name=pmid21804394&amp;gt;{{Cite journal  | last1 = He | first1 = H. | last2 = Zhou | first2 = GX. | last3 = Zhou | first3 = M. | last4 = Chen | first4 = L. | title = The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray. | journal = Int J Gynecol Pathol | volume = 30 | issue = 5 | pages = 425-30 | month = Sep | year = 2011 | doi = 10.1097/PGP.0b013e318214dd4f | PMID = 21804394 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*TFE3 -ve.&lt;br /&gt;
**By definition +ve in [[Xp11.2 translocation carcinoma]].&lt;br /&gt;
*[[AMACR]] -ve.&amp;lt;ref name=pmid23791764&amp;gt;{{Cite journal  | last1 = Pramick | first1 = M. | last2 = Ziober | first2 = A. | last3 = Bing | first3 = Z. | title = Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics. | journal = Ann Diagn Pathol | volume = 17 | issue = 5 | pages = 437-40 | month = Oct | year = 2013 | doi = 10.1016/j.anndiagpath.2013.05.004 | PMID = 23791764 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Usu. +ve in [[Papillary RCC]].&lt;br /&gt;
*Smooth muscle actin +ve (focal).&amp;lt;ref name=pmid23238627&amp;gt;{{Cite journal  | last1 = Williamson | first1 = SR. | last2 = Eble | first2 = JN. | last3 = Cheng | first3 = L. | last4 = Grignon | first4 = DJ. | title = Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. | journal = Mod Pathol | volume = 26 | issue = 5 | pages = 697-708 | month = May | year = 2013 | doi = 10.1038/modpathol.2012.204 | PMID = 23238627 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Others:&amp;lt;ref name=pmid21602815/&amp;gt;&lt;br /&gt;
*HIF-1alpha +ve. &lt;br /&gt;
*GLUT-1 +ve.&lt;br /&gt;
*[[CA9]] +ve (cup-shaped pattern).&amp;lt;ref name=pmid25550767&amp;gt;{{Cite journal  | last1 = Kuroda | first1 = N. | last2 = Ohe | first2 = C. | last3 = Kawakami | first3 = F. | last4 = Mikami | first4 = S. | last5 = Furuya | first5 = M. | last6 = Matsuura | first6 = K. | last7 = Moriyama | first7 = M. | last8 = Nagashima | first8 = Y. | last9 = Zhou | first9 = M. | title = Clear cell papillary renal cell carcinoma: a review. | journal = Int J Clin Exp Pathol | volume = 7 | issue = 11 | pages = 7312-8 | month =  | year = 2014 | doi =  | PMID = 25550767 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*CK34betaE12 +ve.&amp;lt;ref name=pmid25676555&amp;gt;{{Cite journal  | last1 = Hakimi | first1 = AA. | last2 = Tickoo | first2 = SK. | last3 = Jacobsen | first3 = A. | last4 = Sarungbam | first4 = J. | last5 = Sfakianos | first5 = JP. | last6 = Sato | first6 = Y. | last7 = Morikawa | first7 = T. | last8 = Kume | first8 = H. | last9 = Fukayama | first9 = M. | title = TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype. | journal = Mod Pathol | volume = 28 | issue = 6 | pages = 845-53 | month = Jun | year = 2015 | doi = 10.1038/modpathol.2015.6 | PMID = 25676555 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[GATA3]] +ve.&amp;lt;ref name=pmid28705707&amp;gt;{{cite journal |authors=Mantilla JG, Antic T, Tretiakova M |title=GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics |journal=Hum Pathol |volume=66 |issue= |pages=152–158 |date=August 2017 |pmid=28705707 |doi=10.1016/j.humpath.2017.06.016 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
How to remember: ''The two key stains are opposite of what the name implies''.&lt;br /&gt;
*''Clear cell'' RCC: CK7 negative.  In this tumour it is the opposite - CK7 is positive.&lt;br /&gt;
*''Papillary'' RCC: AMACR positive.  In this tumour it is the opposite - AMACR is negative.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
A. Left Kidney Mass, Radical Nephrectomy:&lt;br /&gt;
    - CLEAR CELL PAPILLARY RENAL CELL TUMOUR, nucleolar grade 1 of 4, see comment.&lt;br /&gt;
    -- Margins clear.&lt;br /&gt;
    -- Please see synoptic report.&lt;br /&gt;
&lt;br /&gt;
Comment:&lt;br /&gt;
The tumour has a tubulocystic architecture and is composed of cuboidal cells with clear cytoplasm. The nuclei are reverse stratified.&lt;br /&gt;
&lt;br /&gt;
The tumour stains as follows: &lt;br /&gt;
POSITIVE: PAX8 (strong, diffuse), CK7 (strong, diffuse), MA903 (strong, diffuse), CAIX (moderate, patchy cup-like), AE1/AE3 (moderate, diffuse), GATA3 (moderate, diffuse).&lt;br /&gt;
NEGATIVE: CD10, AMACR.&lt;br /&gt;
&lt;br /&gt;
The findings are in keeping with clear cell papillary renal cell tumour. These tumours were previously called &amp;quot;clear cell papillary renal cell carcinoma&amp;quot;.[1]&lt;br /&gt;
&lt;br /&gt;
These tumours have a highly favourable clinical behaviour.[2,3] &lt;br /&gt;
&lt;br /&gt;
1. Pathologica. 2022 Feb;115(1):8-22. doi: 10.32074/1591-951X-818. https://pmc.ncbi.nlm.nih.gov/articles/PMC10342217/&lt;br /&gt;
2. Am J Surg Pathol. 2015 Dec;39(12):1621-34. DOI: 10.1097/PAS.0000000000000513&lt;br /&gt;
3. Pathology. 2020 Nov 19;S0031-3025(20)30957-0. DOI: 10.1016/j.pathol.2020.10.002&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Biopsy===&lt;br /&gt;
Diagnosing the this entity on biopsy should be done with caution as:&lt;br /&gt;
*Overlaps are described between ''clear cell renal cell carcinoma'' and ''clear cell papillary renal cell tumour''.&amp;lt;ref name=pmid26752401&amp;gt;{{cite journal |vauthors=Dhakal HP, McKenney JK, Khor LY, Reynolds JP, Magi-Galluzzi C, Przybycin CG |title=Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution |journal=Am J Surg Pathol |volume=40 |issue=2 |pages=141–54 |date=February 2016 |pmid=26752401 |doi=10.1097/PAS.0000000000000583 |url=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
*''Clear cell papillary renal cell tumour'' may also be seen in conjunction with (other) renal cell carcinoma(s).&amp;lt;ref name=pmid26857533&amp;gt;{{cite journal |authors=Shao T, Yousef P, Shipilova I, Saleeb R, Lee JY, Krizova A |title=Clear cell papillary renal cell carcinoma as part of histologically discordant multifocal renal cell carcinoma: A case report and review of literature |journal=Pathol Res Pract |volume=212 |issue=3 |pages=229–33 |date=March 2016 |pmid=26857533 |doi=10.1016/j.prp.2015.12.007 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Kidney tumours]].&lt;br /&gt;
*[[Tubulocystic carcinoma of the kidney]].&lt;br /&gt;
*[[ELOC-mutated renal cell carcinoma]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Kidney tumours]]&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Clear_cell_papillary_renal_cell_tumour&amp;diff=53802</id>
		<title>Clear cell papillary renal cell tumour</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Clear_cell_papillary_renal_cell_tumour&amp;diff=53802"/>
		<updated>2026-06-03T15:43:23Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Clear_cell_papillary_renal_cell_carcinoma_-_very_high_mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Clear cell papillary renal cell tumour. [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   = previously known as ''clear cell tubulopapillary renal cell carcinoma'' and ''clear cell papillary renal cell carcinoma''&lt;br /&gt;
| Micro      = low ([[ISUP nucleolar grade|ISUP nucleolar]]) grade apical nuclei, clear cells, pseudopapillae, cystic and/or tubular architectures&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[clear cell renal cell carcinoma]], [[papillary renal cell carcinoma]], [[Xp11.2 translocation carcinoma]]&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        = CK7 +ve, GATA-3 +ve, MA903 +ve, CD10 -ve, AMACR -ve, TFE3 -ve&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   = [[total nephrectomy for tumour grossing]], [[partial nephrectomy grossing]]&lt;br /&gt;
| Staging    = [[kidney cancer staging]]&lt;br /&gt;
| Site       = [[kidney]] - see [[renal tumours]]&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = uncommon&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = good&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = other [[renal tumours]]&lt;br /&gt;
}}&lt;br /&gt;
'''Clear cell papillary renal cell tumour''', abbreviated '''CCPRCT''', is a relatively common benign renal tumour. &lt;br /&gt;
&lt;br /&gt;
It was previously known as '''clear cell papillary renal cell carcinoma''', abbreviated '''CCPRCC'''&lt;br /&gt;
&lt;br /&gt;
It is also previously known as '''clear cell tubulopapillary renal cell carcinoma''',&amp;lt;ref name=pmid21602815&amp;gt;{{Cite journal  | last1 = Rohan | first1 = SM. | last2 = Xiao | first2 = Y. | last3 = Liang | first3 = Y. | last4 = Dudas | first4 = ME. | last5 = Al-Ahmadie | first5 = HA. | last6 = Fine | first6 = SW. | last7 = Gopalan | first7 = A. | last8 = Reuter | first8 = VE. | last9 = Rosenblum | first9 = MK. | title = Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. | journal = Mod Pathol | volume = 24 | issue = 9 | pages = 1207-20 | month = Sep | year = 2011 | doi = 10.1038/modpathol.2011.80 | PMID = 21602815 }}&amp;lt;/ref&amp;gt; abbreviated '''CCTPRCC'''.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Relatively new entity.&lt;br /&gt;
**Not in the (original) 2004 [[WHO]] classification of renal tumours.&amp;lt;ref name=pmid21602815&amp;gt;{{Cite journal  | last1 = Rohan | first1 = SM. | last2 = Xiao | first2 = Y. | last3 = Liang | first3 = Y. | last4 = Dudas | first4 = ME. | last5 = Al-Ahmadie | first5 = HA. | last6 = Fine | first6 = SW. | last7 = Gopalan | first7 = A. | last8 = Reuter | first8 = VE. | last9 = Rosenblum | first9 = MK. | title = Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. | journal = Mod Pathol | volume = 24 | issue = 9 | pages = 1207-20 | month = Sep | year = 2011 | doi = 10.1038/modpathol.2011.80 | PMID = 21602815 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
***Added in ''[[Vancouver classification|The 2012 Vancouver modification of the WHO classification]]''.&amp;lt;ref name=pmid24025519&amp;gt;{{Cite journal  | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | last3 = Eble | first3 = JN. | last4 = Egevad | first4 = L. | last5 = Epstein | first5 = JI. | last6 = Grignon | first6 = D. | last7 = Hes | first7 = O. | last8 = Moch | first8 = H. | last9 = Montironi | first9 = R. | title = The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. | journal = Am J Surg Pathol | volume = 37 | issue = 10 | pages = 1469-89 | month = Oct | year = 2013 | doi = 10.1097/PAS.0b013e318299f2d1 | PMID = 24025519 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Shown to be distinct on a molecular basis.&amp;lt;ref&amp;gt;{{Cite journal  | last1 = Rohan | first1 = SM. | last2 = Xiao | first2 = Y. | last3 = Liang | first3 = Y. | last4 = Dudas | first4 = ME. | last5 = Al-Ahmadie | first5 = HA. | last6 = Fine | first6 = SW. | last7 = Gopalan | first7 = A. | last8 = Reuter | first8 = VE. | last9 = Rosenblum | first9 = MK. | title = Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. | journal = Mod Pathol | volume = 24 | issue = 9 | pages = 1207-20 | month = Sep | year = 2011 | doi = 10.1038/modpathol.2011.80 | PMID = 21602815 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**No [[vHL]] gene mutations,&amp;lt;ref name=pmid20924276&amp;gt;{{Cite journal  | last1 = Aydin | first1 = H. | last2 = Chen | first2 = L. | last3 = Cheng | first3 = L. | last4 = Vaziri | first4 = S. | last5 = He | first5 = H. | last6 = Ganapathi | first6 = R. | last7 = Delahunt | first7 = B. | last8 = Magi-Galluzzi | first8 = C. | last9 = Zhou | first9 = M. | title = Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. | journal = Am J Surg Pathol | volume = 34 | issue = 11 | pages = 1608-21 | month = Nov | year = 2010 | doi = 10.1097/PAS.0b013e3181f2ee0b | PMID = 20924276 }}&lt;br /&gt;
&amp;lt;/ref&amp;gt; seen in [[clear cell renal cell carcinoma]].&lt;br /&gt;
*Good prognosis.&lt;br /&gt;
*Previously classified as ''carcinoma''.&lt;br /&gt;
**On the basis of 268 cases: it has was suggested that ''clear cell papillary renal cell carcinoma'' be renamed ''clear cell papillary neoplasm of low malignant potential''.&amp;lt;ref name=pmid26426379&amp;gt;{{Cite journal  | last1 = Diolombi | first1 = ML. | last2 = Cheng | first2 = L. | last3 = Argani | first3 = P. | last4 = Epstein | first4 = JI. | title = Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential? | journal = Am J Surg Pathol | volume = 39 | issue = 12 | pages = 1621-34 | month = Dec | year = 2015 | doi = 10.1097/PAS.0000000000000513 | PMID = 26426379 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**The name ''clear cell papillary (cyst)adenoma'' was also proposed.&amp;lt;ref name=pmid33223139&amp;gt;{{cite journal |authors=Williamson SR |title=Clear cell papillary renal cell carcinoma: an update after 15 years |journal=Pathology |volume=53 |issue=1 |pages=109–119 |date=January 2021 |pmid=33223139 |doi=10.1016/j.pathol.2020.10.002 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Relatively common - if one considers it a RCC: it is the fourth most common type.&amp;lt;ref name=pmid24182559&amp;gt;{{Cite journal  | last1 = Zhou | first1 = H. | last2 = Zheng | first2 = S. | last3 = Truong | first3 = LD. | last4 = Ro | first4 = JY. | last5 = Ayala | first5 = AG. | last6 = Shen | first6 = SS. | title = Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. | journal = Hum Pathol | volume =  | issue =  | pages =  | month = Oct | year = 2013 | doi = 10.1016/j.humpath.2013.08.004 | PMID = 24182559 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Most common (in order): [[clear cell RCC]], [[papillary RCC]], [[chromophobe RCC]], clear cell papillary RCC.&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&amp;lt;ref name=pmid21602815/&amp;gt;&lt;br /&gt;
*Some features of both:&lt;br /&gt;
*#Clear cell RCC.&lt;br /&gt;
*#*Clear cells.&lt;br /&gt;
*#Papillary RCC.&lt;br /&gt;
*#*Pseudopapillae - often do not have true papillae.&lt;br /&gt;
*Apical nuclei - should be predominant ‡ - '''key feature'''.&amp;lt;ref name=bing&amp;gt;{{Cite journal  | last1 = Bing | first1 = Z. | last2 = Tomaszewski | first2 = JE. | title = Case Report: Clear Cell Papillary Renal Cell Carcinoma in the  Bilateral Native Kidneys after 2 Years of Renal Transplantation:  Report of a Case and Review of  the Literature. | journal = Case Reports in Transplantation | volume = 2011 | issue = | pages =  | month =  | year = 2011 | doi = 10.1155/2011/387645 | PMID =  | url = http://www.hindawi.com/crim/transplantation/2011/387645/cta/ }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**In most glandular structures the nuclei are usu. basally located, i.e. in the cytoplasm adjacent to the basement membrane.&lt;br /&gt;
*Tubular and/or cystic architecture.&lt;br /&gt;
&lt;br /&gt;
Notes: ‡&lt;br /&gt;
*Apical nuclei may be seen focally in [[clear cell renal cell carcinoma]].&lt;br /&gt;
*Nuclei should be low grade ([[ISUP nucleolar grade]] 1 or 2).&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Clear cell renal cell carcinoma]] - main DDx.&lt;br /&gt;
*[[Papillary renal cell carcinoma]].&lt;br /&gt;
*[[Xp11.2 translocation carcinoma]].&lt;br /&gt;
&lt;br /&gt;
Note:&lt;br /&gt;
*[[Renal angiomyoadenomatous tumour]] has been proposed as separate entity.&amp;lt;ref name=pmid23434146&amp;gt;{{Cite journal  | last1 = Petersson | first1 = F. | last2 = Grossmann | first2 = P. | last3 = Hora | first3 = M. | last4 = Sperga | first4 = M. | last5 = Montiel | first5 = DP. | last6 = Martinek | first6 = P. | last7 = Gutierrez | first7 = ME. | last8 = Bulimbasic | first8 = S. | last9 = Michal | first9 = M. | title = Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma. | journal = Hum Pathol | volume = 44 | issue = 7 | pages = 1412-20 | month = Jul | year = 2013 | doi = 10.1016/j.humpath.2012.11.019 | PMID = 23434146 }}&amp;lt;/ref&amp;gt; ''The Vancouver modification of the WHO classification'' does '''not''' consider it a separate entity; it lumps it with ''clear cell papillary renal cell carcinoma''.&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Clear_cell_papillary_renal_cell_carcinoma_-_high_mag.jpg | CCPRCT - high mag. (WC/Nephron)&lt;br /&gt;
Image:Clear_cell_papillary_renal_cell_carcinoma_-_very_high_mag.jpg | CCPRCT - very high mag. (WC/Nephron)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
www:&lt;br /&gt;
*[http://path.upmc.edu/cases/case682.html Clear cell papillary RCC - several images (upmc.edu)].&lt;br /&gt;
*[http://www.flickr.com/photos/40764007@N08/7177459461/ CCPRCC (flickr.com)].&lt;br /&gt;
&lt;br /&gt;
==IHC==&lt;br /&gt;
Features:&amp;lt;ref name=pmid21602815/&amp;gt;&lt;br /&gt;
*CK7 +ve - esp. diffuse.&amp;lt;ref name=pmid26457355&amp;gt;{{Cite journal  | last1 = Williamson | first1 = SR. | last2 = Gupta | first2 = NS. | last3 = Eble | first3 = JN. | last4 = Rogers | first4 = CG. | last5 = Michalowski | first5 = S. | last6 = Zhang | first6 = S. | last7 = Wang | first7 = M. | last8 = Grignon | first8 = DJ. | last9 = Cheng | first9 = L. | title = Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis. | journal = Am J Surg Pathol | volume = 39 | issue = 11 | pages = 1502-10 | month = Nov | year = 2015 | doi = 10.1097/PAS.0000000000000514 | PMID = 26457355 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Usually -ve (or patchy) in clear cell RCC.&lt;br /&gt;
*CD10 -ve (0 +ve/9 cases in one series&amp;lt;ref name=pmid21602815&amp;gt;{{Cite journal  | last1 = Rohan | first1 = SM. | last2 = Xiao | first2 = Y. | last3 = Liang | first3 = Y. | last4 = Dudas | first4 = ME. | last5 = Al-Ahmadie | first5 = HA. | last6 = Fine | first6 = SW. | last7 = Gopalan | first7 = A. | last8 = Reuter | first8 = VE. | last9 = Rosenblum | first9 = MK. | title = Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. | journal = Mod Pathol | volume = 24 | issue = 9 | pages = 1207-20 | month = Sep | year = 2011 | doi = 10.1038/modpathol.2011.80 | PMID = 21602815 }}&amp;lt;/ref&amp;gt;). &lt;br /&gt;
**Usually +ve in clear cell RCC.&lt;br /&gt;
**Positive in Xp11.2 translocation carcinoma.&amp;lt;ref name=pmid21804394&amp;gt;{{Cite journal  | last1 = He | first1 = H. | last2 = Zhou | first2 = GX. | last3 = Zhou | first3 = M. | last4 = Chen | first4 = L. | title = The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray. | journal = Int J Gynecol Pathol | volume = 30 | issue = 5 | pages = 425-30 | month = Sep | year = 2011 | doi = 10.1097/PGP.0b013e318214dd4f | PMID = 21804394 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*TFE3 -ve.&lt;br /&gt;
**By definition +ve in [[Xp11.2 translocation carcinoma]].&lt;br /&gt;
*[[AMACR]] -ve.&amp;lt;ref name=pmid23791764&amp;gt;{{Cite journal  | last1 = Pramick | first1 = M. | last2 = Ziober | first2 = A. | last3 = Bing | first3 = Z. | title = Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics. | journal = Ann Diagn Pathol | volume = 17 | issue = 5 | pages = 437-40 | month = Oct | year = 2013 | doi = 10.1016/j.anndiagpath.2013.05.004 | PMID = 23791764 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Usu. +ve in [[Papillary RCC]].&lt;br /&gt;
*Smooth muscle actin +ve (focal).&amp;lt;ref name=pmid23238627&amp;gt;{{Cite journal  | last1 = Williamson | first1 = SR. | last2 = Eble | first2 = JN. | last3 = Cheng | first3 = L. | last4 = Grignon | first4 = DJ. | title = Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. | journal = Mod Pathol | volume = 26 | issue = 5 | pages = 697-708 | month = May | year = 2013 | doi = 10.1038/modpathol.2012.204 | PMID = 23238627 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Others:&amp;lt;ref name=pmid21602815/&amp;gt;&lt;br /&gt;
*HIF-1alpha +ve. &lt;br /&gt;
*GLUT-1 +ve.&lt;br /&gt;
*[[CA9]] +ve (cup-shaped pattern).&amp;lt;ref name=pmid25550767&amp;gt;{{Cite journal  | last1 = Kuroda | first1 = N. | last2 = Ohe | first2 = C. | last3 = Kawakami | first3 = F. | last4 = Mikami | first4 = S. | last5 = Furuya | first5 = M. | last6 = Matsuura | first6 = K. | last7 = Moriyama | first7 = M. | last8 = Nagashima | first8 = Y. | last9 = Zhou | first9 = M. | title = Clear cell papillary renal cell carcinoma: a review. | journal = Int J Clin Exp Pathol | volume = 7 | issue = 11 | pages = 7312-8 | month =  | year = 2014 | doi =  | PMID = 25550767 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*CK34betaE12 +ve.&amp;lt;ref name=pmid25676555&amp;gt;{{Cite journal  | last1 = Hakimi | first1 = AA. | last2 = Tickoo | first2 = SK. | last3 = Jacobsen | first3 = A. | last4 = Sarungbam | first4 = J. | last5 = Sfakianos | first5 = JP. | last6 = Sato | first6 = Y. | last7 = Morikawa | first7 = T. | last8 = Kume | first8 = H. | last9 = Fukayama | first9 = M. | title = TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype. | journal = Mod Pathol | volume = 28 | issue = 6 | pages = 845-53 | month = Jun | year = 2015 | doi = 10.1038/modpathol.2015.6 | PMID = 25676555 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[GATA3]] +ve.&amp;lt;ref name=pmid28705707&amp;gt;{{cite journal |authors=Mantilla JG, Antic T, Tretiakova M |title=GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics |journal=Hum Pathol |volume=66 |issue= |pages=152–158 |date=August 2017 |pmid=28705707 |doi=10.1016/j.humpath.2017.06.016 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
How to remember: ''The two key stains are opposite of what the name implies''.&lt;br /&gt;
*''Clear cell'' RCC: CK7 negative.  In this tumour it is the opposite - CK7 is positive.&lt;br /&gt;
*''Papillary'' RCC: AMACR positive.  In this tumour it is the opposite - AMACR is negative.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
A. Left Kidney Mass, Radical Nephrectomy:&lt;br /&gt;
    - CLEAR CELL PAPILLARY RENAL CELL TUMOUR, nucleolar grade 1 of 4, see comment.&lt;br /&gt;
    -- Margins clear.&lt;br /&gt;
    -- Please see synoptic report.&lt;br /&gt;
&lt;br /&gt;
Comment:&lt;br /&gt;
The tumour has a tubulocystic architecture and is composed of cuboidal cells with clear cytoplasm. The nuclei are reverse stratified.&lt;br /&gt;
&lt;br /&gt;
The tumour stains as follows: &lt;br /&gt;
POSITIVE: PAX8 (strong, diffuse), CK7 (strong, diffuse), MA903 (strong, diffuse), CAIX (moderate, patchy cup-like), AE1/AE3 (moderate, diffuse), GATA3 (moderate, diffuse).&lt;br /&gt;
NEGATIVE: CD10, AMACR.&lt;br /&gt;
&lt;br /&gt;
The findings are in keeping with clear cell papillary renal cell tumour. These tumours were previously called &amp;quot;clear cell papillary renal cell carcinoma&amp;quot;.[1]&lt;br /&gt;
&lt;br /&gt;
These tumours have a highly favourable clinical behaviour.[2,3] &lt;br /&gt;
&lt;br /&gt;
1. Pathologica. 2022 Feb;115(1):8-22. doi: 10.32074/1591-951X-818. https://pmc.ncbi.nlm.nih.gov/articles/PMC10342217/&lt;br /&gt;
2. Am J Surg Pathol. 2015 Dec;39(12):1621-34. DOI: 10.1097/PAS.0000000000000513&lt;br /&gt;
3. Pathology. 2020 Nov 19;S0031-3025(20)30957-0. DOI: 10.1016/j.pathol.2020.10.002&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Biopsy===&lt;br /&gt;
Diagnosing the this entity on biopsy should be done with caution as:&lt;br /&gt;
*Overlaps are described between ''clear cell renal cell carcinoma'' and ''clear cell papillary renal cell tumour''.&amp;lt;ref name=pmid26752401&amp;gt;{{cite journal |vauthors=Dhakal HP, McKenney JK, Khor LY, Reynolds JP, Magi-Galluzzi C, Przybycin CG |title=Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution |journal=Am J Surg Pathol |volume=40 |issue=2 |pages=141–54 |date=February 2016 |pmid=26752401 |doi=10.1097/PAS.0000000000000583 |url=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
*''Clear cell papillary renal cell tumour'' may also be seen in conjunction with (other) renal cell carcinoma(s).&amp;lt;ref name=pmid26857533&amp;gt;{{cite journal |authors=Shao T, Yousef P, Shipilova I, Saleeb R, Lee JY, Krizova A |title=Clear cell papillary renal cell carcinoma as part of histologically discordant multifocal renal cell carcinoma: A case report and review of literature |journal=Pathol Res Pract |volume=212 |issue=3 |pages=229–33 |date=March 2016 |pmid=26857533 |doi=10.1016/j.prp.2015.12.007 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Kidney tumours]].&lt;br /&gt;
*[[Tubulocystic carcinoma of the kidney]].&lt;br /&gt;
*[[ELOC-mutated renal cell carcinoma]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Kidney tumours]]&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Nodular_hyperplasia_of_the_prostate_gland&amp;diff=53801</id>
		<title>Nodular hyperplasia of the prostate gland</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Nodular_hyperplasia_of_the_prostate_gland&amp;diff=53801"/>
		<updated>2026-05-29T12:42:57Z</updated>

		<summary type="html">&lt;p&gt;Michael: touch&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}} &lt;br /&gt;
| Image      = Nodular_hyperplasia_of_the_prostate.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Nodular hyperplasia of the prostate gland. [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   = benign prostatic hyperplasia, benign prostatic hypertrophy (misnomer)&lt;br /&gt;
| Micro      = stromal and/or glandular hyperplasia&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[smooth muscle tumour of uncertain malignant potential]], subtle [[prostate carcinoma]]&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      = enlarged prostate gland, nodularity&lt;br /&gt;
| Grossing   = [[prostate chips]], [[radical prostatectomy]]&lt;br /&gt;
| Site       = [[prostate gland]]&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx = old man&lt;br /&gt;
| Signs      = hematuria, weak urine stream, incomplete urinary emptying, post-void dribbling, prolonged voiding, intermittency, hesitancy&lt;br /&gt;
| Symptoms   = increased frequency of urination, straining&lt;br /&gt;
| Prevalence = very common, esp. elderly&lt;br /&gt;
| Bloodwork  = +/-elevation of PSA (mild)&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = benign &lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = other causes of hematuria ([[urothelial carcinoma]], [[renal cell carcinoma]], cystitis), other causes of obstruction ([[prostate carcinoma]], [[urothelial carcinoma]])&lt;br /&gt;
| Tx         = medical, [[TURP]], others&lt;br /&gt;
}}&lt;br /&gt;
'''Nodular hyperplasia of the prostate gland''', also '''benign prostatic hyperplasia''' (abbreviated '''BPH'''), is a common benign pathology of the [[prostate gland]].&lt;br /&gt;
&lt;br /&gt;
It is also known as '''prostatic nodular hyperplasia'''. Occasionally, it is referred to as&lt;br /&gt;
'''benign prostatic hypertrophy'''; this is a [[misnomer]]. This pathology is ''not'' a hypertrophy.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Very common.&lt;br /&gt;
*Incidence increases with age.&lt;br /&gt;
&lt;br /&gt;
Clinical - mnemonic ''I WISH 2p'':&amp;lt;ref&amp;gt;{{Ref TN2006| U5}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Intermittency.&lt;br /&gt;
*Weak stream.&lt;br /&gt;
*Incomplete emptying.&lt;br /&gt;
*Straining.&lt;br /&gt;
*Hesitancy.&lt;br /&gt;
*Post-void dribbling.&lt;br /&gt;
*Prolonged voiding.&lt;br /&gt;
&lt;br /&gt;
Others:&lt;br /&gt;
*Hematuria - common.&amp;lt;ref name=pmid24364522&amp;gt;{{Cite journal  | last1 = Sharp | first1 = VJ. | last2 = Barnes | first2 = KT. | last3 = Erickson | first3 = BA. | title = Assessment of asymptomatic microscopic hematuria in adults. | journal = Am Fam Physician | volume = 88 | issue = 11 | pages = 747-54 | month = Dec | year = 2013 | doi =  | PMID = 24364522 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment:&lt;br /&gt;
*Medications.&lt;br /&gt;
*Transurethral resection of the prostate (TURP).&lt;br /&gt;
*[[Rezum]].&amp;lt;ref&amp;gt;{{cite journal |authors=Westwood J, Geraghty R, Jones P, Rai BP, Somani BK |title=Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia |journal=Ther Adv Urol |volume=10 |issue=11 |pages=327–333 |date=November 2018 |pmid=30344644 |pmc=6180381 |doi=10.1177/1756287218793084 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Laser treatment ([[GreenLight]]).&amp;lt;ref name=pmid31617419&amp;gt;{{cite journal |authors=Campobasso D, Marchioni M, Altieri V, Greco F, De Nunzio C, Destefanis P, Ricciardulli S, Bergamaschi F, Fasolis G, Varvello F, Voce S, Palmieri F, Divan C, Malossini G, Oriti R, Tuccio A, Ruggera L, Tubaro A, Delicato G, Laganà A, Dadone C, De Rienzo G, Frattini A, Pucci L, Carrino M, Montefiore F, Germani S, Miano R, Schips L, Rabito S, Ferrari G, Cindolo L |title=GreenLight Photoselective Vaporization of the Prostate: One Laser for Different Prostate Sizes |journal=J Endourol |volume=34 |issue=1 |pages=54–62 |date=January 2020 |pmid=31617419 |doi=10.1089/end.2019.0478 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Enlargement of the prostate.&lt;br /&gt;
*Nodularity of the prostate.&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&lt;br /&gt;
*Stromal and/or glandular hyperplasia.&lt;br /&gt;
**Stromal component has small blood vessels.&lt;br /&gt;
&lt;br /&gt;
Notes:&lt;br /&gt;
*Should '''not''' be diagnosed on core biopsy!&lt;br /&gt;
*One series suggests clinically relevant prostate cancer is seen in ~1.5% of resections for BPH.&amp;lt;ref&amp;gt;{{Cite journal  | last1 = Skrzypczyk | first1 = MA. | last2 = Dobruch | first2 = J. | last3 = Nyk | first3 = L. | last4 = Szostek | first4 = P. | last5 = Szempliński | first5 = S. | last6 = Borówka | first6 = A. | title = Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist? | journal = Cent European J Urol | volume = 67 | issue = 3 | pages = 227-32 | month =  | year = 2014 | doi = 10.5173/ceju.2014.03.art2 | PMID = 25247076 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Urothelial carcinoma]] - significant nuclear atypia.&lt;br /&gt;
*[[Prostate carcinoma]] - especially low-grade.&lt;br /&gt;
*[[Prostatic stromal tumour of uncertain malignant potential]] - lacks small vessels.&amp;lt;ref name=pmid17170745&amp;gt;{{Cite journal  | last1 = Hansel | first1 = DE. | last2 = Herawi | first2 = M. | last3 = Montgomery | first3 = E. | last4 = Epstein | first4 = JI. | title = Spindle cell lesions of the adult prostate. | journal = Mod Pathol | volume = 20 | issue = 1 | pages = 148-58 | month = Jan | year = 2007 | doi = 10.1038/modpathol.3800676 | PMID = 17170745 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Nodular_hyperplasia_of_the_prostate.jpg | Prostatic nodular hyperplasia. (WC/Nephron)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
===Urothelium present===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
Prostate Tissue, Transurethral Resection of Prostate (TURP):&lt;br /&gt;
	- Benign prostatic tissue with glandular and stromal proliferation.&lt;br /&gt;
	- Benign urothelial mucosa with inflammation.&lt;br /&gt;
	- NEGATIVE for malignancy.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
Prostate Tissue, Transurethral Resection of Prostate (TURP):&lt;br /&gt;
- Benign prostatic tissue.&lt;br /&gt;
- Benign urothelial mucosa with mild inflammation and calcification.&lt;br /&gt;
- NEGATIVE for malignancy.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Block letters====&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
PROSTATE TISSUE, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP):&lt;br /&gt;
- BENIGN PROSTATIC TISSUE WITH GLANDULAR AND STROMAL PROLIFERATION.&lt;br /&gt;
- UROTHELIAL MUCOSA WITH A MILD LYMPHOCYTIC INFILTRATE.&lt;br /&gt;
- NEGATIVE FOR MALIGNANCY.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
PROSTATE TISSUE, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) AND URINARY BLADDER NECK:&lt;br /&gt;
- BENIGN PROSTATIC TISSUE WITH GLANDULAR AND STROMAL PROLIFERATION.&lt;br /&gt;
- UROTHELIUM WITH THE CHANGES OF CYSTITIS CYSTICA ET GLANDULARIS.&lt;br /&gt;
- NEGATIVE FOR MALIGNANCY.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
PROSTATE TISSUE, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) AND URINARY BLADDER NECK:&lt;br /&gt;
- BENIGN PROSTATIC TISSUE WITH GLANDULAR AND STROMAL PROLIFERATION, AND FOCAL &lt;br /&gt;
  ACUTE AND CHRONIC INFLAMMATION.&lt;br /&gt;
- UROTHELIUM WITH THE CHANGES OF CYSTITIS CYSTICA ET GLANDULARIS.&lt;br /&gt;
- NEGATIVE FOR MALIGNANCY.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===No urothelium present===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
PROSTATE GLAND, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP):&lt;br /&gt;
- BENIGN PROSTATIC TISSUE WITH GLANDULAR AND STROMAL PROLIFERATION.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Post-TURP granuloma present===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
PROSTATE TISSUE, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP):&lt;br /&gt;
- BENIGN PROSTATIC TISSUE WITH GLANDULAR AND STROMAL PROLIFERATION WITH &lt;br /&gt;
PROMINENT BLOOD VESSELS AND SQUAMOUS METAPLASIA.&lt;br /&gt;
- PALISADING GRANULOMA WITH NECROTIC CORE, SEE COMMENT.&lt;br /&gt;
- UROTHELIAL MUCOSA WITH A MILD INFLAMMATORY INFILTRATE.&lt;br /&gt;
- NEGATIVE FOR MALIGNANCY.&lt;br /&gt;
&lt;br /&gt;
COMMENT:&lt;br /&gt;
This is morphologically consistent with a post-TURP granuloma.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Prostate gland]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Prostate gland]]&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Collecting_duct_carcinoma&amp;diff=53800</id>
		<title>Collecting duct carcinoma</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Collecting_duct_carcinoma&amp;diff=53800"/>
		<updated>2026-05-28T19:22:40Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}} &lt;br /&gt;
| Image      = Collecting duct carcinoma - 2 WBAL.tif&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Collecting duct carcinoma. (WC/George Netto)&lt;br /&gt;
| Micro      = tubular structures with tapered ends, [[hobnail pattern]], nuclear pleomorphism), high mitotic rate&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[papillary renal cell carcinoma]], [[urothelial carcinoma]] (with glandular differentiation), metastatic [[adenocarcinoma]], [[renal medullary carcinoma]], [[ALK-rearranged renal cell carcinoma]]&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        = CD117 +ve, CK7 +ve, PAX8 +ve, CD10 -ve, AMACR -ve, p63 -ve&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      = medullary tumour&lt;br /&gt;
| Grossing   = [[total nephrectomy for tumour grossing]], [[partial nephrectomy grossing]]&lt;br /&gt;
| Staging    = [[kidney cancer staging]]&lt;br /&gt;
| Site       = [[kidney]] - see [[kidney tumours]]&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = very rare&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = poor&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = other [[renal tumours]]&lt;br /&gt;
}}&lt;br /&gt;
'''Collecting duct carcinoma''', also known as '''Bellini duct carcinoma'''&amp;lt;ref name=pmid21393935&amp;gt;{{Cite journal  | last1 = Stamatiou | first1 = K. | last2 = Zizi-Sermpetzoglou | first2 = A. | title = Bellini duct carcinoma accidentally found upon investigation of uric acid lithiasis. | journal = Indian J Pathol Microbiol | volume = 54 | issue = 1 | pages = 229-30 | month =  | year =  | doi = 10.4103/0377-4929.77425 | PMID = 21393935 }}&amp;lt;/ref&amp;gt; and '''carcinoma of the collecting ducts of Bellini''', is a rare aggressive [[kidney tumour]].&lt;br /&gt;
&lt;br /&gt;
It should '''not''' be confused with [[tubulocystic carcinoma of the kidney]] (also known as ''low-grade collecting duct carcinoma'').&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Rare.&lt;br /&gt;
*Poor prognosis.&lt;br /&gt;
*Usually central location.&lt;br /&gt;
*Typically young adults.&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Medullary location - as opposed to cortical.&amp;lt;ref&amp;gt;{{Cite journal  | last1 = López | first1 = JI. | last2 = Larrinaga | first2 = G. | last3 = Kuroda | first3 = N. | last4 = Angulo | first4 = JC. | title = The normal and pathologic renal medulla: a comprehensive overview. | journal = Pathol Res Pract | volume = 211 | issue = 4 | pages = 271-80 | month = Apr | year = 2015 | doi = 10.1016/j.prp.2014.12.009 | PMID = 25595996 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&amp;lt;ref name=Ref_GUP295&amp;gt;{{Ref GUP|295}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Tubular structures with tapered ends.&lt;br /&gt;
**May be described as ''tubulopapillary''.&lt;br /&gt;
*[[Hobnail pattern]] - cell width smaller at basement membrane than free surface.&amp;lt;ref name=Ref_PBoD1018&amp;gt;{{Ref PBoD|1018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*High grade nuclear features (nuclear pleomorphism).&lt;br /&gt;
*High mitotic rate.&lt;br /&gt;
&lt;br /&gt;
Notes:&lt;br /&gt;
*Benign urothelium must present to excluded urothelial carcinoma.&lt;br /&gt;
*Desmoplastic stroma may be prominent.&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Papillary renal cell carcinoma]].&lt;br /&gt;
*[[Urothelial carcinoma]] with glandular differentiation.&lt;br /&gt;
*Metastatic [[adenocarcinoma]].&lt;br /&gt;
*[[Renal medullary carcinoma]] - typically younger, sickle cell trait.&lt;br /&gt;
*[[Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma]].&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Collecting duct carcinoma - 1 WBAL.tif | CDC - 1 (WC/Netto)&lt;br /&gt;
Image: Collecting duct carcinoma - 2 WBAL.tif | CDC - 2 (WC/Netto)&lt;br /&gt;
Image: Collecting duct carcinoma - 5 WBAL.tif | CDC - 5 (WC/Netto)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
====www====&lt;br /&gt;
*[http://images.rsna.org/index.html?doi=10.1148/rg.266065010&amp;amp;fig=F17 CDC (rsna.org)].&amp;lt;ref name=pmid17102051&amp;gt;{{Cite journal  | last1 = Prasad | first1 = SR. | last2 = Humphrey | first2 = PA. | last3 = Catena | first3 = JR. | last4 = Narra | first4 = VR. | last5 = Srigley | first5 = JR. | last6 = Cortez | first6 = AD. | last7 = Dalrymple | first7 = NC. | last8 = Chintapalli | first8 = KN. | title = Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. | journal = Radiographics | volume = 26 | issue = 6 | pages = 1795-806; discussion 1806-10 | month =  | year =  | doi = 10.1148/rg.266065010 | PMID = 17102051 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==IHC==&lt;br /&gt;
Features:&amp;lt;ref name=pmid19494850&amp;gt;{{Cite journal  | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | title = Uncommon and recently described renal carcinomas. | journal = Mod Pathol | volume = 22 Suppl 2 | issue =  | pages = S2-S23 | month = Jun | year = 2009 | doi = 10.1038/modpathol.2009.70 | PMID = 19494850 | URL = http://www.nature.com/modpathol/journal/v22/n2s/full/modpathol200970a.html }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*HMWCK +ve.&lt;br /&gt;
*LMWCK +ve.&lt;br /&gt;
*CD117 +ve.&lt;br /&gt;
*E-cadherin +ve.&lt;br /&gt;
*CD10 -ve.&lt;br /&gt;
*AMACR -ve.&lt;br /&gt;
*[[PAX8]] +ve.&amp;lt;ref name=pmid20463571&amp;gt;{{Cite journal  | last1 = Albadine | first1 = R. | last2 = Schultz | first2 = L. | last3 = Illei | first3 = P. | last4 = Ertoy | first4 = D. | last5 = Hicks | first5 = J. | last6 = Sharma | first6 = R. | last7 = Epstein | first7 = JI. | last8 = Netto | first8 = GJ. | title = PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. | journal = Am J Surg Pathol | volume = 34 | issue = 7 | pages = 965-9 | month = Jul | year = 2010 | doi = 10.1097/PAS.0b013e3181dc5e8a | PMID = 20463571 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
UCC:&lt;br /&gt;
*CK20 +ve.&amp;lt;ref name=pmid19494850/&amp;gt;&lt;br /&gt;
*p63 +ve.&amp;lt;ref name=pmid20463571&amp;gt;{{Cite journal  | last1 = Albadine | first1 = R. | last2 = Schultz | first2 = L. | last3 = Illei | first3 = P. | last4 = Ertoy | first4 = D. | last5 = Hicks | first5 = J. | last6 = Sharma | first6 = R. | last7 = Epstein | first7 = JI. | last8 = Netto | first8 = GJ. | title = PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. | journal = Am J Surg Pathol | volume = 34 | issue = 7 | pages = 965-9 | month = Jul | year = 2010 | doi = 10.1097/PAS.0b013e3181dc5e8a | PMID = 20463571 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*CK5/6 +ve.&lt;br /&gt;
*PAX8 -ve.&amp;lt;ref name=pmid20463571/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Others:&lt;br /&gt;
*CK7 +ve.&amp;lt;ref name=pmid12613443&amp;gt;{{Cite journal  | last1 = Kim | first1 = MK. | last2 = Kim | first2 = S. | title = Immunohistochemical profile of common epithelial neoplasms arising in the kidney. | journal = Appl Immunohistochem Mol Morphol | volume = 10 | issue = 4 | pages = 332-8 | month = Dec | year = 2002 | doi =  | PMID = 12613443 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*UEA-1 +ve.&lt;br /&gt;
**-ve in [[HLRCC]].&amp;lt;ref name=pmid17895761&amp;gt;{{Cite journal  | last1 = Merino | first1 = MJ. | last2 = Torres-Cabala | first2 = C. | last3 = Pinto | first3 = P. | last4 = Linehan | first4 = WM. | title = The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. | journal = Am J Surg Pathol | volume = 31 | issue = 10 | pages = 1578-85 | month = Oct | year = 2007 | doi = 10.1097/PAS.0b013e31804375b8 | PMID = 17895761 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Kidney tumours]].&lt;br /&gt;
*[[Tubulocystic carcinoma of the kidney]] (low-grade collecting duct carcinoma).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;br /&gt;
[[Category:Kidney tumours]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53799</id>
		<title>Undescended testis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53799"/>
		<updated>2026-05-28T15:37:14Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Undescended testis''', also '''cryptorchidism''', is when the [[testis]] fails to descend into the [[scrotum]] - from it embryological origin in the abdomen.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Right more common than left.&lt;br /&gt;
**In a larger series: 218 on left side, 459 right side and 96 bilateral.&amp;lt;ref&amp;gt;{{cite journal |authors=You J, Li G, Chen H, Wang J, Li S |title=Laparoscopic orchiopexy of palpable undescended testes_ experience of a single tertiary institution with over 773 cases |journal=BMC Pediatr |volume=20 |issue=1 |pages=124 |date=March 2020 |pmid=32178653 |pmc=7075009 |doi=10.1186/s12887-020-2021-6 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Four patterns are described by Nistal ''et al.'':&amp;lt;ref&amp;gt;{{cite journal |authors=Nistal M, Paniagua R, Díez-Pardo JA |title=Histologic classification of undescended testes |journal=Hum Pathol |volume=11 |issue=6 |pages=666–74 |date=November 1980 |pmid=6108912 |doi=10.1016/s0046-8177(80)80078-5 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Type I cases testes with minimal lesions.&lt;br /&gt;
*Type II cases marked germinal hypoplasia as well as slight or marked tubular hypoplasia.&lt;br /&gt;
*Type III cases diffuse tubular hypoplasia.&lt;br /&gt;
*Type IV diffuse Sertoli cell hyperplasia.&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Germ cell neoplasia in situ]].&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
A. Right Testis, Orchiectomy:&lt;br /&gt;
	- Benign testis with germ cell hypoplasia, absent Leydig cells and absent spermatogenesis.&lt;br /&gt;
	- Unremarkable epididymis.&lt;br /&gt;
	- NEGATIVE for germ cell neoplasia.&lt;br /&gt;
&lt;br /&gt;
Comment:&lt;br /&gt;
The findings are compatible with an undescended testis.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testicular atrophy]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53798</id>
		<title>Undescended testis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53798"/>
		<updated>2026-05-28T15:36:42Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Sign out */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Undescended testis''', also '''cryptorchidism''', is when the [[testis]] fails to descend into the [[scrotum]] - from it embryological origin in the abdomen.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Right more common than left.&lt;br /&gt;
**In a larger series: 218 on left side, 459 right side and 96 bilateral.&amp;lt;ref&amp;gt;{{cite journal |authors=You J, Li G, Chen H, Wang J, Li S |title=Laparoscopic orchiopexy of palpable undescended testes_ experience of a single tertiary institution with over 773 cases |journal=BMC Pediatr |volume=20 |issue=1 |pages=124 |date=March 2020 |pmid=32178653 |pmc=7075009 |doi=10.1186/s12887-020-2021-6 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Four patterns are described by Nistal ''et al.'':&amp;lt;ref&amp;gt;{{cite journal |authors=Nistal M, Paniagua R, Díez-Pardo JA |title=Histologic classification of undescended testes |journal=Hum Pathol |volume=11 |issue=6 |pages=666–74 |date=November 1980 |pmid=6108912 |doi=10.1016/s0046-8177(80)80078-5 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Type I cases testes with minimal lesions.&lt;br /&gt;
*Type II cases marked germinal hypoplasia as well as slight or marked tubular hypoplasia.&lt;br /&gt;
*Type III cases diffuse tubular hypoplasia.&lt;br /&gt;
*Type IV diffuse Sertoli cell hyperplasia.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
A. Right Testis, Orchiectomy:&lt;br /&gt;
	- Benign testis with germ cell hypoplasia, absent Leydig cells and absent spermatogenesis.&lt;br /&gt;
	- Unremarkable epididymis.&lt;br /&gt;
	- NEGATIVE for germ cell neoplasia.&lt;br /&gt;
&lt;br /&gt;
Comment:&lt;br /&gt;
The findings are compatible with an undescended testis.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testicular atrophy]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53797</id>
		<title>Undescended testis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53797"/>
		<updated>2026-05-28T15:34:22Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Undescended testis''', also '''cryptorchidism''', is when the [[testis]] fails to descend into the [[scrotum]] - from it embryological origin in the abdomen.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Right more common than left.&lt;br /&gt;
**In a larger series: 218 on left side, 459 right side and 96 bilateral.&amp;lt;ref&amp;gt;{{cite journal |authors=You J, Li G, Chen H, Wang J, Li S |title=Laparoscopic orchiopexy of palpable undescended testes_ experience of a single tertiary institution with over 773 cases |journal=BMC Pediatr |volume=20 |issue=1 |pages=124 |date=March 2020 |pmid=32178653 |pmc=7075009 |doi=10.1186/s12887-020-2021-6 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Four patterns are described by Nistal ''et al.'':&amp;lt;ref&amp;gt;{{cite journal |authors=Nistal M, Paniagua R, Díez-Pardo JA |title=Histologic classification of undescended testes |journal=Hum Pathol |volume=11 |issue=6 |pages=666–74 |date=November 1980 |pmid=6108912 |doi=10.1016/s0046-8177(80)80078-5 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Type I cases testes with minimal lesions.&lt;br /&gt;
*Type II cases marked germinal hypoplasia as well as slight or marked tubular hypoplasia.&lt;br /&gt;
*Type III cases diffuse tubular hypoplasia.&lt;br /&gt;
*Type IV diffuse Sertoli cell hyperplasia.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
A. Right Testis, Orchiectomy:&lt;br /&gt;
	- Benign testis with germ cell hypoplasia, absent Leydig cells and absent spermatogenesis.&lt;br /&gt;
	- Unremarkable epididymis.&lt;br /&gt;
	- NEGATIVE for germ cell neoplasia.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testicular atrophy]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53796</id>
		<title>Undescended testis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53796"/>
		<updated>2026-05-28T15:24:02Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Undescended testis''', also '''cryptorchidism''', is when the [[testis]] fails to descend into the [[scrotum]] - from it embryological origin in the abdomen.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Right more common than left.&lt;br /&gt;
**In a larger series: 218 on left side, 459 right side and 96 bilateral.&amp;lt;ref&amp;gt;{{cite journal |authors=You J, Li G, Chen H, Wang J, Li S |title=Laparoscopic orchiopexy of palpable undescended testes_ experience of a single tertiary institution with over 773 cases |journal=BMC Pediatr |volume=20 |issue=1 |pages=124 |date=March 2020 |pmid=32178653 |pmc=7075009 |doi=10.1186/s12887-020-2021-6 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Four patterns are described by Nistal ''et al.'':&amp;lt;ref&amp;gt;{{cite journal |authors=Nistal M, Paniagua R, Díez-Pardo JA |title=Histologic classification of undescended testes |journal=Hum Pathol |volume=11 |issue=6 |pages=666–74 |date=November 1980 |pmid=6108912 |doi=10.1016/s0046-8177(80)80078-5 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Type I cases testes with minimal lesions.&lt;br /&gt;
*Type II cases marked germinal hypoplasia as well as slight or marked tubular hypoplasia.&lt;br /&gt;
*Type III cases diffuse tubular hypoplasia.&lt;br /&gt;
*Type IV diffuse Sertoli cell hyperplasia.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testicular atrophy]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53795</id>
		<title>Undescended testis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53795"/>
		<updated>2026-05-28T15:23:43Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Undescended testis''', also '''cryptorchidism''', is when the [[testis]] fails to descend into the [[scrotum]] - from it embryological origin in the abdomen.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Right more common than left.&lt;br /&gt;
**In a larger series: 218 on left side, 459 right side and 96 bilateral.&amp;lt;ref&amp;gt;{{cite journal |authors=You J, Li G, Chen H, Wang J, Li S |title=Laparoscopic orchiopexy of palpable undescended testes_ experience of a single tertiary institution with over 773 cases |journal=BMC Pediatr |volume=20 |issue=1 |pages=124 |date=March 2020 |pmid=32178653 |pmc=7075009 |doi=10.1186/s12887-020-2021-6 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Four patterns are described by Nistal ''et al.'':&amp;lt;ref&amp;gt;{{cite journal |authors=Nistal M, Paniagua R, Díez-Pardo JA |title=Histologic classification of undescended testes |journal=Hum Pathol |volume=11 |issue=6 |pages=666–74 |date=November 1980 |pmid=6108912 |doi=10.1016/s0046-8177(80)80078-5 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Type I cases testes with minimal lesions.&lt;br /&gt;
*Type II cases marked germinal hypoplasia as well as slight or marked tubular hypoplasia.&lt;br /&gt;
*Type III cases diffuse tubular hypoplasia.&lt;br /&gt;
*Type IV diffuse Sertoli cell hyperplasia.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testicular atrophy]].&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53794</id>
		<title>Undescended testis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53794"/>
		<updated>2026-05-28T15:14:11Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Undescended testis''', also '''cryptorchidism''', is when the [[testis]] fails to descend into the [[scrotum]] - from it embryological origin in the abdomen.&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Four patterns are described by Nistal ''et al.'':&amp;lt;ref&amp;gt;{{cite journal |authors=Nistal M, Paniagua R, Díez-Pardo JA |title=Histologic classification of undescended testes |journal=Hum Pathol |volume=11 |issue=6 |pages=666–74 |date=November 1980 |pmid=6108912 |doi=10.1016/s0046-8177(80)80078-5 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Type I cases testes with minimal lesions.&lt;br /&gt;
*Type II cases marked germinal hypoplasia as well as slight or marked tubular hypoplasia.&lt;br /&gt;
*Type III cases diffuse tubular hypoplasia.&lt;br /&gt;
*Type IV diffuse Sertoli cell hyperplasia.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testicular atrophy]].&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Testicular_atrophy&amp;diff=53793</id>
		<title>Testicular atrophy</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Testicular_atrophy&amp;diff=53793"/>
		<updated>2026-05-28T15:07:47Z</updated>

		<summary type="html">&lt;p&gt;Michael: touch&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}} &lt;br /&gt;
| Image      = Atrophic changes of the testis - alt -- high mag.jpg &lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Atrophic changes of the testis (bottom). [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   = atrophic testis, atrophy of the testis &lt;br /&gt;
| Micro      = thickening of seminiferous tubule basement membrane, decreased sperm/no sperm present, +/-intertubular fibrosis &lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[sertoli cell nodule]], [[testicular scar]], [[germ cell neoplasia in situ]], [[seminoma]] - esp. intertubular &lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = [[testis]]&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx = +/-[[undescended testis]] (cryptorchidism)&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = not common&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = benign&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = &lt;br /&gt;
| Tx         = long standing cryptorchidism - removal &lt;br /&gt;
}}&lt;br /&gt;
'''Testicular atrophy''' is relatively common change seen in undescended [[testes]]. It is also known as '''atrophic testis''' and '''atrophy of the testis'''.&lt;br /&gt;
&lt;br /&gt;
'''Cryptorchidism''' redirects here.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Microscopic appearance identical to ''cryptorchidism'' (undescended testis).&amp;lt;ref name=Ref_PCPBoD8_506-7&amp;gt;{{Ref PCPBoD8|506-7}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Decreased size.&amp;lt;ref&amp;gt;{{cite journal |author=Zvizdic Z, Milisic E, Halimic A, Zvizdic D, Zubovic SV |title=Testicular volume and testicular atrophy index as predictors of functionality of unilaterally cryptorchid testis |journal=Med Arch |volume=68 |issue=2 |pages=79–82 |year=2014 |pmid=24937926 |doi= |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&amp;lt;ref name=Ref_PCPBoD8_506-7&amp;gt;{{Ref PCPBoD8|506-7}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Thickening of seminiferous tubule basement membrane.&lt;br /&gt;
*Intertubular fibrosis.&lt;br /&gt;
*Decreased sperm/no sperm present.&lt;br /&gt;
&lt;br /&gt;
Notes:&lt;br /&gt;
*End-stage testicle - only has Sertoli cell within the seminiferous tubules.&lt;br /&gt;
*Sertoli cells may have a cytoplasm with eosinophilic granules (lysosomes). This is a nonspecific finding described in several contexts.&amp;lt;ref name=pmid1672120&amp;gt;{{Cite journal  | last1 = Nistal | first1 = M. | last2 = Garcia-Rodeja | first2 = E. | last3 = Paniagua | first3 = R. | title = Granular transformation of Sertoli cells in testicular disorders. | journal = Hum Pathol | volume = 22 | issue = 2 | pages = 131-7 | month = Feb | year = 1991 | doi =  | PMID = 1672120 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Sertoli cell nodule]].&lt;br /&gt;
*[[Testicular scar]].&lt;br /&gt;
*[[Germ cell neoplasia in situ]] (intratubular germ cell neoplasia).&lt;br /&gt;
*[[Seminoma]] - especially where intertubular growth is predominant.&amp;lt;ref name=pmid15316315&amp;gt;{{Cite journal  | last1 = Henley | first1 = JD. | last2 = Young | first2 = RH. | last3 = Wade | first3 = CL. | last4 = Ulbright | first4 = TM. | title = Seminomas with exclusive intertubular growth: a report of 12 clinically and grossly inconspicuous tumors. | journal = Am J Surg Pathol | volume = 28 | issue = 9 | pages = 1163-8 | month = Sep | year = 2004 | doi =  | PMID = 15316315 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Atrophic changes of the testis -- intermed mag.jpg | Atrophic changes (left) - intermed. mag.&lt;br /&gt;
Image: Atrophic changes of the testis -- high mag.jpg | Atrophic changes (left) - high mag.&lt;br /&gt;
Image: Atrophic changes of the testis - alt -- high mag.jpg | Atrophic changes (bottom) - high mag.&lt;br /&gt;
Image: Testis -- very high mag.jpg | Testis - very high mag.&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
www:&lt;br /&gt;
*[http://www.surgicalpathologyatlas.com/glfusion/mediagallery/media.php?f=0&amp;amp;sort=0&amp;amp;s=20080802171227609 Testicular atrophy (surgicalpathologyatlas.com)].&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
TESTICLE, RIGHT, ORCHIECTOMY:&lt;br /&gt;
- ATROPHIC TESTICLE.&lt;br /&gt;
- NEGATIVE FOR GERM CELL NEOPLASIA IN SITU (INTRATUBULAR GERM CELL NEOPLASIA).&lt;br /&gt;
- NEGATIVE FOR MALIGNANCY.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Micro===&lt;br /&gt;
The sections show seminiferous tubules surrounded by thick hyaline sleeves.  In a large number of sections only Sertoli cells are found in the tubules.  &lt;br /&gt;
&lt;br /&gt;
In some sections poorly defined paucicellular tubular structures reminiscent of seminiferous tubules composed of hyaline material are present; these probably represent obsolete seminiferous tubules.  Focally, fibrosis is seen without definite tumour outlines.  There is no significant inflammation.  The rete testis is identified.&lt;br /&gt;
&lt;br /&gt;
Rare seminiferous tubules have spermatid within. The germ cells seen do not have appreciable nuclear atypia.&lt;br /&gt;
&lt;br /&gt;
Small Leydig cell clusters are seen in some sections.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testis]].&lt;br /&gt;
*[[Pick's adenoma]] (Sertoli cell nodule).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;br /&gt;
[[Category:Testis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53792</id>
		<title>Undescended testis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Undescended_testis&amp;diff=53792"/>
		<updated>2026-05-28T15:07:31Z</updated>

		<summary type="html">&lt;p&gt;Michael: Created page with &amp;quot;'''Undescended testis''', also '''cryptorchidism''', is when the testis fails to descend into the scrotum - from it embryological origin in the abdomen.   ==See also==...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Undescended testis''', also '''cryptorchidism''', is when the [[testis]] fails to descend into the [[scrotum]] - from it embryological origin in the abdomen.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testicular atrophy]].&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Testicular_atrophy&amp;diff=53791</id>
		<title>Testicular atrophy</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Testicular_atrophy&amp;diff=53791"/>
		<updated>2026-05-28T15:04:44Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Atrophic changes of the testis - alt -- high mag.jpg &lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Atrophic changes of the testis (bottom). [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   = atrophic testis, atrophy of the testis &lt;br /&gt;
| Micro      = thickening of seminiferous tubule basement membrane, decreased sperm/no sperm present, +/-intertubular fibrosis &lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[sertoli cell nodule]], [[testicular scar]], [[germ cell neoplasia in situ]], [[seminoma]] - esp. intertubular &lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = [[testis]]&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx = +/-[[undescended testis]] (cryptorchidism)&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = not common&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = benign&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = &lt;br /&gt;
| Tx         = long standing cryptorchidism - removal &lt;br /&gt;
}}&lt;br /&gt;
'''Testicular atrophy''' is relatively common change seen in undescended [[testes]]. It is also known as '''atrophic testis''' and '''atrophy of the testis'''.&lt;br /&gt;
&lt;br /&gt;
'''Cryptorchidism''' redirects here.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Microscopic appearance identical to ''cryptorchidism'' (undescended testis).&amp;lt;ref name=Ref_PCPBoD8_506-7&amp;gt;{{Ref PCPBoD8|506-7}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Decreased size.&amp;lt;ref&amp;gt;{{cite journal |author=Zvizdic Z, Milisic E, Halimic A, Zvizdic D, Zubovic SV |title=Testicular volume and testicular atrophy index as predictors of functionality of unilaterally cryptorchid testis |journal=Med Arch |volume=68 |issue=2 |pages=79–82 |year=2014 |pmid=24937926 |doi= |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&amp;lt;ref name=Ref_PCPBoD8_506-7&amp;gt;{{Ref PCPBoD8|506-7}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Thickening of seminiferous tubule basement membrane.&lt;br /&gt;
*Intertubular fibrosis.&lt;br /&gt;
*Decreased sperm/no sperm present.&lt;br /&gt;
&lt;br /&gt;
Notes:&lt;br /&gt;
*End-stage testicle - only has Sertoli cell within the seminiferous tubules.&lt;br /&gt;
*Sertoli cells may have a cytoplasm with eosinophilic granules (lysosomes). This is a nonspecific finding described in several contexts.&amp;lt;ref name=pmid1672120&amp;gt;{{Cite journal  | last1 = Nistal | first1 = M. | last2 = Garcia-Rodeja | first2 = E. | last3 = Paniagua | first3 = R. | title = Granular transformation of Sertoli cells in testicular disorders. | journal = Hum Pathol | volume = 22 | issue = 2 | pages = 131-7 | month = Feb | year = 1991 | doi =  | PMID = 1672120 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Sertoli cell nodule]].&lt;br /&gt;
*[[Testicular scar]].&lt;br /&gt;
*[[Germ cell neoplasia in situ]] (intratubular germ cell neoplasia).&lt;br /&gt;
*[[Seminoma]] - especially where intertubular growth is predominant.&amp;lt;ref name=pmid15316315&amp;gt;{{Cite journal  | last1 = Henley | first1 = JD. | last2 = Young | first2 = RH. | last3 = Wade | first3 = CL. | last4 = Ulbright | first4 = TM. | title = Seminomas with exclusive intertubular growth: a report of 12 clinically and grossly inconspicuous tumors. | journal = Am J Surg Pathol | volume = 28 | issue = 9 | pages = 1163-8 | month = Sep | year = 2004 | doi =  | PMID = 15316315 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Atrophic changes of the testis -- intermed mag.jpg | Atrophic changes (left) - intermed. mag.&lt;br /&gt;
Image: Atrophic changes of the testis -- high mag.jpg | Atrophic changes (left) - high mag.&lt;br /&gt;
Image: Atrophic changes of the testis - alt -- high mag.jpg | Atrophic changes (bottom) - high mag.&lt;br /&gt;
Image: Testis -- very high mag.jpg | Testis - very high mag.&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
www:&lt;br /&gt;
*[http://www.surgicalpathologyatlas.com/glfusion/mediagallery/media.php?f=0&amp;amp;sort=0&amp;amp;s=20080802171227609 Testicular atrophy (surgicalpathologyatlas.com)].&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
TESTICLE, RIGHT, ORCHIECTOMY:&lt;br /&gt;
- ATROPHIC TESTICLE.&lt;br /&gt;
- NEGATIVE FOR GERM CELL NEOPLASIA IN SITU (INTRATUBULAR GERM CELL NEOPLASIA).&lt;br /&gt;
- NEGATIVE FOR MALIGNANCY.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Micro===&lt;br /&gt;
The sections show seminiferous tubules surrounded by thick hyaline sleeves.  In a large number of sections only Sertoli cells are found in the tubules.  &lt;br /&gt;
&lt;br /&gt;
In some sections poorly defined paucicellular tubular structures reminiscent of seminiferous tubules composed of hyaline material are present; these probably represent obsolete seminiferous tubules.  Focally, fibrosis is seen without definite tumour outlines.  There is no significant inflammation.  The rete testis is identified.&lt;br /&gt;
&lt;br /&gt;
Rare seminiferous tubules have spermatid within. The germ cells seen do not have appreciable nuclear atypia.&lt;br /&gt;
&lt;br /&gt;
Small Leydig cell clusters are seen in some sections.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testis]].&lt;br /&gt;
*[[Pick's adenoma]] (Sertoli cell nodule).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;br /&gt;
[[Category:Testis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Sertoli_cell_nodule&amp;diff=53790</id>
		<title>Sertoli cell nodule</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Sertoli_cell_nodule&amp;diff=53790"/>
		<updated>2026-05-28T14:28:37Z</updated>

		<summary type="html">&lt;p&gt;Michael: wikify&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Sertoli_cell_nodule_high_mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Sertoli cell nodule. [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   = Pick's adenoma, testicular [[tubular adenoma]], tubular adenoma of the testis&lt;br /&gt;
| Micro      = unencapsulated nodules composed of well-formed tubules, +/eosinophilic (hyaline) blob in lumen (centre), cells - vaguely resemble immature Sertoli cells (bland hyperchromatic oval/round nuclei) but are stratified (somewhat like a [[tubular adenoma of the gastrointestinal tract]])&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[Sertoli cell tumour]], [[sex cord tumour with annular tubules]], [[gonadoblastoma]]&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        = alpha-inhibin +ve, PLAP -ve&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = [[testis]]&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx = +/- [[undescended testis]]&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = uncommon in general&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  =&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    =&lt;br /&gt;
| Tx         =&lt;br /&gt;
}}&lt;br /&gt;
'''Sertoli cell nodule''', abbreviated '''SCN''', is a benign lesion of the testis that is usually incidental.&lt;br /&gt;
&lt;br /&gt;
It is also known as '''Pick's adenoma''', '''testicular tubular adenoma''' and '''tubular adenoma of the testis'''.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Benign proliferation of Sertoli cells - associated with [[cryptorchidism]] (undescended testis).&lt;br /&gt;
*Not composed of a clonal cell population, i.e. ''not'' neoplastic; thus, technically, should not be called an ''adenoma''.&amp;lt;ref name=Ref_DCHH227&amp;gt;{{Ref DCHH|227}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Usually an incidental finding, rarely presents as a testicular mass.&amp;lt;ref name=pmid21107095&amp;gt;{{Cite journal  | last1 = Vallangeon | first1 = BD. | last2 = Eble | first2 = JN. | last3 = Ulbright | first3 = TM. | title = Macroscopic sertoli cell nodule: a study of 6 cases that presented as testicular masses. | journal = Am J Surg Pathol | volume = 34 | issue = 12 | pages = 1874-80 | month = Dec | year = 2010 | doi = 10.1097/PAS.0b013e3181fcab70 | PMID = 21107095 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&amp;lt;ref name=Ref_DCHH227&amp;gt;{{Ref DCHH|227}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{cite journal |author=Ricco R, Bufo P |title=[Histologic study of 3 cases of so-called tubular adenoma of the testis] |language=Italian |journal=Boll. Soc. Ital. Biol. Sper. |volume=56 |issue=20 |pages=2110–5 |year=1980 |month=October |pmid=6109541 |doi= |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Unencapsulated nodules composed of well-formed tubules.&lt;br /&gt;
**May contain eosinophilic (hyaline) blob in lumen (centre).&lt;br /&gt;
*Cells - vaguely resemble immature Sertoli cells:&lt;br /&gt;
**Bland hyperchromatic oval/round nuclei that are stratified - somewhat like a [[tubular adenoma of the gastrointestinal tract]] - '''key feature'''.&lt;br /&gt;
&lt;br /&gt;
DDx:&amp;lt;ref name=pmid21107095/&amp;gt;&lt;br /&gt;
*[[Sertoli cell tumour]].&lt;br /&gt;
*[[Sex cord tumour with annular tubules]].&lt;br /&gt;
*[[Gonadoblastoma]].&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Sertoli_cell_nodule_high_mag.jpg | Sertoli cell nodule - high mag. (WC)&lt;br /&gt;
Image:Sertoli_cell_nodule_low_mag.jpg | Sertoli cell nodule - low mag. (WC)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
==IHC==&lt;br /&gt;
Features:&amp;lt;ref name=pmid21107095/&amp;gt;&lt;br /&gt;
*Alpha-inhibin +ve (5/5 cases).&lt;br /&gt;
*OCT3/4 -ve (5/5 cases).&lt;br /&gt;
&lt;br /&gt;
Other:&lt;br /&gt;
*[[PLAP]] -ve.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
TESTICLE, LEFT, ORCHIECTOMY:&lt;br /&gt;
- ATROPHIC TESTICLE WITH SERTOLI CELL NODULES.&lt;br /&gt;
- NEGATIVE FOR GERM CELL NEOPLASIA IN SITU (INTRATUBULAR GERM CELL NEOPLASIA).&lt;br /&gt;
- NEGATIVE FOR MALIGNANCY.&lt;br /&gt;
&lt;br /&gt;
COMMENT:&lt;br /&gt;
The above findings are supported by immunostains. The tubules stain with alpha-inhibin and&lt;br /&gt;
are negative for PLAP. &lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testis]].&lt;br /&gt;
*[[Sertoli cell tumour]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Testis]]&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Eosinophilic,_solid_and_cystic_renal_cell_carcinoma&amp;diff=53789</id>
		<title>Eosinophilic, solid and cystic renal cell carcinoma</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Eosinophilic,_solid_and_cystic_renal_cell_carcinoma&amp;diff=53789"/>
		<updated>2026-05-19T02:06:39Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Eosinophilic, solid and cystic renal cell carcinoma -- low mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Eosinophilic, solid and cystic renal cell carcinoma. [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   =&lt;br /&gt;
| Micro      = epithelioid cells with abundant stippled eosinophilic cytoplasm +/- peripheral clearing, round nuclei with prominent [[nucleoli]], nested or solid architecture +/- cystic spaces with [[hobnail]] lining cells, +/-scattered histiocytes (common), +/-multi-nucleation (common), +/-small intracytoplasmic globules&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[chromophobe renal cell carcinoma]] (eosinophilic variant), [[clear cell renal cell carcinoma]], [[t(6;11) renal cell carcinoma]], other [[renal tumours with eosinophilic cytoplasm]]&lt;br /&gt;
| Stains     = &lt;br /&gt;
| IHC        = [[PAX8]] +ve, [[CK20]] +ve, [[CK7]] -ve, CA9 -ve, CD117 -ve, HMB-45 -ve&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  = [[Renal neoplasms with TSC/mTOR pathway mutations|TSC/mTOR pathway mutations]]&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      = solid and cystic&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = [[kidney]] - see ''[[kidney tumours]]''&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx = women only&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = rare&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = good - data limited&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = other [[kidney tumours]]&lt;br /&gt;
| Tx         =&lt;br /&gt;
}}&lt;br /&gt;
'''Eosinophilic, solid and cystic renal cell carcinoma''', abbreviated '''ESC-RCC''', is a maligant [[kidney tumour]].&amp;lt;ref name=pmid26414221&amp;gt;{{Cite journal  | last1 = Trpkov | first1 = K. | last2 = Hes | first2 = O. | last3 = Bonert | first3 = M. | last4 = Lopez | first4 = JI. | last5 = Bonsib | first5 = SM. | last6 = Nesi | first6 = G. | last7 = Comperat | first7 = E. | last8 = Sibony | first8 = M. | last9 = Berney | first9 = DM. | title = Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women. | journal = Am J Surg Pathol | volume =  | issue =  | pages =  | month = Sep | year = 2015 | doi = 10.1097/PAS.0000000000000508 | PMID = 26414221 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It is relatively new entity. It was added in the WHO 2022 classification of [[renal tumours|renal neoplasia]].&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Evolving entity.&lt;br /&gt;
*Similar to one of the three morphologic patterns of [[tuberous sclerosis-associated renal cell carcinoma]] described by Guo ''et al.''&amp;lt;ref name=pmid25093518&amp;gt;{{Cite journal  | last1 = Guo | first1 = J. | last2 = Tretiakova | first2 = MS. | last3 = Troxell | first3 = ML. | last4 = Osunkoya | first4 = AO. | last5 = Fadare | first5 = O. | last6 = Sangoi | first6 = AR. | last7 = Shen | first7 = SS. | last8 = Lopez-Beltran | first8 = A. | last9 = Mehra | first9 = R. | title = Tuberous Sclerosis-associated Renal Cell Carcinoma: A Clinicopathologic Study of 57 Separate Carcinomas in 18 Patients. | journal = Am J Surg Pathol | volume = 38 | issue = 11 | pages = 1457-67 | month = Nov | year = 2014 | doi = 10.1097/PAS.0000000000000248 | PMID = 25093518 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Women only - in the initial series.&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
Features:&amp;lt;ref name=pmid26414221/&amp;gt;&lt;br /&gt;
*Tan colour.&lt;br /&gt;
*Solid and usually cystic.&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&amp;lt;ref name=pmid26414221/&amp;gt;&lt;br /&gt;
*Epithelioid cells with abundant stippled eosinophilic cytoplasm +/- peripheral clearing.&lt;br /&gt;
*Round nuclei with one prominent [[nucleolus]].&lt;br /&gt;
*Nested or solid architecture +/- cystic spaces with [[hobnail]] lining cells.&lt;br /&gt;
*+/-Scattered histiocytes (common).&lt;br /&gt;
*+/-Multi-nucleation (common).&lt;br /&gt;
*+/-Small intracytoplasmic globules - usually seen but only present in a handful of cells. &lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Chromophobe renal cell carcinoma]] - perinuclear halos.&lt;br /&gt;
*[[Clear cell renal cell carcinoma]], eosinophilic variant - chicken-wire vessels.&lt;br /&gt;
*[[Tuberous sclerosis-associated renal cell carcinoma]].&lt;br /&gt;
*[[TFEB-rearranged renal cell carcinoma]].&lt;br /&gt;
*Other [[kidney tumours with eosinophilic cytoplasm]].&lt;br /&gt;
  &lt;br /&gt;
===Images===&lt;br /&gt;
====Case 1====&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma -- low mag.jpg | ESC-RCC - low mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma -- intermed mag.jpg | ESC-RCC - intermed. mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma -- high mag.jpg | ESC-RCC - high mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma -- very high mag.jpg | ESC-RCC - very high mag.&lt;br /&gt;
&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - solid -- intermed mag.jpg | ESC-RCC - intermed. mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - solid -- high mag.jpg | ESC-RCC - high mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - solid -- very high mag.jpg | ESC-RCC - very high mag.&lt;br /&gt;
&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - histiocytes -- intermed mag.jpg | ESC-RCC - intermed. mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - histiocytes -- high mag.jpg | ESC-RCC - high mag.&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Case 2====&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 2 -- low mag.jpg | ESC-RCC - low mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 2 -- intermed mag.jpg | ESC-RCC - intermed. mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 2 -- high mag.jpg | ESC-RCC - high mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 2 -- very high mag.jpg | ESC-RCC - very high mag.&lt;br /&gt;
&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 2 alt -- high mag.jpg | ESC-RCC - high mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 2 alt -- very high mag.jpg | ESC-RCC - very high mag.&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Case 3====&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 3 -- low mag.jpg | ESC-RCC - low mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 3 -- intermed mag.jpg | ESC-RCC - intermed. mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 3 -- high mag.jpg | ESC-RCC - high mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 3 -- very high mag.jpg | ESC-RCC - very high mag.&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Case 4====&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 4 ~ intermed mag.jpg | ESC-RCC - intermed. mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 4 ~ high mag.jpg | ESC-RCC - high mag.&lt;br /&gt;
Image: Eosinophilic, solid and cystic renal cell carcinoma - 4 ~ very high mag.jpg | ESC-RCC - very high mag.&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==IHC==&lt;br /&gt;
Features:&amp;lt;ref name=pmid26414221/&amp;gt;&lt;br /&gt;
*[[PAX8]] +ve.&lt;br /&gt;
*[[CK20]] +ve (14/19 cases).&amp;lt;ref name=pmid28786877 &amp;gt;{{Cite journal  | last1 = Trpkov | first1 = K. | last2 = Abou-Ouf | first2 = H. | last3 = Hes | first3 = O. | last4 = Lopez | first4 = JI. | last5 = Nesi | first5 = G. | last6 = Comperat | first6 = E. | last7 = Sibony | first7 = M. | last8 = Osunkoya | first8 = AO. | last9 = Zhou | first9 = M. | title = Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity. | journal = Am J Surg Pathol | volume = 41 | issue = 10 | pages = 1299-1308 | month = Oct | year = 2017 | doi = 10.1097/PAS.0000000000000838 | PMID = 28786877 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[CK7]] -ve.&lt;br /&gt;
*CD117 -ve.&lt;br /&gt;
*CA9 -ve.&lt;br /&gt;
*HMB-45 -ve.&lt;br /&gt;
*Melan A +ve/-ve.&lt;br /&gt;
*Cathepsin K +ve/-ve.&amp;lt;ref&amp;gt;{{cite journal |authors=Caliò A, Brunelli M, Gobbo S, Argani P, Munari E, Netto G, Martignoni G |title=Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors |journal=Cancers (Basel) |volume=13 |issue=10 |pages= |date=May 2021 |pmid=34069976 |pmc=8157838 |doi=10.3390/cancers13102441 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[GPNMB]] +ve.{{fact}}&lt;br /&gt;
&lt;br /&gt;
==Molecular==&lt;br /&gt;
*[[Renal neoplasms with TSC/mTOR pathway mutations|TSC/mTOR pathway mutations]].&amp;lt;ref name=pmid35203531&amp;gt;{{cite journal |authors=Pivovarcikova K, Alaghehbandan R, Vanecek T, Ohashi R, Pitra T, Hes O |title=TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background |journal=Biomedicines |volume=10 |issue=2 |pages= |date=January 2022 |pmid=35203531 |pmc=8869370 |doi=10.3390/biomedicines10020322 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*TFE3 FISH negative.&lt;br /&gt;
*TFEB FISH negative.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Kidney tumours]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;br /&gt;
[[Category:Kidney tumours]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Talk:ABCC2&amp;diff=53788</id>
		<title>Talk:ABCC2</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Talk:ABCC2&amp;diff=53788"/>
		<updated>2026-05-19T01:16:30Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Abstract ==&lt;br /&gt;
&lt;br /&gt;
Castillo VF, Yacoub JM, Cornacchia K, Patel S, Mimosa M, Zakhary A, van der Kwast T, Trpkov K, Saleeb R, 2026, &amp;quot;Papillary renal cell carcinoma with ABCC2 brush border immunoreactivity confers resistance to cabozantinib, highlighting the therapeutic potential of ABCC2 inhibition&amp;quot;, Canadian Kidney Cancer Forum.&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Talk:ABCC2&amp;diff=53787</id>
		<title>Talk:ABCC2</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Talk:ABCC2&amp;diff=53787"/>
		<updated>2026-05-19T00:30:59Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Abstract */ new section&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Abstract ==&lt;br /&gt;
&lt;br /&gt;
''Papillary renal cell carcinoma with ABCC2 brush border immunoreactivity confers resistance to cabozantinib, highlighting the therapeutic potential of ABCC2 inhibition'' - CKCis 2026&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=GomerBlog&amp;diff=53786</id>
		<title>GomerBlog</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=GomerBlog&amp;diff=53786"/>
		<updated>2026-05-19T00:19:16Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''GomerBlog''' a satirical web site about the practice of medicine.&lt;br /&gt;
&lt;br /&gt;
==Pathology stories==&lt;br /&gt;
*Pathology Resident Makes Up Disease at Tumor Board, Groundbreaking Discovery - https://gomerblog.com/2014/10/pathology-resident/&lt;br /&gt;
*Pathology and Radiology Reports Recommend Correlation with Each Other, Endless Loop Ensues - https://gomerblog.com/2016/08/pathology-and-radiology-reports/&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
*[https://gomerblog.com/ GomerBlog (gomerblog.com)].&lt;br /&gt;
&lt;br /&gt;
[[Category:Pathology links]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=GomerBlog&amp;diff=53785</id>
		<title>GomerBlog</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=GomerBlog&amp;diff=53785"/>
		<updated>2026-05-19T00:18:42Z</updated>

		<summary type="html">&lt;p&gt;Michael: create&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''GomerBlog''' a satirical web site about the practice of medicine.&lt;br /&gt;
&lt;br /&gt;
==Pathology stories==&lt;br /&gt;
*Pathology Resident Makes Up Disease at Tumor Board, Groundbreaking Discovery - https://gomerblog.com/2014/10/pathology-resident/&lt;br /&gt;
*Pathology and Radiology Reports Recommend Correlation with Each Other, Endless Loop Ensues - https://gomerblog.com/2016/08/pathology-and-radiology-reports/&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
*[https://gomerblog.com/ GomerBlog (gomerblog.com)].&lt;br /&gt;
&lt;br /&gt;
[[Category:Links]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=ABCC2&amp;diff=53784</id>
		<title>ABCC2</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=ABCC2&amp;diff=53784"/>
		<updated>2026-05-18T22:59:55Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''ABCC2''' is an [[immunostain]].&lt;br /&gt;
&lt;br /&gt;
==Papillary renal cell carcinoma==&lt;br /&gt;
ABCC2 staining is predictive of outcome in [[papillary renal cell carcinoma]]:&lt;br /&gt;
*Brush border staining is associated with a worse survival.&amp;lt;ref name=pmid37680023&amp;gt;{{cite journal |authors=Castillo VF, Masoomian M, Trpkov K, Downes M, Brimo F, van der Kwast T, Yousef GM, Zakhary A, Rotondo F, Saad G, Nguyen VN, Kidanewold W, Streutker C, Rowsell C, Hamdani M, Saleeb RM |title=ABCC2 brush-border expression predicts outcome in papillary renal cell carcinoma: a multi-institutional study of 254 cases |journal=Histopathology |volume=83 |issue=6 |pages=949–958 |date=December 2023 |pmid=37680023 |doi=10.1111/his.15042 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Brush border staining suggests response to immunotherapy.&amp;lt;ref&amp;gt;{{cite journal |authors=Castillo VF, Zakhary A, Rotondo F, Di Ciano-Oliveira C, Hamdani M, Adona E, van der Kwast T, Trpkov K, Saleeb R |title=Papillary renal cell carcinoma with high-ABCC2 shows an immune-evasive profile associated with favorable response to immunotherapy |journal=J Pathol |volume=268 |issue=2 |pages=188–199 |date=February 2026 |pmid=41259021 |doi=10.1002/path.70001 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Immunohistochemistry]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=ABCC2&amp;diff=53783</id>
		<title>ABCC2</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=ABCC2&amp;diff=53783"/>
		<updated>2026-05-18T22:54:12Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''ABCC2''' is an [[immunostain]].&lt;br /&gt;
&lt;br /&gt;
==Papillary renal cell carcinoma==&lt;br /&gt;
ABCC2 staining is predictive of outcome in [[papillary renal cell carcinoma]]; when brush border staining is present it is associated with a worse survival.&amp;lt;ref name=pmid37680023&amp;gt;{{cite journal |authors=Castillo VF, Masoomian M, Trpkov K, Downes M, Brimo F, van der Kwast T, Yousef GM, Zakhary A, Rotondo F, Saad G, Nguyen VN, Kidanewold W, Streutker C, Rowsell C, Hamdani M, Saleeb RM |title=ABCC2 brush-border expression predicts outcome in papillary renal cell carcinoma: a multi-institutional study of 254 cases |journal=Histopathology |volume=83 |issue=6 |pages=949–958 |date=December 2023 |pmid=37680023 |doi=10.1111/his.15042 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Immunohistochemistry]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Papillary_renal_cell_carcinoma&amp;diff=53782</id>
		<title>Papillary renal cell carcinoma</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Papillary_renal_cell_carcinoma&amp;diff=53782"/>
		<updated>2026-05-18T22:53:20Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* IHC */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Papillary renal cell carcinoma -- very high mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Papillary renal cell carcinoma. [[H&amp;amp;E stain]].&lt;br /&gt;
| Micro      = cuboidal or low columnar cells (simple or pseudostratified) on papillae, interstitial foam cells in the vascular cores&lt;br /&gt;
| Subtypes   = no ''World Health Organization'' recognized subtypes; defunct subtypes: &amp;quot;type 1&amp;quot; and &amp;quot;type 2&amp;quot;, oncocytic variant&lt;br /&gt;
| LMDDx      = [[clear cell renal cell carcinoma]], [[clear cell papillary renal cell carcinoma]], [[metanephric adenoma]], [[collecting duct carcinoma]], [[renal papillary adenoma]], [[acquired cystic disease-associated renal cell carcinoma]], [[urothelial carcinoma]], [[renal mucinous tubular and spindle cell carcinoma]], [[ALK translocation renal cell carcinoma]], [[Xp11 translocation renal cell carcinoma]], [[FH-deficient renal cell carcinoma]]&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  = MET mutation (hereditary papillary renal cell carcinoma)&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      = may be multifocal, must be &amp;gt;1.5 cm (if low ISUP grade), often necrotic-appearing (brown, soft, friable)&lt;br /&gt;
| Grossing   = [[total nephrectomy for tumour grossing]], [[partial nephrectomy grossing]]&lt;br /&gt;
| Staging    = [[kidney cancer staging]]&lt;br /&gt;
| Site       = [[kidney]] - see [[kidney tumours]]&lt;br /&gt;
| Assdx      = [[acquired renal cystic disease]] ([[end-stage renal disease]])&lt;br /&gt;
| Syndromes  = hereditary papillary renal cell carcinoma&lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = relatively common&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  =&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = other [[kidney tumours]]&lt;br /&gt;
| Tx         = surgical excision, ablation&lt;br /&gt;
}}&lt;br /&gt;
'''Papillary renal cell carcinoma''', abbreviated '''PRCC''', '''PaRCC''' and '''papillary RCC''', is the second most common type of [[renal cell carcinoma]].&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Historically, PaRCC was subclassified&amp;lt;ref name=Ref_GUP289&amp;gt;{{Ref GUP|289}}&amp;lt;/ref&amp;gt; into ''type 1'' and ''type 2''.&lt;br /&gt;
**Type 1 and Type 2 are different on a cytogenetic and molecular basis.&amp;lt;ref&amp;gt;{{Cite journal  | last1 = Klatte | first1 = T. | last2 = Pantuck | first2 = AJ. | last3 = Said | first3 = JW. | last4 = Seligson | first4 = DB. | last5 = Rao | first5 = NP. | last6 = LaRochelle | first6 = JC. | last7 = Shuch | first7 = B. | last8 = Zisman | first8 = A. | last9 = Kabbinavar | first9 = FF. | title = Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. | journal = Clin Cancer Res | volume = 15 | issue = 4 | pages = 1162-9 | month = Feb | year = 2009 | doi = 10.1158/1078-0432.CCR-08-1229 | PMID = 19228721 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Epidemiology===&lt;br /&gt;
*Associated with ''[[acquired renal cystic disease]]''.&amp;lt;ref name=Ref_DARP438&amp;gt;{{Ref DARP|438}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*May be familial - uncommon.&amp;lt;ref name=pmid12629341&amp;gt;{{Cite journal  | last1 = Czene | first1 = K. | last2 = Hemminki | first2 = K. | title = Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden. | journal = J Urol | volume = 169 | issue = 4 | pages = 1271-5 | month = Apr | year = 2003 | doi = 10.1097/01.ju.0000052373.36963.12 | PMID = 12629341 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**MET mutation&amp;lt;ref name=pmid22717761&amp;gt;{{Cite journal  | last1 = Wadt | first1 = KA. | last2 = Gerdes | first2 = AM. | last3 = Hansen | first3 = TV. | last4 = Toft | first4 = BG. | last5 = Friis-Hansen | first5 = L. | last6 = Andersen | first6 = MK. | title = Novel germline c-MET mutation in a family with hereditary papillary renal carcinoma. | journal = Fam Cancer | volume = 11 | issue = 3 | pages = 535-7 | month = Sep | year = 2012 | doi = 10.1007/s10689-012-9542-6 | PMID = 22717761 }}&amp;lt;/ref&amp;gt; - autosomal dominant transmission (previously ''PaRCC type 1'').&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Renal cortical mass usually &amp;gt;1.5 cm.&lt;br /&gt;
*May be multifocal. ‡&lt;br /&gt;
*Often necrotic appearing - light-to-dark brown, soft/mushy, friable.&lt;br /&gt;
&lt;br /&gt;
Note:&lt;br /&gt;
*‡ Approximately 10% of PaRCCs are multifocal (based on a set of 5378 patients);&amp;lt;ref name=pmid22502873&amp;gt;{{Cite journal  | last1 = Siracusano | first1 = S. | last2 = Novara | first2 = G. | last3 = Antonelli | first3 = A. | last4 = Artibani | first4 = W. | last5 = Bertini | first5 = R. | last6 = Carini | first6 = M. | last7 = Carmignani | first7 = G. | last8 = Ciciliato | first8 = S. | last9 = Cunico | first9 = SC. | title = Prognostic role of tumour multifocality in renal cell carcinoma. | journal = BJU Int | volume = 110 | issue = 11 Pt B | pages = E443-8 | month = Dec | year = 2012 | doi = 10.1111/j.1464-410X.2012.11121.x | PMID = 22502873 }}&amp;lt;/ref&amp;gt; it is the renal tumour that is most commonly multifocal.&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&amp;lt;ref name=Ref_PBoD1017-8&amp;gt;{{Ref PBoD|1017-8}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Cuboidal or low columnar cell in papillae.&lt;br /&gt;
*Interstitial foam cells in vascular cores - '''key feature'''.&lt;br /&gt;
**Most sensitive and specific feature of PaRCC.&amp;lt;ref&amp;gt;{{cite journal |author=Granter SR, Perez-Atayde AR, Renshaw AA |title=Cytologic analysis of papillary renal cell carcinoma |journal=Cancer |volume=84 |issue=5 |pages=303?8 |year=1998 |month=October |pmid=9801205 |doi= |url=http://dx.doi.org/10.1002/(SICI)1097-0142(19981025)84:5&amp;lt;303::AID-CNCR6&amp;gt;3.0.CO;2-7}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Highly vascular.&lt;br /&gt;
&lt;br /&gt;
Size criterion:&lt;br /&gt;
*Papillary lesions with low [[ISUP nucleolar grade|ISUP grade]] '''''must''''' be &amp;gt;1.5 cm to be called ''carcinoma''; smaller lesions (&amp;lt;=1.5 cm) with low ISUP grade are called ''[[renal papillary adenoma|papillary adenoma]]s''.&amp;lt;ref name=pmid26935559&amp;gt;{{Cite journal  | last1 = Moch | first1 = H. | last2 = Cubilla | first2 = AL. | last3 = Humphrey | first3 = PA. | last4 = Reuter | first4 = VE. | last5 = Ulbright | first5 = TM. | title = The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. | journal = Eur Urol | volume =  | issue =  | pages =  | month = Feb | year = 2016 | doi = 10.1016/j.eururo.2016.02.029 | PMID = 26935559 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=Ref_GUP288&amp;gt;{{Ref GUP|288}}&amp;lt;/ref&amp;gt; †&lt;br /&gt;
&lt;br /&gt;
Mnemonic ''HIP'':  '''h'''ighly vascular, '''i'''nterstitial foam cells, '''p'''apillae.&lt;br /&gt;
&lt;br /&gt;
Note:&lt;br /&gt;
*† The [[diagnostic size cut-off]] in the 2004 [[WHO]] GU (blue) book was 0.5 cm.&amp;lt;ref name=pmid26935559/&amp;gt;&amp;lt;ref&amp;gt;{{Ref WHOGU|28}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Clear cell RCC]].&lt;br /&gt;
**Papillary: histiocytes, intracellular hemosiderin, [[CK7]] +ve.&lt;br /&gt;
*[[Clear cell papillary renal cell carcinoma]] - apical nuclei, usu. no true papillae.&lt;br /&gt;
*[[Metanephric adenoma]] (esp. solid PaRCC type 1) - no histiocytes, WT-1 +ve.&lt;br /&gt;
*[[Collecting duct carcinoma]] - esp. PaRCC type 2.&lt;br /&gt;
*[[Urothelial carcinoma]].&lt;br /&gt;
*[[Renal papillary adenoma]] - doesn't fulfill size criterion for PaRCC.&lt;br /&gt;
*[[Acquired cystic disease-associated renal cell carcinoma]].&lt;br /&gt;
*[[Renal mucinous tubular and spindle cell carcinoma]].&lt;br /&gt;
*[[Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma]] - for ''type 2 PaRCC''; CK7 -ve, prominent eosinophilic nucleoli.  &lt;br /&gt;
*[[ALK translocation renal cell carcinoma]].&lt;br /&gt;
*[[Mixed epithelial and stromal tumour]].&amp;lt;ref name=pmid31862520&amp;gt;{{cite journal |authors=Rogala J, Kojima F, Alaghehbandan R, Agaimy A, Martinek P, Ondic O, Ulamec M, Sperga M, Michalova K, Pivovarcikova K, Pitra T, Hora M, Ferak I, Marečková J, Michal M, Hes O |title=Papillary renal cell carcinoma with prominent spindle cell stroma - tumor mimicking mixed epithelial and stromal tumor of the kidney: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 6 cases |journal=Ann Diagn Pathol |volume=44 |issue= |pages=151441 |date=February 2020 |pmid=31862520 |doi=10.1016/j.anndiagpath.2019.151441 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Papillary renal neoplasm with reverse polarity]] (PRNRP) - nuclei at luminal aspect of cell (rather than closer to the basement membrane).&amp;lt;ref name=pmid31135486&amp;gt;{{cite journal |authors=Al-Obaidy KI, Eble JN, Cheng L, Williamson SR, Sakr WA, Gupta N, Idrees MT, Grignon DJ |title=Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study |journal=Am J Surg Pathol |volume=43 |issue=8 |pages=1099–1111 |date=August 2019 |pmid=31135486 |doi=10.1097/PAS.0000000000001288 |url=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
**May be considered a subtype of papillary renal cell carcinoma (rather than a distinct entity).&lt;br /&gt;
*[[Xp11 translocation renal cell carcinoma]].&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Papillary_renal_cell_carcinoma_intermed_mag.jpg| PaRCC - intermed. mag. (WC/Nephron) &lt;br /&gt;
Image:Papillary_renal_cell_carcinoma_high_mag.jpg| PaRCC - high mag. (WC/Nephron)&lt;br /&gt;
Image:Papillary_renal_cell_carcinoma_very_high_mag.jpg| PaRCC - very high mag. (WC/Nephron)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Papillary renal cell carcinoma - 2 -- intermed mag.jpg | PaRCC - intermed. mag. (WC)&lt;br /&gt;
Image: Papillary renal cell carcinoma - 2 -- high mag.jpg | PaRCC - high mag. (WC)&lt;br /&gt;
Image: Papillary renal cell carcinoma - 2 -- very high mag.jpg | PaRCC - very high mag. (WC)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Papillary renal cell carcinoma -- high mag.jpg | PaRCC - high mag. (WC/Nephron)&lt;br /&gt;
Image: Papillary renal cell carcinoma -- very high mag.jpg | PaRCC - very high mag. (WC/Nephron)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Histological subtyping=== &lt;br /&gt;
====Historical type 1 and type 2====&lt;br /&gt;
Historically, PaRCC was subtyped:&amp;lt;ref name=Ref_GUP289&amp;gt;{{Ref GUP|289}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal  | last1 = Delahunt | first1 = B. | last2 = Eble | first2 = JN. | title = Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. | journal = Mod Pathol | volume = 10 | issue = 6 | pages = 537-44 | month = Jun | year = 1997 | doi =  | PMID = 9195569 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*''Type 1'' - single layer of cells on basement membrane - '''most important'''.&lt;br /&gt;
** Usually low grade nuclear features, i.e. low [[ISUP nucleolar grade]].&lt;br /&gt;
** Other characteristics:&lt;br /&gt;
*** Clear cytoplasm.&lt;br /&gt;
*** Foamy macrophages - common.&lt;br /&gt;
*** Cells smaller.&lt;br /&gt;
*''Type 2'' - pseudostratification of cells - '''most important'''.&lt;br /&gt;
** Usually high grade nuclear features, i.e. high [[ISUP nucleolar grade]].&lt;br /&gt;
** Other characteristics:&lt;br /&gt;
*** Eosinophilic cytoplasm.&lt;br /&gt;
*** Foamy macrophages - uncommon.&lt;br /&gt;
*** Cells larger.&lt;br /&gt;
&lt;br /&gt;
The WHO GU Blue Book 5th Ed. recommends against subtyping.&lt;br /&gt;
&lt;br /&gt;
How are ''Type 1'' and ''Type 2'' now classified?&lt;br /&gt;
*The defunct ''Type 1'' is ''papillary renal cell carcinoma''.  It is classically associated with a MET gene alteration.&lt;br /&gt;
*The defunct ''Type 2'' is a mix of different RCCs, e.g. ALK-RCC, translocation RCC, FH-deficient RCC.&lt;br /&gt;
&lt;br /&gt;
===Oncocytic subtype===&lt;br /&gt;
*''Oncocytic'' - oncocytic cytoplasm.&lt;br /&gt;
**Extremely rare ~ a few dozen reported.&amp;lt;ref name=pmid19494850 &amp;gt;{{Cite journal  | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | title = Uncommon and recently described renal carcinomas. | journal = Mod Pathol | volume = 22 Suppl 2 | issue =  | pages = S2-S23 | month = Jun | year = 2009 | doi = 10.1038/modpathol.2009.70 | PMID = 19494850 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=pmid16730306&amp;gt;{{Cite journal  | last1 = Hes | first1 = O. | last2 = Brunelli | first2 = M. | last3 = Michal | first3 = M. | last4 = Cossu Rocca | first4 = P. | last5 = Hora | first5 = M. | last6 = Chilosi | first6 = M. | last7 = Mina | first7 = M. | last8 = Boudova | first8 = L. | last9 = Menestrina | first9 = F. | title = Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. | journal = Ann Diagn Pathol | volume = 10 | issue = 3 | pages = 133-9 | month = Jun | year = 2006 | doi = 10.1016/j.anndiagpath.2005.12.002 | PMID = 16730306 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
***One &amp;quot;large&amp;quot; series was 14 cases.&amp;lt;ref name=pmid27931799&amp;gt;{{Cite journal  | last1 = Han | first1 = G. | last2 = Yu | first2 = W. | last3 = Chu | first3 = J. | last4 = Liu | first4 = Y. | last5 = Jiang | first5 = Y. | last6 = Li | first6 = Y. | last7 = Zhang | first7 = W. | title = Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases. | journal = Pathol Res Pract | volume = 213 | issue = 1 | pages = 1-6 | month = Jan | year = 2017 | doi = 10.1016/j.prp.2016.04.009 | PMID = 27931799 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==IHC==&lt;br /&gt;
Features:&amp;lt;ref name=Ref_GUP289&amp;gt;{{Ref GUP|289}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*AMACR +ve.&lt;br /&gt;
*HMWCK (34betaE12) +ve.&lt;br /&gt;
*Panker (AE1/AE3) +ve.&lt;br /&gt;
*CK7 +ve ~90% of type 1, 20% of type 2.&lt;br /&gt;
*CD10 +ve.&amp;lt;ref&amp;gt;[http://surgpathcriteria.stanford.edu/kidney/papillary-renal-cell-carcinoma/differential-diagnosis.html http://surgpathcriteria.stanford.edu/kidney/papillary-renal-cell-carcinoma/differential-diagnosis.html]. Accessed on: 6 May 2014.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Others:&lt;br /&gt;
*[[GATA3]] +ve - oncocytic variant of PaRCC; negative in other PaRCC subtypes.&amp;lt;ref name=pmid28984673&amp;gt;{{cite journal |authors=Saleeb RM, Brimo F, Farag M, Rompré-Brodeur A, Rotondo F, Beharry V, Wala S, Plant P, Downes MR, Pace K, Evans A, Bjarnason G, Bartlett JMS, Yousef GM |title=Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis |journal=Am J Surg Pathol |volume=41 |issue=12 |pages=1618–1629 |date=December 2017 |pmid=28984673 |doi=10.1097/PAS.0000000000000962 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[ABCC2]] brush border staining = worse survival.&amp;lt;ref name=pmid37680023&amp;gt;{{cite journal |authors=Castillo VF, Masoomian M, Trpkov K, Downes M, Brimo F, van der Kwast T, Yousef GM, Zakhary A, Rotondo F, Saad G, Nguyen VN, Kidanewold W, Streutker C, Rowsell C, Hamdani M, Saleeb RM |title=ABCC2 brush-border expression predicts outcome in papillary renal cell carcinoma: a multi-institutional study of 254 cases |journal=Histopathology |volume=83 |issue=6 |pages=949–958 |date=December 2023 |pmid=37680023 |doi=10.1111/his.15042 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Metanephric adenoma vs. PaRCC type 1:&amp;lt;ref name=pmid24083046&amp;gt;{{Cite journal  | last1 = Watanabe | first1 = S. | last2 = Naganuma | first2 = H. | last3 = Shimizu | first3 = M. | last4 = Ota | first4 = S. | last5 = Murata | first5 = S. | last6 = Nihei | first6 = N. | last7 = Matsushima | first7 = J. | last8 = Mikami | first8 = S. | last9 = Kuroda | first9 = N. | title = Adult nephroblastoma with predominant epithelial component: a differential diagnostic candidate of papillary renal cell carcinoma and metanephric adenoma-report of three cases. | journal = Case Rep Pathol | volume = 2013 | issue =  | pages = 675875 | month =  | year = 2013 | doi = 10.1155/2013/675875 | PMID = 24083046 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*AMACR +ve.&lt;br /&gt;
*WT-1 -ve.&lt;br /&gt;
*CD57 -ve.&lt;br /&gt;
&lt;br /&gt;
==Molecular==&lt;br /&gt;
Features:&amp;lt;ref name=Ref_PBoD1016&amp;gt;{{Ref PBoD|1016}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Sporadic: trisomies 7, 16, 17.&lt;br /&gt;
*Familial: trisomy 7.&lt;br /&gt;
**Chromosome 7 = location of MET gene.&lt;br /&gt;
&lt;br /&gt;
Note:&lt;br /&gt;
*Not used for diagnosis.&amp;lt;ref&amp;gt;{{Ref WMSP|292}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
Kidney Tumour, Left, Partial Nephrectomy: &lt;br /&gt;
- PAPILLARY RENAL CELL CARCINOMA. &lt;br /&gt;
-- Surgical margins NEGATIVE. &lt;br /&gt;
-- ISUP nucleolar (Fuhrman) Grade 3. &lt;br /&gt;
-- TNM stage: pT1a pNx. &lt;br /&gt;
-- Please see tumour summary. &lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Block letters===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
KIDNEY, RIGHT, RADICAL NEPHRECTOMY:&lt;br /&gt;
- PAPILLARY RENAL CELL CARCINOMA, WHO/ISUP NUCLEOLAR GRADE 3, pT2a(2), pNx.&lt;br /&gt;
-- SURGICAL MARGINS NEGATIVE.&lt;br /&gt;
-- PLEASE SEE TUMOUR SUMMARY.&lt;br /&gt;
- RENAL PAPILLARY ADENOMAS.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Micro====&lt;br /&gt;
The sections show a tumour in the kidney with fibrovascular cores (papillae) that focally contain macrophages. Psammoma bodies are present. Siderophages are present.&lt;br /&gt;
&lt;br /&gt;
The papillae predominantly have a single layer of tumour cells and the cytoplasm of the tumour cells is predominantly clear.&lt;br /&gt;
&lt;br /&gt;
Nucleoli are visible focally with the 10x objective (ISUP nucleolar grade 3).&lt;br /&gt;
&lt;br /&gt;
A second tumour with the same morphology is present and measures 8 millimetres.&lt;br /&gt;
&lt;br /&gt;
Multiple small lesions, like the largest tumour, less than 1.5 cm are present.&lt;br /&gt;
&lt;br /&gt;
=====Alternate=====&lt;br /&gt;
The sections show a tumour in the kidney with fibrovascular cores (papillae) that contain macrophages. The papillae predominantly have a single layer of tumour cells. Nucleoli are not prominent with the 10x objective (ISUP nucleolar grade 2).&lt;br /&gt;
&lt;br /&gt;
===Oncocytic variant===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
KIDNEY, RIGHT, NEPHRECTOMY:&lt;br /&gt;
- PAPILLARY RENAL CELL CARCINOMA, ONCOCYTIC -- SEE COMMENT;&lt;br /&gt;
- WHO/ISUP GRADE 2;&lt;br /&gt;
- SURGICAL MARGINS NEGATIVE;&lt;br /&gt;
- PLEASE SEE TUMOUR SUMMARY.&lt;br /&gt;
&lt;br /&gt;
COMMENT:&lt;br /&gt;
The oncocytic variant of papillary renal cell carcinoma (RCC) is uncommon and not widely&lt;br /&gt;
recognized as a subtype of papillary RCC.  The prognostic significance of the oncocytic &lt;br /&gt;
cytoplasm is uncertain.[1]  The histomorphology in this case is compatible with a type 1 &lt;br /&gt;
papillary RCC.&lt;br /&gt;
&lt;br /&gt;
1. Ann Diagn Pathol. 2006 Jun;10(3):133-9.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Kidney tumours]].&lt;br /&gt;
*[[Acquired cystic disease-associated renal cell carcinoma]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Kidney tumours]]&lt;br /&gt;
[[Category:Diagnosis]]&lt;br /&gt;
[[Category:Papillary tumour]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=ABCC2&amp;diff=53781</id>
		<title>ABCC2</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=ABCC2&amp;diff=53781"/>
		<updated>2026-05-18T22:52:05Z</updated>

		<summary type="html">&lt;p&gt;Michael: create&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''ABCC2''' is an [[immunostain]].&lt;br /&gt;
&lt;br /&gt;
==Papillary renal cell carcinoma==&lt;br /&gt;
ABCC2 staining is predictive of outcome in [[papillary renal cell carcinoma]].&amp;lt;ref name=pmid37680023&amp;gt;{{cite journal |authors=Castillo VF, Masoomian M, Trpkov K, Downes M, Brimo F, van der Kwast T, Yousef GM, Zakhary A, Rotondo F, Saad G, Nguyen VN, Kidanewold W, Streutker C, Rowsell C, Hamdani M, Saleeb RM |title=ABCC2 brush-border expression predicts outcome in papillary renal cell carcinoma: a multi-institutional study of 254 cases |journal=Histopathology |volume=83 |issue=6 |pages=949–958 |date=December 2023 |pmid=37680023 |doi=10.1111/his.15042 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Immunohistochemistry]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Libre_Pathology_news:New_offline_version_of_Libre_Pathology&amp;diff=53780</id>
		<title>Libre Pathology news:New offline version of Libre Pathology</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Libre_Pathology_news:New_offline_version_of_Libre_Pathology&amp;diff=53780"/>
		<updated>2026-05-18T22:42:56Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* External links */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image:Libre Pathology - logo - white background.png|200px|thumb|The [[Libre Pathology]] logo.]]&lt;br /&gt;
A '''new offline version of Libre Pathology''' is available at ''kiwix.org'' and will be updated quarterly by the team at Kiwix.&lt;br /&gt;
&lt;br /&gt;
It has been a long term goal to give ''you'' the whole site. After all, ''libre'' (free), is in the name ''[[Libre Pathology]]''.  &lt;br /&gt;
&lt;br /&gt;
We hope the offline version helps make pathology information available to those that do not have an internet connection ''or'' a less than optimal one.  &lt;br /&gt;
&lt;br /&gt;
==User experience==&lt;br /&gt;
Kiwix has a strong built-in search feature, and navigation otherwise is similar to online. The hyperlinks work.&lt;br /&gt;
&lt;br /&gt;
Unfortunately, the [[Quizzes|short spot diagnosis quizzes]] and [[Cases|learning with simulated cases]] do not work.&lt;br /&gt;
Images are lower resolution to make a file that is approximately 80 MB.&lt;br /&gt;
&lt;br /&gt;
==Setting up an offline version of Libre Pathology==&lt;br /&gt;
# Install Kiwix - takes less than 5 minutes.&lt;br /&gt;
#* Android: https://play.google.com/store/apps/details?id=org.kiwix.kiwixmobile&amp;amp;hl=en&lt;br /&gt;
#* MacOS: https://itunes.apple.com/us/app/kiwix/id997079563&lt;br /&gt;
#* Windows: https://download.kiwix.org/release/kiwix-tools/kiwix-tools_win-i686.zip&lt;br /&gt;
#* Linux (64 bit): https://download.kiwix.org/release/kiwix-tools/kiwix-tools_linux-x86_64.tar.gz&lt;br /&gt;
# Download the Libre Pathology ZIM file.&lt;br /&gt;
#* A direct link is here: https://download.kiwix.org/zim/other/librepathology_en_all_maxi_2025-09.zim&lt;br /&gt;
# Open Kiwix and load the ZIM file - this should take less than 2 minutes.&lt;br /&gt;
# Enjoy Libre Pathology offline!&lt;br /&gt;
&lt;br /&gt;
==Acknowledgements==&lt;br /&gt;
Special thanks go to [[User:Maxwell|Maxwell Martin]] for his work on generating a new ZIM file and coordinating with Kiwix.&lt;br /&gt;
[[Libre Pathology news:Offline version of Libre Pathology|An earlier offline version]] was inspired by Dr. Parkash.&lt;br /&gt;
&lt;br /&gt;
Emmanuel Engelhart made this all possible. He did all the heavy lifting in this project; he developed Kiwix, initially that [[Wikipedia]] could go offline.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Libre Pathology news]].&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
*[https://meta.wikimedia.org/wiki/Kiwix_-_Wikipedia_Offline Wikipedia Offline (wikimedia.org)].&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Kiwix Kiwix (wikipedia.org)].&lt;br /&gt;
*[https://browse.library.kiwix.org/#lang=eng Kiwix Library (kiwix.org)].&lt;br /&gt;
&lt;br /&gt;
[[Category:Libre Pathology news]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Libre_Pathology_news:Architecture_Upgrade_2026&amp;diff=53779</id>
		<title>Libre Pathology news:Architecture Upgrade 2026</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Libre_Pathology_news:Architecture_Upgrade_2026&amp;diff=53779"/>
		<updated>2026-05-09T05:20:12Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image:Libre Pathology - logo - white background.png|150px|thumb|The Libre Pathology logo.]]&lt;br /&gt;
[[Libre Pathology]] got a much overdue '''architecture upgrade''' on May, 9 2026.  It should lead to perceptible performance improvements.  We hope that this will make the site more enjoyable to use.  &lt;br /&gt;
&lt;br /&gt;
In the future, we plan to revisit the issue of performance, aware that more can be done. Also, we are aware that no one enjoys a slow unresponsive website. &lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Libre Pathology]].&lt;br /&gt;
*[[Libre Pathology news]].&lt;br /&gt;
&lt;br /&gt;
[[Category:Libre Pathology]]&lt;br /&gt;
[[Category:Libre Pathology news]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Libre_Pathology_news&amp;diff=53778</id>
		<title>Libre Pathology news</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Libre_Pathology_news&amp;diff=53778"/>
		<updated>2026-05-09T05:19:39Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image:Libre Pathology - logo - white background.png|250px|thumb|The Libre Pathology logo.]]&lt;br /&gt;
'''Libre Pathology news''' collects news related to [[Libre Pathology]].&lt;br /&gt;
&lt;br /&gt;
==Upcoming events==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Past events==&lt;br /&gt;
&lt;br /&gt;
===2025===&lt;br /&gt;
*[[Libre Pathology news:New offline version of Libre Pathology|New offline version of Libre Pathology]].&lt;br /&gt;
&lt;br /&gt;
===2023===&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2017|Libre Pathology and USCAP 2023]].&lt;br /&gt;
&lt;br /&gt;
===2023===&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2017|Libre Pathology and USCAP 2022]].&lt;br /&gt;
&lt;br /&gt;
===2021===&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2017|Libre Pathology and USCAP 2021]].&lt;br /&gt;
&lt;br /&gt;
===2020===&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2017|Libre Pathology and USCAP 2020]].&lt;br /&gt;
&lt;br /&gt;
===2017===&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2017|Libre Pathology and USCAP 2017]].&lt;br /&gt;
&lt;br /&gt;
===2016===&lt;br /&gt;
*[[Libre Pathology:ESP/IAP Congress 2016|ESP/IAP Congress 2016]].&lt;br /&gt;
*[[Libre Pathology:Libre Pathology at two years|Libre Pathology at two years]].&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2016|Libre Pathology and USCAP 2016]].&lt;br /&gt;
*[[Libre Pathology:Survey|Libre Pathology Survey]].&lt;br /&gt;
*[[Libre Pathology:Shorter URLs|Shorter URLs]] - February 22, 2016.&lt;br /&gt;
*[[Libre Pathology:Introducing quizzes|Introducing quizzes]] - December 30, 2016.&lt;br /&gt;
&lt;br /&gt;
===2015===&lt;br /&gt;
*[[Libre Pathology news:Offline version of Libre Pathology|Offline version of Libre Pathology]] - September 15, 2015.&lt;br /&gt;
*[[Libre Pathology at one year]] - July 12, 2015.&lt;br /&gt;
*[[Image annotations added to Libre Pathology]] - April 20, 2015.&lt;br /&gt;
*[[Libre Pathology &amp;amp; USCAP 2015]] - March 23, 2015.&lt;br /&gt;
*[[Libre Pathology:Libre Pathology in 2014 and looking forward|Libre Pathology in 2014 and looking forward]] - January 28, 2015.&lt;br /&gt;
===2014===&lt;br /&gt;
*[[Libre Pathology:Performance Improvements|Performance Improvements]] - October 13, 2014.&lt;br /&gt;
*[[Robot joins Libre Pathology]] - September 1, 2014.&lt;br /&gt;
*[[Images on Libre Pathology]] - August 27, 2014.&lt;br /&gt;
*[[Libre Pathology on Twitter]] - August 9, 2014.&lt;br /&gt;
*[[Presentations at the 2014 Annual Meeting of the Canadian Association of Pathologists|Presentation at Canadian Association of Pathologists Annual Meeting]] (''Developing a wiki-based [[Cases|case simulator]] for anatomical pathology'') - Toronto, Ontario, July 14,2014.&lt;br /&gt;
*[[Libre Pathology officially launches]] - July 12, 2014.&lt;br /&gt;
*[[Presentations at the 2014 Annual Meeting of the Canadian Association of Pathologists|Presentation at the Special Interest Group for Informatics at the Canadian Association of Pathologists Annual Meeting - Toronto, Ontario]] - July 12, 2014.&lt;br /&gt;
*[[Presentation at the Provincial Laboratory Medicine Rounds]] (''Onlinepathology.org: Building an open online collaborative pathology knowledge base'') - Newfoundland and Labrador - April 15, 2014.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Libre Pathology]].&lt;br /&gt;
&lt;br /&gt;
[[Category:Libre Pathology]]&lt;br /&gt;
[[Category:Libre Pathology news]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Libre_Pathology_news&amp;diff=53777</id>
		<title>Libre Pathology news</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Libre_Pathology_news&amp;diff=53777"/>
		<updated>2026-05-09T05:19:22Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Past events */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image:Libre Pathology - logo - white background.png|250px|thumb|The Libre Pathology logo.]]&lt;br /&gt;
'''Libre Pathology news''' collects news related to [[Libre Pathology]].&lt;br /&gt;
&lt;br /&gt;
==Upcoming events==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Past events==&lt;br /&gt;
&lt;br /&gt;
==2025==&lt;br /&gt;
*[[Libre Pathology news:New offline version of Libre Pathology|New offline version of Libre Pathology]].&lt;br /&gt;
&lt;br /&gt;
==2023==&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2017|Libre Pathology and USCAP 2023]].&lt;br /&gt;
&lt;br /&gt;
==2023==&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2017|Libre Pathology and USCAP 2022]].&lt;br /&gt;
&lt;br /&gt;
==2021==&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2017|Libre Pathology and USCAP 2021]].&lt;br /&gt;
&lt;br /&gt;
==2020==&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2017|Libre Pathology and USCAP 2020]].&lt;br /&gt;
&lt;br /&gt;
===2017===&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2017|Libre Pathology and USCAP 2017]].&lt;br /&gt;
&lt;br /&gt;
===2016===&lt;br /&gt;
*[[Libre Pathology:ESP/IAP Congress 2016|ESP/IAP Congress 2016]].&lt;br /&gt;
*[[Libre Pathology:Libre Pathology at two years|Libre Pathology at two years]].&lt;br /&gt;
*[[Libre Pathology:Libre Pathology and USCAP 2016|Libre Pathology and USCAP 2016]].&lt;br /&gt;
*[[Libre Pathology:Survey|Libre Pathology Survey]].&lt;br /&gt;
*[[Libre Pathology:Shorter URLs|Shorter URLs]] - February 22, 2016.&lt;br /&gt;
*[[Libre Pathology:Introducing quizzes|Introducing quizzes]] - December 30, 2016.&lt;br /&gt;
&lt;br /&gt;
===2015===&lt;br /&gt;
*[[Libre Pathology news:Offline version of Libre Pathology|Offline version of Libre Pathology]] - September 15, 2015.&lt;br /&gt;
*[[Libre Pathology at one year]] - July 12, 2015.&lt;br /&gt;
*[[Image annotations added to Libre Pathology]] - April 20, 2015.&lt;br /&gt;
*[[Libre Pathology &amp;amp; USCAP 2015]] - March 23, 2015.&lt;br /&gt;
*[[Libre Pathology:Libre Pathology in 2014 and looking forward|Libre Pathology in 2014 and looking forward]] - January 28, 2015.&lt;br /&gt;
===2014===&lt;br /&gt;
*[[Libre Pathology:Performance Improvements|Performance Improvements]] - October 13, 2014.&lt;br /&gt;
*[[Robot joins Libre Pathology]] - September 1, 2014.&lt;br /&gt;
*[[Images on Libre Pathology]] - August 27, 2014.&lt;br /&gt;
*[[Libre Pathology on Twitter]] - August 9, 2014.&lt;br /&gt;
*[[Presentations at the 2014 Annual Meeting of the Canadian Association of Pathologists|Presentation at Canadian Association of Pathologists Annual Meeting]] (''Developing a wiki-based [[Cases|case simulator]] for anatomical pathology'') - Toronto, Ontario, July 14,2014.&lt;br /&gt;
*[[Libre Pathology officially launches]] - July 12, 2014.&lt;br /&gt;
*[[Presentations at the 2014 Annual Meeting of the Canadian Association of Pathologists|Presentation at the Special Interest Group for Informatics at the Canadian Association of Pathologists Annual Meeting - Toronto, Ontario]] - July 12, 2014.&lt;br /&gt;
*[[Presentation at the Provincial Laboratory Medicine Rounds]] (''Onlinepathology.org: Building an open online collaborative pathology knowledge base'') - Newfoundland and Labrador - April 15, 2014.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Libre Pathology]].&lt;br /&gt;
&lt;br /&gt;
[[Category:Libre Pathology]]&lt;br /&gt;
[[Category:Libre Pathology news]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Main_Page&amp;diff=53776</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Main_Page&amp;diff=53776"/>
		<updated>2026-05-09T04:56:09Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div id=&amp;quot;mf-home&amp;quot;&amp;gt; &lt;br /&gt;
&amp;lt;!-- The main elements of this page are in 'Template:Collection' and 'Template:Subspeciality'. Don't edit this page unless you know what you're doing! --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--        BANNER ACROSS TOP OF PAGE       --&amp;gt;&lt;br /&gt;
{| id=&amp;quot;topbanner&amp;quot; style=&amp;quot;width:100%; background:#f9f9f9; margin:1.2em 0 5px 0; border:1px solid #ddd;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:61%; color:#000;&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div style=&amp;quot;font-size:180%; text-align:center; border:none; padding:.1em&amp;quot;&amp;gt;Welcome to [[Libre Pathology]]! A wiki looking for [[Libre Pathology:Contributing|contributors]]!&amp;lt;/div&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
{| id=&amp;quot;topbanner&amp;quot; style=&amp;quot;width:100%; background:#f9f9f9; margin:1.2em 0 5px 0; border:1px solid #ddd;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:61%; color:#000;&amp;quot; |&lt;br /&gt;
&amp;lt;div style=&amp;quot;font-size:150%; text-align:center; border:none; padding:.1em&amp;quot;&amp;gt;''[[Libre Pathology news]]'': ''[[Libre Pathology news:Architecture Upgrade 2026|Architecture Upgrade 2026]]''&amp;lt;/div&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- VIRTUAL CASES--&amp;gt;  &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=100%&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;50%&amp;quot; | Weekly [[senior virtual case]]&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;50%&amp;quot; | Weekly [[junior virtual case]]&lt;br /&gt;
|-&lt;br /&gt;
| [[Image:{{Main Page senior image}}|200px|link=http://librepathology.org/wiki/index.php/Case_{{Main Page senior case number}}|center|]]&lt;br /&gt;
&amp;lt;center&amp;gt;[[Case {{Main Page senior case number}}|{{Main Page senior tease}}]]&amp;lt;/center&amp;gt; &lt;br /&gt;
&lt;br /&gt;
| [[Image:{{Main Page junior image}}|200px|link=http://librepathology.org/wiki/index.php/Case_{{Main Page junior case number}}|center|]]&lt;br /&gt;
&amp;lt;center&amp;gt;[[Case {{Main Page junior case number}}|{{Main Page junior tease}}]]&amp;lt;/center&amp;gt; &lt;br /&gt;
|} &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- DIRECTORY  --&amp;gt;&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; width=100%&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;50%&amp;quot; | The Collection&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;50%&amp;quot; | By Area&lt;br /&gt;
|-&lt;br /&gt;
| {{Collection}}&lt;br /&gt;
| {{Subspeciality}}&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
__NOTOC__&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Libre_Pathology:Architecture_Upgrade_2026&amp;diff=53775</id>
		<title>Libre Pathology:Architecture Upgrade 2026</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Libre_Pathology:Architecture_Upgrade_2026&amp;diff=53775"/>
		<updated>2026-05-09T04:55:44Z</updated>

		<summary type="html">&lt;p&gt;Michael: Redirected page to Libre Pathology news:Architecture Upgrade 2026&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;#redirect [[Libre Pathology news:Architecture Upgrade 2026]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Libre_Pathology_news:Architecture_Upgrade_2026&amp;diff=53774</id>
		<title>Libre Pathology news:Architecture Upgrade 2026</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Libre_Pathology_news:Architecture_Upgrade_2026&amp;diff=53774"/>
		<updated>2026-05-09T04:55:27Z</updated>

		<summary type="html">&lt;p&gt;Michael: Created page with &amp;quot;Libre Pathology got a much overdue '''architecture upgrade''' on May, 9 2026.  It should lead to perceptible performance improvements.  We hope that this will make the sit...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Libre Pathology]] got a much overdue '''architecture upgrade''' on May, 9 2026.  It should lead to perceptible performance improvements.  We hope that this will make the site more enjoyable to use.  &lt;br /&gt;
&lt;br /&gt;
In the future, we plan to revisit the issue of performance, aware that more can be done. Also, we are aware that no one enjoys a slow unresponsive website. &lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Libre Pathology]].&lt;br /&gt;
*[[Libre Pathology news]].&lt;br /&gt;
&lt;br /&gt;
[[Category:Libre Pathology]]&lt;br /&gt;
[[Category:Libre Pathology news]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Libre_Pathology:Architecture_Upgrade_2026&amp;diff=53773</id>
		<title>Libre Pathology:Architecture Upgrade 2026</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Libre_Pathology:Architecture_Upgrade_2026&amp;diff=53773"/>
		<updated>2026-05-09T04:52:45Z</updated>

		<summary type="html">&lt;p&gt;Michael: Created page with &amp;quot;Libre Pathology got a much overdue '''architecture upgrade''' on May, 9 2026.  It should lead to perceptible performance improvements.  We hope that this will make the sit...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Libre Pathology]] got a much overdue '''architecture upgrade''' on May, 9 2026.  It should lead to perceptible performance improvements.  We hope that this will make the site more enjoyable to use.  &lt;br /&gt;
&lt;br /&gt;
In the future, we plan to revisit the issue of performance, aware that more can be done. Also, we are aware that no one enjoys a slow unresponsive website. &lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Libre Pathology]].&lt;br /&gt;
*[[Libre Pathology news]].&lt;br /&gt;
&lt;br /&gt;
[[Category:Libre Pathology]]&lt;br /&gt;
[[Category:Libre Pathology news]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Squamous_cell_carcinoma_of_the_penis&amp;diff=53772</id>
		<title>Squamous cell carcinoma of the penis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Squamous_cell_carcinoma_of_the_penis&amp;diff=53772"/>
		<updated>2026-02-28T14:44:01Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Sign out */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Squamous carcinoma of the penis -- low mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Squamous carcinoma of the penis. [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   =&lt;br /&gt;
| Micro      =&lt;br /&gt;
| Subtypes   = HPV-related SCC, Non-HPV-related SCC&lt;br /&gt;
| LMDDx      = [[penile intraepithelial neoplasia]], [[pseudoepitheliomatous hyperplasia]]&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      = mass lesion, scaly patches/nodules, usu. erythematous, +/-ulceration.&lt;br /&gt;
| Grossing   = [[penectomy]]&lt;br /&gt;
| Site       = [[penis]]&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx = uncircumcised&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = uncommon overall, most common form of penis cancer&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = good&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    =&lt;br /&gt;
| Tx         = surgery&lt;br /&gt;
}}&lt;br /&gt;
'''Squamous cell carcinoma of the penis''' is the most common malignancy of the [[penis]].&lt;br /&gt;
&lt;br /&gt;
''Penile cancer'' redirects to this article.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Not very common overall.&amp;lt;ref name=pmid24119832&amp;gt;{{Cite journal  | last1 = Burt | first1 = LM. | last2 = Shrieve | first2 = DC. | last3 = Tward | first3 = JD. | title = Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. | journal = Int J Radiat Oncol Biol Phys | volume = 88 | issue = 1 | pages = 94-100 | month = Jan | year = 2014 | doi = 10.1016/j.ijrobp.2013.08.013 | PMID = 24119832 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Most common form of penile cancer.&lt;br /&gt;
**Non-squamous penis cancer only ~5% of cases.&amp;lt;ref name=pmid24292119&amp;gt;{{Cite journal  | last1 = Moses | first1 = KA. | last2 = Sfakianos | first2 = JP. | last3 = Winer | first3 = A. | last4 = Bernstein | first4 = M. | last5 = Russo | first5 = P. | last6 = Dalbagni | first6 = G. | title = Non-squamous cell carcinoma of the penis: single-center, 15-year experience. | journal = World J Urol | volume =  | issue =  | pages =  | month = Dec | year = 2013 | doi = 10.1007/s00345-013-1216-y | PMID = 24292119 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Epidemiology:&amp;lt;ref name=pmid24119832/&amp;gt;&lt;br /&gt;
*Median age ~ 67 years old.&lt;br /&gt;
*Usually a good outcome - 5 year cause specific survival ~ 81%.&amp;lt;ref name=pmid24119832/&amp;gt;&lt;br /&gt;
*Possible association with sex with animals.&amp;lt;ref&amp;gt;{{Cite journal  | last1 = Zequi | first1 = Sde C. | last2 = Guimarães | first2 = GC. | last3 = da Fonseca | first3 = FP. | last4 = Ferreira | first4 = U. | last5 = de Matheus | first5 = WE. | last6 = Reis | first6 = LO. | last7 = Aita | first7 = GA. | last8 = Glina | first8 = S. | last9 = Fanni | first9 = VS. | title = Sex with animals (SWA): behavioral characteristics and possible association with penile cancer. A multicenter study. | journal = J Sex Med | volume = 9 | issue = 7 | pages = 1860-7 | month = Jul | year = 2012 | doi = 10.1111/j.1743-6109.2011.02512.x | PMID = 22023719 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Scaly patches/nodules.&lt;br /&gt;
*Usually erythematous.&lt;br /&gt;
*+/-Ulceration.&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&lt;br /&gt;
*See ''[[squamous cell carcinoma]]''.&lt;br /&gt;
&lt;br /&gt;
Notes:&lt;br /&gt;
*[[Lymphovascular invasion]] - prognostically important,&amp;lt;ref name=pmid19488760&amp;gt;{{Cite journal  | last1 = Bhagat | first1 = SK. | last2 = Gopalakrishnan | first2 = G. | last3 = Kekre | first3 = NS. | last4 = Chacko | first4 = NK. | last5 = Kumar | first5 = S. | last6 = Manipadam | first6 = MT. | last7 = Samuel | first7 = P. | title = Factors predicting inguinal node metastasis in squamous cell cancer of penis. | journal = World J Urol | volume = 28 | issue = 1 | pages = 93-8 | month = Feb | year = 2010 | doi = 10.1007/s00345-009-0421-1 | PMID = 19488760 }}&amp;lt;/ref&amp;gt; and changes the T-stage for pT1a tumours to pT1b.&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Penile intraepithelial neoplasia]] (squamous dysplasia).&lt;br /&gt;
*[[Pseudoepitheliomatous hyperplasia]].&lt;br /&gt;
&lt;br /&gt;
===Subtyping===&lt;br /&gt;
*''Non-HPV-related squamous cell carcinoma. &lt;br /&gt;
**p16 -ve, p53 +ve.{{fact}}&lt;br /&gt;
*''HPV-related squamous cell carcinoma''. &lt;br /&gt;
**p16 +ve, p53 -ve.{{fact}}&lt;br /&gt;
&lt;br /&gt;
===Grading===&lt;br /&gt;
*G1 - well differentiated. §&lt;br /&gt;
**Almost normal appearing - diagnosis of malignancy may be challenging.&lt;br /&gt;
*G2 - moderately differentiated. §&lt;br /&gt;
*G3 - poorly differentiated.&lt;br /&gt;
**Anaplastic cells.&lt;br /&gt;
**Typically little or no keratinization.&lt;br /&gt;
*GX - cannot be assessed.&lt;br /&gt;
&lt;br /&gt;
Notes:&lt;br /&gt;
*§ The differentiation between G1 and G2 is similar to [[squamous cell carcinoma of the head and neck]].&lt;br /&gt;
*G2 (moderately differentiated) is the most common.&amp;lt;ref name=pmid24119832/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Staging===&lt;br /&gt;
T-stage:&lt;br /&gt;
*pT1a - subepithelial tissue involved, no [[LVI]], not poorly differentiated (G3).&lt;br /&gt;
*pT1b - subepithelial tissue involved with [[LVI]] ''or'' poorly differentiated.&lt;br /&gt;
*pT2 - corpus spongiosum or cavernosum involved.&lt;br /&gt;
*pT3 - urethral involvement.&lt;br /&gt;
*pT4 - adjacent structure(s) involved.&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Squamous carcinoma of the penis -- low mag.jpg | Penile SCC - low mag.&lt;br /&gt;
Image: Squamous carcinoma of the penis -- high mag.jpg | Penile SCC - high mag.&lt;br /&gt;
Image: Squamous carcinoma of the penis - alt -- high mag.jpg | Penile SCC - high mag.&lt;br /&gt;
Image: Squamous carcinoma of the penis - 2 -- intermed mag.jpg | Penile SCC - intermed. mag.&lt;br /&gt;
Image: Squamous carcinoma of the penis - 2 -- high mag.jpg | Penile SCC - high mag.&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==IHC==&lt;br /&gt;
*p16 +ve - in types associated with [[HPV]] (basaloid SCC, warty SCC and warty-basaloid SCC).&amp;lt;ref name=pmid22367299&amp;gt;{{Cite journal  | last1 = Cubilla | first1 = AL. | last2 = Lloveras | first2 = B. | last3 = Alemany | first3 = L. | last4 = Alejo | first4 = M. | last5 = Vidal | first5 = A. | last6 = Kasamatsu | first6 = E. | last7 = Clavero | first7 = O. | last8 = Alvarado-Cabrero | first8 = I. | last9 = Lynch | first9 = C. | title = Basaloid squamous cell carcinoma of the penis with papillary features: a clinicopathologic study of 12 cases. | journal = Am J Surg Pathol | volume = 36 | issue = 6 | pages = 869-75 | month = Jun | year = 2012 | doi = 10.1097/PAS.0b013e318249c6f3 | PMID = 22367299 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
===Biopsy===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
Penis, Biopsy:&lt;br /&gt;
- INVASIVE SQUAMOUS CELL CARCINOMA, well differentiated.&lt;br /&gt;
&lt;br /&gt;
Comment:&lt;br /&gt;
The tumour has differentiated penile intraepithelial neoplasia adjacent to it. The tumour is p16 negative and p53 positive.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Resection===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
Tip of Penis, Partial Penectomy:&lt;br /&gt;
- Invasive squamous cell carcinoma, moderately differentiated (G2).&lt;br /&gt;
-- Invasion into the lamina propria.&lt;br /&gt;
-- Surgical margins negative for dysplasia and negative for malignancy.&lt;br /&gt;
-- TNM stage: pT1a pNx.&lt;br /&gt;
-- Please see tumour summary.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===All caps===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
TIP OF PENIS, PARTIAL PENECTOMY:&lt;br /&gt;
- INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED.&lt;br /&gt;
-- SURGICAL MARGINS NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.&lt;br /&gt;
-- PLEASE SEE TUMOUR SUMMARY.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
TIP OF PENIS, PARTIAL PENECTOMY:&lt;br /&gt;
- INVASIVE SQUAMOUS CELL CARCINOMA OF CORONAL SULCUS, MODERATELY DIFFERENTIATED.&lt;br /&gt;
-- SURGICAL MARGINS NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.&lt;br /&gt;
- LICHEN SCLEROSIS.&lt;br /&gt;
- POST-SURGICAL CHANGES (GRANULOMATOUS INFLAMMATION (NON-NECROTIZING), SIDEROPHAGES).&lt;br /&gt;
&lt;br /&gt;
COMMENT:&lt;br /&gt;
This lesion was previously excised. The surgical clearance is 1 mm. The tumour &lt;br /&gt;
thickness is approximately 4 mm. No lymphovascular invasion is identified. No &lt;br /&gt;
lymphovascular invasion is identified. No corpus spongiosum or corpus cavernosum&lt;br /&gt;
invasion is seen. The staging is unchanged.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Micro===&lt;br /&gt;
The sections show a malignant tumour with moderate to severe anisonucleosis. It focally underlies keratinizing epithelium that matures to the surface. Intracellular bridges are present focally. Keratinization is present.  Mitotic activity is easily identified.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Penis]].&lt;br /&gt;
*[[Squamous cell carcinoma]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnosis]]&lt;br /&gt;
[[Category:Penis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Talk:Adrenal_cortical_adenoma&amp;diff=53771</id>
		<title>Talk:Adrenal cortical adenoma</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Talk:Adrenal_cortical_adenoma&amp;diff=53771"/>
		<updated>2025-12-24T15:57:45Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Adrenal cortical tumour */ new section&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Molecular==&lt;br /&gt;
https://www.ncbi.nlm.nih.gov/books/NBK539906/&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
! Gene&lt;br /&gt;
! Serology&lt;br /&gt;
! Association&lt;br /&gt;
|-&lt;br /&gt;
|CTNNB1&lt;br /&gt;
|non-secreting adenoma&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|PRKACA &lt;br /&gt;
|cortisol-producing&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|GNAS1 &lt;br /&gt;
|cortisol-producing&lt;br /&gt;
|[[McCune-Albright syndrome]]&lt;br /&gt;
|-&lt;br /&gt;
|MENIN &lt;br /&gt;
|cortisol-producing&lt;br /&gt;
|[[multiple endocrine neoplasm type 1]]&lt;br /&gt;
|-&lt;br /&gt;
|ARMC5 &lt;br /&gt;
|cortisol-producing&lt;br /&gt;
|primary bilateral macronodular adrenal hyperplasia&lt;br /&gt;
|-&lt;br /&gt;
|APC &lt;br /&gt;
|cortisol-producing&lt;br /&gt;
|primary bilateral macronodular adrenal hyperplasia&lt;br /&gt;
|-&lt;br /&gt;
|FH &lt;br /&gt;
|cortisol-producing&lt;br /&gt;
|primary bilateral macronodular adrenal hyperplasia&lt;br /&gt;
&lt;br /&gt;
--&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Adrenal cortical tumour ==&lt;br /&gt;
&lt;br /&gt;
https://pubmed.ncbi.nlm.nih.gov/35288842/ - 2022 Classification&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Talk:Male_infertility&amp;diff=53770</id>
		<title>Talk:Male infertility</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Talk:Male_infertility&amp;diff=53770"/>
		<updated>2025-12-24T14:41:46Z</updated>

		<summary type="html">&lt;p&gt;Michael: Created page with &amp;quot;==Notes== post-testicular cause??: spinal cord injury * https://pubmed.ncbi.nlm.nih.gov/3544454/ - general causes in assoc with SCI * https://pubmed.ncbi.nlm.nih.gov/20932558/...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Notes==&lt;br /&gt;
post-testicular cause??: spinal cord injury&lt;br /&gt;
* https://pubmed.ncbi.nlm.nih.gov/3544454/ - general causes in assoc with SCI&lt;br /&gt;
* https://pubmed.ncbi.nlm.nih.gov/20932558/  - electroejaculatory stimulation&lt;br /&gt;
&lt;br /&gt;
* https://pubmed.ncbi.nlm.nih.gov/16887924/ -  review of testicular biopsy&lt;br /&gt;
** nuggets: (1) not every tubule must have spermatids (but ought to have various cell types), (to confirm) (2)  Sertoli only tubules may be seen with adjacent normal -&amp;gt; likely hypospermatogenesis; (3) inter-tubular tissue must be normal for &amp;quot;normal testis&amp;quot; diagnosis (e.g. no ''Leydig cell micronodules'')&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53769</id>
		<title>Male infertility</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53769"/>
		<updated>2025-12-24T14:40:15Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Hypospematogensis */ fix sp&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Male infertility -- intermed mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Mixed pattern male infertility (Sertoli cells only mixed with hypospermatogensis). [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   =&lt;br /&gt;
| Micro      = various patterns - see ''microscopic''&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[germ cell neoplasia in situ]], [[germ cell tumour]], inflammation of the testis&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = [[testis]], [[vas deferens]] and other sites&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = not very common&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = benign&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = ([[clinical diagnosis]])&lt;br /&gt;
| Tx         = dependent on underlying cause&lt;br /&gt;
}}&lt;br /&gt;
'''Male infertility''' is a [[clinical diagnosis]].  It is pretty much the only reason for a [[testis|testicular]] biopsy.&lt;br /&gt;
&lt;br /&gt;
This article focuses on the testicular causes of infertility. ''Testicular biopsy'' redirects to here.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Infertility is a [[clinical diagnosis]].&lt;br /&gt;
&lt;br /&gt;
It can be divided into:&amp;lt;ref name=pmid20670143&amp;gt;{{cite journal |authors=Cerilli LA, Kuang W, Rogers D |title=A practical approach to testicular biopsy interpretation for male infertility |journal=Arch Pathol Lab Med |volume=134 |issue=8 |pages=1197–204 |date=August 2010 |pmid=20670143 |doi=10.5858/2009-0379-RA.1 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Pre-testicular - e.g. hormonal, [[pituitary gland|pituitary]].&lt;br /&gt;
*Testicular.&lt;br /&gt;
*Post-testicular - e.g. blockage of [[vas deferens]].&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Male infertility on testicular biopsy shows one the following patterns:&amp;lt;ref name=pmid20670143/&amp;gt;&lt;br /&gt;
#Normal testis.&lt;br /&gt;
#Hypospermatogensis.&lt;br /&gt;
#Maturation arrest.&lt;br /&gt;
#Sertoli cells only.&lt;br /&gt;
#Seminiferous tubule hyalinization&lt;br /&gt;
#Some combination of the above patterns.&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Germ cell neoplasia in situ]] (GCNIS).&lt;br /&gt;
*[[Germ cell tumour]].&lt;br /&gt;
*[[Testicular adrenal rest tumour]] in the context of congenital adrenal hyperplasia - case report.&amp;lt;ref name=pmid23342900&amp;gt;{{Cite journal  | last1 = Niedziela | first1 = M. | last2 = Joanna | first2 = T. | last3 = Piotr | first3 = J. | title = Testicular adrenal rest tumors (TARTs) as a male infertility factor. Case report. | journal = Ginekol Pol | volume = 83 | issue = 9 | pages = 700-2 | month = Sep | year = 2012 | doi =  | PMID = 23342900 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Inflammation of the testis.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
*The diagnosis should be the pattern (#1-6 above).&lt;br /&gt;
&lt;br /&gt;
The following should be commented on:&lt;br /&gt;
*The number of tubules.&lt;br /&gt;
*The number of tubules with sperm.&lt;br /&gt;
*Hyalinization of the tubules.&lt;br /&gt;
*Inflammation.&lt;br /&gt;
*Absence of [[germ cell neoplasia in situ]].&lt;br /&gt;
&lt;br /&gt;
===Mixed pattern===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
LEFT TESTIS, BIOPSY WITH SPERM RETRIEVAL:&lt;br /&gt;
- SERTOLI CELLS ONLY REGIONS (25% OF BIOPSY) INTERMIXED WITH&lt;br /&gt;
  HISTOLOGICALLY NORMAL TESTIS (75% OF BIOPSY) WITH NORMAL NUMBERS&lt;br /&gt;
  OF SPERM.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT SEMINIFEROUS TUBULE HYALINIZATION.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT INFLAMMATION.&lt;br /&gt;
- NEGATIVE FOR GERM CELL NEOPLASIA IN SITU (INTRATUBULAR GERM CELL NEOPLASIA).&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Hypospematogensis===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
A. Left Testis, Biopsy with Sperm Retrieval:&lt;br /&gt;
- Hypospematogensis (70% of biopsy) intermixed with histologically normal &lt;br /&gt;
  test (30% of biopsy) with normal numbers of sperm.&lt;br /&gt;
- NEGATIVE for significant seminiferous tubule hyalinization.&lt;br /&gt;
- NEGATIVE for significant inflammation.&lt;br /&gt;
- NEGATIVE for germ cell neoplasia in situ.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Normal===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
A. Right Testis, Biopsy:&lt;br /&gt;
- Testis within normal limits with spermatogenesis.&lt;br /&gt;
- NEGATIVE for significant inter-tubular changes.&lt;br /&gt;
- NEGATIVE for significant seminiferous tubule hyalinization.&lt;br /&gt;
- NEGATIVE for significant inflammation.&lt;br /&gt;
- NEGATIVE for germ cell neoplasia in situ.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testis]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Genitourinary pathology]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Testicular_metastasis&amp;diff=53768</id>
		<title>Testicular metastasis</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Testicular_metastasis&amp;diff=53768"/>
		<updated>2025-11-19T16:43:18Z</updated>

		<summary type="html">&lt;p&gt;Michael: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Testis with prostate carcinoma -- low mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Testis with metastatic prostate carcinoma. [[H&amp;amp;E stain]]. (WC)&lt;br /&gt;
| Synonyms   = testicle with metastatic disease&lt;br /&gt;
| Micro      = atypical cells between seminiferous tubules, negative for [[GCNIS]], +/-lymphovascular invasion&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[Primary testicular carcinoid tumour]], [[germ cell tumours]], others&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        = IHC dependent on primary site (usually OCT4 -ve, AFP -ve, beta-hCG -ve, [[SALL4]] -ve)&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Staging    =&lt;br /&gt;
| Site       = [[testis]]&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx = +/-history of malignancy&lt;br /&gt;
| Signs      = testicular mass&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = rare - esp. as first presentation&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = poor&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = primary testicular tumour&lt;br /&gt;
| Tx         =&lt;br /&gt;
}}&lt;br /&gt;
'''Testicular metastasis''' is a the discontiguous spread of a [[cancer|malignant tumour]] to the [[testis]].&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Rare as first presentation - case report worthy.&amp;lt;ref name=pmid26074716&amp;gt;{{Cite journal  | last1 = Li | first1 = B. | last2 = Cai | first2 = H. | last3 = Kang | first3 = ZC. | last4 = Wu | first4 = H. | last5 = Hou | first5 = JG. | last6 = Ma | first6 = LY. | title = Testicular metastasis from gastric carcinoma: A case report. | journal = World J Gastroenterol | volume = 21 | issue = 21 | pages = 6764-8 | month = Jun | year = 2015 | doi = 10.3748/wjg.v21.i21.6764 | PMID = 26074716 }}&amp;lt;/ref&amp;gt;&amp;lt;reF name=pmid26066034&amp;gt;{{Cite journal  | last1 = Cormio | first1 = L. | last2 = Sanguedolce | first2 = F. | last3 = Massenio | first3 = P. | last4 = Di Fino | first4 = G. | last5 = Bruno | first5 = M. | last6 = Carrieri | first6 = G. | title = Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: a case report. | journal = J Med Case Rep | volume = 9 | issue =  | pages = 139 | month =  | year = 2015 | doi = 10.1186/s13256-015-0626-4 | PMID = 26066034 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*May be the first manifestation of an abdominal malignancy.&amp;lt;ref name=pmid26066034/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Reports:&lt;br /&gt;
*Stomach ([[gastric carcinoma]]).&amp;lt;ref name=pmid26074716/&amp;gt;&lt;br /&gt;
*Pancreas.&amp;lt;ref name=pmid26066034/&amp;gt;&lt;br /&gt;
*Kidney ([[renal cell carcinoma]]).&amp;lt;ref name=pmi26011366&amp;gt;{{Cite journal  | last1 = Fragkoulis | first1 = C. | last2 = Pappas | first2 = A. | last3 = Goumas | first3 = G. | last4 = Gkialas | first4 = I. | last5 = Ntoumas | first5 = K. | title = Renal cell carcinoma with metastasis to the testis. | journal = J BUON | volume = 20 | issue = 2 | pages = 663 | month =  | year =  | doi =  | PMID = 26011366 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Prostatic carcinoma|Prostate]].&amp;lt;ref name=pmid25994435&amp;gt;{{Cite journal  | last1 = Shinn | first1 = BJ. | last2 = Greenwald | first2 = DW. | last3 = Ahmad | first3 = N. | title = Unilateral testicular metastasis of low PSA level prostatic adenocarcinoma. | journal = BMJ Case Rep | volume = 2015 | issue =  | pages =  | month =  | year = 2015 | doi = 10.1136/bcr-2015-209914 | PMID = 25994435 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Lung ([[squamous cell carcinoma of the lung]]).&amp;lt;ref name=pmid25873879&amp;gt;{{Cite journal  | last1 = Buck | first1 = DA. | last2 = Byrd | first2 = RH. | last3 = Holmes | first3 = CL. | last4 = Pollock | first4 = T. | title = Testicular metastasis in a case of squamous cell carcinoma of the lung. | journal = Case Rep Oncol | volume = 8 | issue = 1 | pages = 133-7 | month =  | year =  | doi = 10.1159/000380814 | PMID = 25873879 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Most common in order:&amp;lt;ref name=pmid26066034/&amp;gt;&lt;br /&gt;
*Prostate, lung, melanoma, kidney, GI tract.&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&lt;br /&gt;
*Lack of [[germ cell neoplasia in situ]] (GCNIS).&lt;br /&gt;
*Atypical cells infiltrating between benign-appearing seminiferous tubules.&lt;br /&gt;
*+/-[[Lymphovascular invasion]].&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Germ cell tumours]] - esp. [[embryonal carcinoma]].&lt;br /&gt;
*Malignant [[sex cord stromal tumour]].&lt;br /&gt;
*[[Lymphoma]].&lt;br /&gt;
*[[Primary testicular carcinoid tumour]].&amp;lt;ref name=pmid30799770&amp;gt;{{cite journal |authors=Darré T, Doukouré B, Kouyaté M, Djiwa T, Kwamé D, Napo-Koura G |title=A rare testicular tumor: primary carcinoid tumor |journal=Tumori |volume=105 |issue=6 |pages=NP20–NP23 |date=December 2019 |pmid=30799770 |doi=10.1177/0300891619832263 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image: Testis with prostate carcinoma -- very low mag.jpg | Testis with PCa - very low mag.&lt;br /&gt;
Image: Testis with prostate carcinoma -- low mag.jpg | Testis with PCa - low mag.&lt;br /&gt;
Image: Testis with prostate carcinoma -- intermed mag.jpg | Testis with PCa - intermed. mag.&lt;br /&gt;
Image: Testis with prostate carcinoma - alt -- intermed mag.jpg | Testis with PCa - intermed. mag.&lt;br /&gt;
Image: Testis with prostate carcinoma -- high mag.jpg | Testis with PCa - high mag.&lt;br /&gt;
&lt;br /&gt;
Image: Testis with prostate carcinoma - 2 -- low mag.jpg | Testis with PCa - low mag.&lt;br /&gt;
Image: Testis with prostate carcinoma - 2 -- intermed mag.jpg | Testis with PCa - intermed. mag.&lt;br /&gt;
Image: Testis with prostate carcinoma - 2 -- high mag.jpg | Testis with PCa - high mag.&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
====www====&lt;br /&gt;
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376918/figure/F1/ Lung squamous carcinoma in the testis (nih.gov)].&amp;lt;ref name=pmid25873879&amp;gt;{{Cite journal  | last1 = Buck | first1 = DA. | last2 = Byrd | first2 = RH. | last3 = Holmes | first3 = CL. | last4 = Pollock | first4 = T. | title = Testicular metastasis in a case of squamous cell carcinoma of the lung. | journal = Case Rep Oncol | volume = 8 | issue = 1 | pages = 133-7 | month =  | year =  | doi = 10.1159/000380814 | PMID = 25873879 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testis]].&lt;br /&gt;
*[[Metastasis]].&lt;br /&gt;
*[[Ovarian metastasis]].&lt;br /&gt;
*[[Testicular cancer]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Testis]]&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53767</id>
		<title>Male infertility</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53767"/>
		<updated>2025-11-14T15:03:00Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Hypospematogensis */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Male infertility -- intermed mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Mixed pattern male infertility (Sertoli cells only mixed with hypospermatogensis). [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   =&lt;br /&gt;
| Micro      = various patterns - see ''microscopic''&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[germ cell neoplasia in situ]], [[germ cell tumour]], inflammation of the testis&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = [[testis]], [[vas deferens]] and other sites&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = not very common&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = benign&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = ([[clinical diagnosis]])&lt;br /&gt;
| Tx         = dependent on underlying cause&lt;br /&gt;
}}&lt;br /&gt;
'''Male infertility''' is a [[clinical diagnosis]].  It is pretty much the only reason for a [[testis|testicular]] biopsy.&lt;br /&gt;
&lt;br /&gt;
This article focuses on the testicular causes of infertility. ''Testicular biopsy'' redirects to here.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Infertility is a [[clinical diagnosis]].&lt;br /&gt;
&lt;br /&gt;
It can be divided into:&amp;lt;ref name=pmid20670143&amp;gt;{{cite journal |authors=Cerilli LA, Kuang W, Rogers D |title=A practical approach to testicular biopsy interpretation for male infertility |journal=Arch Pathol Lab Med |volume=134 |issue=8 |pages=1197–204 |date=August 2010 |pmid=20670143 |doi=10.5858/2009-0379-RA.1 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Pre-testicular - e.g. hormonal, [[pituitary gland|pituitary]].&lt;br /&gt;
*Testicular.&lt;br /&gt;
*Post-testicular - e.g. blockage of [[vas deferens]].&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Male infertility on testicular biopsy shows one the following patterns:&amp;lt;ref name=pmid20670143/&amp;gt;&lt;br /&gt;
#Normal testis.&lt;br /&gt;
#Hypospermatogensis.&lt;br /&gt;
#Maturation arrest.&lt;br /&gt;
#Sertoli cells only.&lt;br /&gt;
#Seminiferous tubule hyalinization&lt;br /&gt;
#Some combination of the above patterns.&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Germ cell neoplasia in situ]] (GCNIS).&lt;br /&gt;
*[[Germ cell tumour]].&lt;br /&gt;
*[[Testicular adrenal rest tumour]] in the context of congenital adrenal hyperplasia - case report.&amp;lt;ref name=pmid23342900&amp;gt;{{Cite journal  | last1 = Niedziela | first1 = M. | last2 = Joanna | first2 = T. | last3 = Piotr | first3 = J. | title = Testicular adrenal rest tumors (TARTs) as a male infertility factor. Case report. | journal = Ginekol Pol | volume = 83 | issue = 9 | pages = 700-2 | month = Sep | year = 2012 | doi =  | PMID = 23342900 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Inflammation of the testis.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
*The diagnosis should be the pattern (#1-6 above).&lt;br /&gt;
&lt;br /&gt;
The following should be commented on:&lt;br /&gt;
*The number of tubules.&lt;br /&gt;
*The number of tubules with sperm.&lt;br /&gt;
*Hyalinization of the tubules.&lt;br /&gt;
*Inflammation.&lt;br /&gt;
*Absence of [[germ cell neoplasia in situ]].&lt;br /&gt;
&lt;br /&gt;
===Mixed pattern===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
LEFT TESTIS, BIOPSY WITH SPERM RETRIEVAL:&lt;br /&gt;
- SERTOLI CELLS ONLY REGIONS (25% OF BIOPSY) INTERMIXED WITH&lt;br /&gt;
  HISTOLOGICALLY NORMAL TESTIS (75% OF BIOPSY) WITH NORMAL NUMBERS&lt;br /&gt;
  OF SPERM.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT SEMINIFEROUS TUBULE HYALINIZATION.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT INFLAMMATION.&lt;br /&gt;
- NEGATIVE FOR GERM CELL NEOPLASIA IN SITU (INTRATUBULAR GERM CELL NEOPLASIA).&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Hypospematogensis===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
A. Left Testis, Biopsy with Sperm Retrieval:&lt;br /&gt;
- Hypospematogensis (70% of biopsy) intermixed with histologically normal &lt;br /&gt;
  test (30% of biopsy) with normal numbers of sperm.&lt;br /&gt;
- NEGATIVE for significant semineferous tubule hyalinization.&lt;br /&gt;
- NEGATIVE for significant inflammation.&lt;br /&gt;
- NEGATIVE for germ cell neoplasia in situ.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testis]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Genitourinary pathology]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53766</id>
		<title>Male infertility</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53766"/>
		<updated>2025-11-14T15:02:27Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Sign out */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Male infertility -- intermed mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Mixed pattern male infertility (Sertoli cells only mixed with hypospermatogensis). [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   =&lt;br /&gt;
| Micro      = various patterns - see ''microscopic''&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[germ cell neoplasia in situ]], [[germ cell tumour]], inflammation of the testis&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = [[testis]], [[vas deferens]] and other sites&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = not very common&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = benign&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = ([[clinical diagnosis]])&lt;br /&gt;
| Tx         = dependent on underlying cause&lt;br /&gt;
}}&lt;br /&gt;
'''Male infertility''' is a [[clinical diagnosis]].  It is pretty much the only reason for a [[testis|testicular]] biopsy.&lt;br /&gt;
&lt;br /&gt;
This article focuses on the testicular causes of infertility. ''Testicular biopsy'' redirects to here.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Infertility is a [[clinical diagnosis]].&lt;br /&gt;
&lt;br /&gt;
It can be divided into:&amp;lt;ref name=pmid20670143&amp;gt;{{cite journal |authors=Cerilli LA, Kuang W, Rogers D |title=A practical approach to testicular biopsy interpretation for male infertility |journal=Arch Pathol Lab Med |volume=134 |issue=8 |pages=1197–204 |date=August 2010 |pmid=20670143 |doi=10.5858/2009-0379-RA.1 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Pre-testicular - e.g. hormonal, [[pituitary gland|pituitary]].&lt;br /&gt;
*Testicular.&lt;br /&gt;
*Post-testicular - e.g. blockage of [[vas deferens]].&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Male infertility on testicular biopsy shows one the following patterns:&amp;lt;ref name=pmid20670143/&amp;gt;&lt;br /&gt;
#Normal testis.&lt;br /&gt;
#Hypospermatogensis.&lt;br /&gt;
#Maturation arrest.&lt;br /&gt;
#Sertoli cells only.&lt;br /&gt;
#Seminiferous tubule hyalinization&lt;br /&gt;
#Some combination of the above patterns.&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Germ cell neoplasia in situ]] (GCNIS).&lt;br /&gt;
*[[Germ cell tumour]].&lt;br /&gt;
*[[Testicular adrenal rest tumour]] in the context of congenital adrenal hyperplasia - case report.&amp;lt;ref name=pmid23342900&amp;gt;{{Cite journal  | last1 = Niedziela | first1 = M. | last2 = Joanna | first2 = T. | last3 = Piotr | first3 = J. | title = Testicular adrenal rest tumors (TARTs) as a male infertility factor. Case report. | journal = Ginekol Pol | volume = 83 | issue = 9 | pages = 700-2 | month = Sep | year = 2012 | doi =  | PMID = 23342900 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Inflammation of the testis.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
*The diagnosis should be the pattern (#1-6 above).&lt;br /&gt;
&lt;br /&gt;
The following should be commented on:&lt;br /&gt;
*The number of tubules.&lt;br /&gt;
*The number of tubules with sperm.&lt;br /&gt;
*Hyalinization of the tubules.&lt;br /&gt;
*Inflammation.&lt;br /&gt;
*Absence of [[germ cell neoplasia in situ]].&lt;br /&gt;
&lt;br /&gt;
===Mixed pattern===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
LEFT TESTIS, BIOPSY WITH SPERM RETRIEVAL:&lt;br /&gt;
- SERTOLI CELLS ONLY REGIONS (25% OF BIOPSY) INTERMIXED WITH&lt;br /&gt;
  HISTOLOGICALLY NORMAL TESTIS (75% OF BIOPSY) WITH NORMAL NUMBERS&lt;br /&gt;
  OF SPERM.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT SEMINIFEROUS TUBULE HYALINIZATION.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT INFLAMMATION.&lt;br /&gt;
- NEGATIVE FOR GERM CELL NEOPLASIA IN SITU (INTRATUBULAR GERM CELL NEOPLASIA).&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Hypospematogensis===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
A. Left Testis, Biopsy with Sperm Retrieval:&lt;br /&gt;
- Hypospematogensis (70% of biopsy) intermixed with histologically normal &lt;br /&gt;
  test (30% of biopsy) with normal numbers of sperm.&lt;br /&gt;
- NEGATIVE for significant semineferous tubule hyalinization.&lt;br /&gt;
- NEGATIVE for significant inflammation&lt;br /&gt;
- NEGATIVE for germ cell neoplasia in situ.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testis]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Genitourinary pathology]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53765</id>
		<title>Male infertility</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53765"/>
		<updated>2025-11-14T15:00:22Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Mixed pattern */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Male infertility -- intermed mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Mixed pattern male infertility (Sertoli cells only mixed with hypospermatogensis). [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   =&lt;br /&gt;
| Micro      = various patterns - see ''microscopic''&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[germ cell neoplasia in situ]], [[germ cell tumour]], inflammation of the testis&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = [[testis]], [[vas deferens]] and other sites&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = not very common&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = benign&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = ([[clinical diagnosis]])&lt;br /&gt;
| Tx         = dependent on underlying cause&lt;br /&gt;
}}&lt;br /&gt;
'''Male infertility''' is a [[clinical diagnosis]].  It is pretty much the only reason for a [[testis|testicular]] biopsy.&lt;br /&gt;
&lt;br /&gt;
This article focuses on the testicular causes of infertility. ''Testicular biopsy'' redirects to here.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Infertility is a [[clinical diagnosis]].&lt;br /&gt;
&lt;br /&gt;
It can be divided into:&amp;lt;ref name=pmid20670143&amp;gt;{{cite journal |authors=Cerilli LA, Kuang W, Rogers D |title=A practical approach to testicular biopsy interpretation for male infertility |journal=Arch Pathol Lab Med |volume=134 |issue=8 |pages=1197–204 |date=August 2010 |pmid=20670143 |doi=10.5858/2009-0379-RA.1 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Pre-testicular - e.g. hormonal, [[pituitary gland|pituitary]].&lt;br /&gt;
*Testicular.&lt;br /&gt;
*Post-testicular - e.g. blockage of [[vas deferens]].&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Male infertility on testicular biopsy shows one the following patterns:&amp;lt;ref name=pmid20670143/&amp;gt;&lt;br /&gt;
#Normal testis.&lt;br /&gt;
#Hypospermatogensis.&lt;br /&gt;
#Maturation arrest.&lt;br /&gt;
#Sertoli cells only.&lt;br /&gt;
#Seminiferous tubule hyalinization&lt;br /&gt;
#Some combination of the above patterns.&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Germ cell neoplasia in situ]] (GCNIS).&lt;br /&gt;
*[[Germ cell tumour]].&lt;br /&gt;
*[[Testicular adrenal rest tumour]] in the context of congenital adrenal hyperplasia - case report.&amp;lt;ref name=pmid23342900&amp;gt;{{Cite journal  | last1 = Niedziela | first1 = M. | last2 = Joanna | first2 = T. | last3 = Piotr | first3 = J. | title = Testicular adrenal rest tumors (TARTs) as a male infertility factor. Case report. | journal = Ginekol Pol | volume = 83 | issue = 9 | pages = 700-2 | month = Sep | year = 2012 | doi =  | PMID = 23342900 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Inflammation of the testis.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
*The diagnosis should be the pattern (#1-6 above).&lt;br /&gt;
&lt;br /&gt;
The following should be commented on:&lt;br /&gt;
*The number of tubules.&lt;br /&gt;
*The number of tubules with sperm.&lt;br /&gt;
*Hyalinization of the tubules.&lt;br /&gt;
*Inflammation.&lt;br /&gt;
*Absence of [[germ cell neoplasia in situ]].&lt;br /&gt;
&lt;br /&gt;
===Mixed pattern===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
LEFT TESTIS, BIOPSY FOR SPERM RETRIEVAL:&lt;br /&gt;
- SERTOLI CELLS ONLY REGIONS (25% OF BIOPSY) INTERMIXED WITH&lt;br /&gt;
  HISTOLOGICALLY NORMAL TESTIS (75% OF BIOPSY) WITH NORMAL NUMBERS&lt;br /&gt;
  OF SPERM.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT SEMINIFEROUS TUBULE HYALINIZATION.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT INFLAMMATION.&lt;br /&gt;
- NEGATIVE FOR GERM CELL NEOPLASIA IN SITU (INTRATUBULAR GERM CELL NEOPLASIA).&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Hypospematogensis===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
A. Left Testis, Biopsy:&lt;br /&gt;
- Hypospematogensis (70% of biopsy) intermixed with histologically normal &lt;br /&gt;
  test (30% of biopsy) with normal numbers of sperm.&lt;br /&gt;
- NEGATIVE for significant semineferous tubule hyalinization.&lt;br /&gt;
- NEGATIVE for significant inflammation&lt;br /&gt;
- NEGATIVE for germ cell neoplasia in situ.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testis]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Genitourinary pathology]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53764</id>
		<title>Male infertility</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53764"/>
		<updated>2025-11-14T14:56:14Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Mixed pattern */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Male infertility -- intermed mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Mixed pattern male infertility (Sertoli cells only mixed with hypospermatogensis). [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   =&lt;br /&gt;
| Micro      = various patterns - see ''microscopic''&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[germ cell neoplasia in situ]], [[germ cell tumour]], inflammation of the testis&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = [[testis]], [[vas deferens]] and other sites&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = not very common&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = benign&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = ([[clinical diagnosis]])&lt;br /&gt;
| Tx         = dependent on underlying cause&lt;br /&gt;
}}&lt;br /&gt;
'''Male infertility''' is a [[clinical diagnosis]].  It is pretty much the only reason for a [[testis|testicular]] biopsy.&lt;br /&gt;
&lt;br /&gt;
This article focuses on the testicular causes of infertility. ''Testicular biopsy'' redirects to here.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Infertility is a [[clinical diagnosis]].&lt;br /&gt;
&lt;br /&gt;
It can be divided into:&amp;lt;ref name=pmid20670143&amp;gt;{{cite journal |authors=Cerilli LA, Kuang W, Rogers D |title=A practical approach to testicular biopsy interpretation for male infertility |journal=Arch Pathol Lab Med |volume=134 |issue=8 |pages=1197–204 |date=August 2010 |pmid=20670143 |doi=10.5858/2009-0379-RA.1 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Pre-testicular - e.g. hormonal, [[pituitary gland|pituitary]].&lt;br /&gt;
*Testicular.&lt;br /&gt;
*Post-testicular - e.g. blockage of [[vas deferens]].&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Male infertility on testicular biopsy shows one the following patterns:&amp;lt;ref name=pmid20670143/&amp;gt;&lt;br /&gt;
#Normal testis.&lt;br /&gt;
#Hypospermatogensis.&lt;br /&gt;
#Maturation arrest.&lt;br /&gt;
#Sertoli cells only.&lt;br /&gt;
#Seminiferous tubule hyalinization&lt;br /&gt;
#Some combination of the above patterns.&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Germ cell neoplasia in situ]] (GCNIS).&lt;br /&gt;
*[[Germ cell tumour]].&lt;br /&gt;
*[[Testicular adrenal rest tumour]] in the context of congenital adrenal hyperplasia - case report.&amp;lt;ref name=pmid23342900&amp;gt;{{Cite journal  | last1 = Niedziela | first1 = M. | last2 = Joanna | first2 = T. | last3 = Piotr | first3 = J. | title = Testicular adrenal rest tumors (TARTs) as a male infertility factor. Case report. | journal = Ginekol Pol | volume = 83 | issue = 9 | pages = 700-2 | month = Sep | year = 2012 | doi =  | PMID = 23342900 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Inflammation of the testis.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
*The diagnosis should be the pattern (#1-6 above).&lt;br /&gt;
&lt;br /&gt;
The following should be commented on:&lt;br /&gt;
*The number of tubules.&lt;br /&gt;
*The number of tubules with sperm.&lt;br /&gt;
*Hyalinization of the tubules.&lt;br /&gt;
*Inflammation.&lt;br /&gt;
*Absence of [[germ cell neoplasia in situ]].&lt;br /&gt;
&lt;br /&gt;
===Mixed pattern===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
LEFT TESTIS, BIOPSY FOR SPERM RETRIEVAL:&lt;br /&gt;
- SERTOLI CELLS ONLY REGIONS (25% OF BIOPSY) INTERMIXED WITH&lt;br /&gt;
  HISTOLOGICALLY NORMAL TESTIS (75% OF BIOPSY) WITH NORMAL NUMBERS&lt;br /&gt;
  OF SPERM.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT SEMINIFEROUS TUBULE HYALINIZATION.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT INFLAMMATION.&lt;br /&gt;
- NEGATIVE FOR GERM CELL NEOPLASIA IN SITU (INTRATUBULAR GERM CELL NEOPLASIA).&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testis]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Genitourinary pathology]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53763</id>
		<title>Male infertility</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Male_infertility&amp;diff=53763"/>
		<updated>2025-11-14T14:31:06Z</updated>

		<summary type="html">&lt;p&gt;Michael: fix ref&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Male infertility -- intermed mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Mixed pattern male infertility (Sertoli cells only mixed with hypospermatogensis). [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   =&lt;br /&gt;
| Micro      = various patterns - see ''microscopic''&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[germ cell neoplasia in situ]], [[germ cell tumour]], inflammation of the testis&lt;br /&gt;
| Stains     =&lt;br /&gt;
| IHC        =&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      =&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = [[testis]], [[vas deferens]] and other sites&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  =&lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = not very common&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = benign&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    = ([[clinical diagnosis]])&lt;br /&gt;
| Tx         = dependent on underlying cause&lt;br /&gt;
}}&lt;br /&gt;
'''Male infertility''' is a [[clinical diagnosis]].  It is pretty much the only reason for a [[testis|testicular]] biopsy.&lt;br /&gt;
&lt;br /&gt;
This article focuses on the testicular causes of infertility. ''Testicular biopsy'' redirects to here.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Infertility is a [[clinical diagnosis]].&lt;br /&gt;
&lt;br /&gt;
It can be divided into:&amp;lt;ref name=pmid20670143&amp;gt;{{cite journal |authors=Cerilli LA, Kuang W, Rogers D |title=A practical approach to testicular biopsy interpretation for male infertility |journal=Arch Pathol Lab Med |volume=134 |issue=8 |pages=1197–204 |date=August 2010 |pmid=20670143 |doi=10.5858/2009-0379-RA.1 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Pre-testicular - e.g. hormonal, [[pituitary gland|pituitary]].&lt;br /&gt;
*Testicular.&lt;br /&gt;
*Post-testicular - e.g. blockage of [[vas deferens]].&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Male infertility on testicular biopsy shows one the following patterns:&amp;lt;ref name=pmid20670143/&amp;gt;&lt;br /&gt;
#Normal testis.&lt;br /&gt;
#Hypospermatogensis.&lt;br /&gt;
#Maturation arrest.&lt;br /&gt;
#Sertoli cells only.&lt;br /&gt;
#Seminiferous tubule hyalinization&lt;br /&gt;
#Some combination of the above patterns.&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Germ cell neoplasia in situ]] (GCNIS).&lt;br /&gt;
*[[Germ cell tumour]].&lt;br /&gt;
*[[Testicular adrenal rest tumour]] in the context of congenital adrenal hyperplasia - case report.&amp;lt;ref name=pmid23342900&amp;gt;{{Cite journal  | last1 = Niedziela | first1 = M. | last2 = Joanna | first2 = T. | last3 = Piotr | first3 = J. | title = Testicular adrenal rest tumors (TARTs) as a male infertility factor. Case report. | journal = Ginekol Pol | volume = 83 | issue = 9 | pages = 700-2 | month = Sep | year = 2012 | doi =  | PMID = 23342900 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Inflammation of the testis.&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
*The diagnosis should be the pattern (#1-6 above).&lt;br /&gt;
&lt;br /&gt;
The following should be commented on:&lt;br /&gt;
*The number of tubules.&lt;br /&gt;
*The number of tubules with sperm.&lt;br /&gt;
*Hyalinization of the tubules.&lt;br /&gt;
*Inflammation.&lt;br /&gt;
*Absence of [[germ cell neoplasia in situ]].&lt;br /&gt;
&lt;br /&gt;
===Mixed pattern===&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
LEFT TESTIS, BIOPSY FOR SPERM RETRIEVAL:&lt;br /&gt;
- SERTOLI CELLS ONLY REGIONS (25% OF BIOPSY) INTERMEIXED WITH&lt;br /&gt;
  HISTOLOGICALLY NORMAL TESTIS (75% OF BIOPSY) WITH NORMAL NUMBERS&lt;br /&gt;
  OF SPERM.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT SEMINIFEROUS TUBULE HYALINIZATION.&lt;br /&gt;
- NEGATIVE FOR SIGNIFICANT INFLAMMATION.&lt;br /&gt;
- NEGATIVE FOR GERM CELL NEOPLASIA IN SITU (INTRATUBULAR GERM CELL NEOPLASIA).&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Testis]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Genitourinary pathology]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=GATA-3&amp;diff=53762</id>
		<title>GATA-3</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=GATA-3&amp;diff=53762"/>
		<updated>2025-11-13T22:38:02Z</updated>

		<summary type="html">&lt;p&gt;Michael: Redirected page to GATA3&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;#redirect [[GATA3]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=GATA3&amp;diff=53761</id>
		<title>GATA3</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=GATA3&amp;diff=53761"/>
		<updated>2025-11-13T22:35:23Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Positive */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox immunostain&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Benign urothelium - GATA3 -- high mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = GATA3 staining in benign [[urothelium]].&lt;br /&gt;
| Abbrev     =&lt;br /&gt;
| Synonyms   =&lt;br /&gt;
| Similar    = [[thrombomodulin]], mammaglobin&lt;br /&gt;
| Clones     =       &lt;br /&gt;
| Use        = bladder versus prostate, bladder versus SCC, breast versus other, parathyroid versus thyroid&lt;br /&gt;
| Subspecial = [[Genitourinary pathology]], [[Breast pathology]]&lt;br /&gt;
| Pattern    = nuclear&lt;br /&gt;
| Positive   = [[urothelial carcinoma]], [[invasive ductal carcinoma of the breast]], [[lobular breast carcinoma]]&lt;br /&gt;
| Negative   = [[prostatic carcinoma]], [[squamous cell carcinoma of the lung]]&lt;br /&gt;
| Other      =&lt;br /&gt;
}}&lt;br /&gt;
'''GATA3''' an [[immunostain]] that is increasingly used in [[genitourinary pathology]]. &lt;br /&gt;
&lt;br /&gt;
==Positive==&lt;br /&gt;
*[[Urothelial carcinoma]].&amp;lt;ref name=pmid22982890&amp;gt;{{cite journal |author=Chang A, Amin A, Gabrielson E, ''et al.'' |title=Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung |journal=Am. J. Surg. Pathol. |volume=36 |issue=10 |pages=1472–6 |year=2012 |month=October |pmid=22982890 |pmc=3444740 |doi=10.1097/PAS.0b013e318260cde7 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Invasive breast cancer|Breast carcinoma]] - more sensitive than [[GCDFP-15]].&amp;lt;ref name=pmid24145643&amp;gt;{{Cite journal  | last1 = Miettinen | first1 = M. | last2 = McCue | first2 = PA. | last3 = Sarlomo-Rikala | first3 = M. | last4 = Rys | first4 = J. | last5 = Czapiewski | first5 = P. | last6 = Wazny | first6 = K. | last7 = Langfort | first7 = R. | last8 = Waloszczyk | first8 = P. | last9 = Biernat | first9 = W. | title = GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. | journal = Am J Surg Pathol | volume = 38 | issue = 1 | pages = 13-22 | month = Jan | year = 2014 | doi = 10.1097/PAS.0b013e3182a0218f | PMID = 24145643 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**[[Lobular breast carcinoma]].&amp;lt;ref name=pmid24061521&amp;gt;{{Cite journal  | last1 = Ellis | first1 = CL. | last2 = Chang | first2 = AG. | last3 = Cimino-Mathews | first3 = A. | last4 = Argani | first4 = P. | last5 = Youssef | first5 = RF. | last6 = Kapur | first6 = P. | last7 = Montgomery | first7 = EA. | last8 = Epstein | first8 = JI. | title = GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder. | journal = Am J Surg Pathol | volume = 37 | issue = 11 | pages = 1756-60 | month = Nov | year = 2013 | doi = 10.1097/PAS.0b013e31829cdba7 | PMID = 24061521 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Chromophobe renal cell carcinoma]] ~50% of cases.&amp;lt;ref name=pmid24145643/&amp;gt;&lt;br /&gt;
*[[Trophoblastic tumours]] +ve&amp;lt;ref&amp;gt;{{Cite journal  | last1 = Mirkovic | first1 = J. | last2 = Elias | first2 = K. | last3 = Drapkin | first3 = R. | last4 = Barletta | first4 = JA. | last5 = Quade | first5 = B. | last6 = Hirsch | first6 = MS. | title = GATA3 expression in gestational trophoblastic tissues and tumours. | journal = Histopathology | volume = 67 | issue = 5 | pages = 636-44 | month = Nov | year = 2015 | doi = 10.1111/his.12681 | PMID = 25753145 }}&amp;lt;/ref&amp;gt; including [[choriocarcinoma]].&amp;lt;ref name=pmid26772394 &amp;gt;{{cite journal |authors=Osman H, Cheng L, Ulbright TM, Idrees MT |title=The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases |journal=Hum Pathol |volume=48 |issue= |pages=18–24 |date=February 2016 |pmid=26772394 |doi=10.1016/j.humpath.2015.09.028 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Parathyroid - [[parathyroid hyperplasia]], [[parathyroid adenoma]], [[parathyroid carcinoma]].&amp;lt;ref name=pmid25046229&amp;gt;{{Cite journal  | last1 = Ordóñez | first1 = NG. | title = Value of GATA3 immunostaining in the diagnosis of parathyroid tumors. | journal = Appl Immunohistochem Mol Morphol | volume = 22 | issue = 10 | pages = 756-61 | month =  | year =  | doi = 10.1097/PAI.0000000000000007 | PMID = 25046229 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Salivary gland tumours &amp;lt;ref name=pmid23604756&amp;gt;{{Cite journal  | last1 = Schwartz | first1 = LE. | last2 = Begum | first2 = S. | last3 = Westra | first3 = WH. | last4 = Bishop | first4 = JA. | title = GATA3 immunohistochemical expression in salivary gland neoplasms. | journal = Head Neck Pathol | volume = 7 | issue = 4 | pages = 311-5 | month = Dec | year = 2013 | doi = 10.1007/s12105-013-0442-3 | PMID = 23604756 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Pheochromocytoma (~70%) vs adrenocortical carcinoma (&amp;lt;10%&amp;lt;ref name=pmid2837449&amp;gt;{{Cite journal  | last1 = Perrino | first1 = CM. | last2 = Ho | first2 = A. | last3 = Dall | first3 = CP. | last4 = Zynger | first4 = DL. | title = Utility of GATA3 in the differential diagnosis of pheochromocytoma. | journal = Histopathology | volume = 71 | issue = 3 | pages = 475-479 | month = Sep | year = 2017 | doi = 10.1111/his.13229 | PMID = 28374498 }}&amp;lt;/ref&amp;gt;).&lt;br /&gt;
*[[Brenner tumour]]s and [[Walthard cell rest]]s.&amp;lt;ref name=pmid25281026&amp;gt;{{Cite journal  | last1 = Roma | first1 = AA. | last2 = Masand | first2 = RP. | title = Ovarian Brenner tumors and Walthard nests: a histologic and immunohistochemical study. | journal = Hum Pathol | volume = 45 | issue = 12 | pages = 2417-22 | month = Dec | year = 2014 | doi = 10.1016/j.humpath.2014.08.003 | PMID = 25281026 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Malignant mesothelioma]]s (58%&amp;lt;ref name=pmid24145643/&amp;gt;).&lt;br /&gt;
*Most [[T-lymphocytes]].&amp;lt;ref name=pmid19151747&amp;gt;{{cite journal |authors=Ho IC, Tai TS, Pai SY |title=GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation |journal=Nat. Rev. Immunol. |volume=9 |issue=2 |pages=125–35 |date=February 2009 |pmid=19151747 |pmc=2998182 |doi=10.1038/nri2476 |url=}}&amp;lt;/ref&amp;gt; Used as part of a wider panel of IHC to sub-type peripheral T-cell lymphoma, NOS.&amp;lt;ref name=pmid31562134&amp;gt;{{cite journal |authors=Amador C, Greiner TC, Heavican TB, Smith LM, Galvis KT, Lone W, Bouska A, D'Amore F, Pedersen MB, Pileri S, Agostinelli C, Feldman AL, Rosenwald A, Ott G, Mottok A, Savage KJ, de Leval L, Gaulard P, Lim ST, Ong CK, Ondrejka SL, Song J, Campo E, Jaffe ES, Staudt LM, Rimsza LM, Vose J, Weisenburger DD, Chan WC, Iqbal J |title=Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry |journal=Blood |volume=134 |issue=24 |pages=2159–2170 |date=December 2019 |pmid=31562134 |doi=10.1182/blood.2019000779 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Skin squamous cell carcinoma]].&amp;lt;ref name=pmid26595821&amp;gt;{{cite journal |authors=Mertens RB, de Peralta-Venturina MN, Balzer BL, Frishberg DP |title=GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms |journal=Am J Dermatopathol |volume=37 |issue=12 |pages=885–91 |date=December 2015 |pmid=26595821 |pmc=4894790 |doi=10.1097/DAD.0000000000000306 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Clear cell tubulopapillary renal cell carcinoma]].&amp;lt;ref name=pmid28705707&amp;gt;{{cite journal |authors=Mantilla JG, Antic T, Tretiakova M |title=GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics |journal=Hum Pathol |volume=66 |issue= |pages=152–158 |date=August 2017 |pmid=28705707 |doi=10.1016/j.humpath.2017.06.016 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Seminal vesicles]] +ve.&amp;lt;ref name=pmid28461097&amp;gt;{{cite journal |authors=Ortiz-Rey JA, Chantada-de la Fuente D, Peteiro-Cancelo MÁ, Gómez-de María C, San Miguel-Fraile MP |title=Usefulness of GATA-3 as a marker of seminal epithelium in prostate biopsies |journal=Actas Urol Esp |volume=41 |issue=9 |pages=577–583 |date=November 2017 |pmid=28461097 |doi=10.1016/j.acuro.2017.03.004 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444740/figure/F1/ GATA3 nuclear staining - urothelial carcinoma (nih.gov)].&amp;lt;ref name=pmid22982890/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Negative==&lt;br /&gt;
*[[Prostate carcinoma]].&lt;br /&gt;
**Positive in benign prostate glands with radiation atypia.&amp;lt;ref name=pmid28316088&amp;gt;{{cite journal |authors=Tian W, Dorn D, Wei S, Sanders RD, Matoso A, Shah RB, Gordetsky J |title=GATA3 expression in benign prostate glands with radiation atypia: a diagnostic pitfall |journal=Histopathology |volume=71 |issue=1 |pages=150–155 |date=July 2017 |pmid=28316088 |doi=10.1111/his.13214 |url=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
**Positive staining may be seen in prostatic adenocarcinoma.&amp;lt;ref name=pmid32769430&amp;gt;{{cite journal |vauthors=McDonald TM, Epstein JI |title=Aberrant GATA3 Staining in Prostatic Adenocarcinoma: A Potential Diagnostic Pitfall |journal=Am J Surg Pathol |volume=45 |issue=3 |pages=341–346 |date=March 2021 |pmid=32769430 |doi=10.1097/PAS.0000000000001557 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Squamous cell carcinoma of the lung]].&amp;lt;ref name=pmid22982890/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Immunohistochemistry]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Immunohistochemistry]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Seminal_vesicles&amp;diff=53760</id>
		<title>Seminal vesicles</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Seminal_vesicles&amp;diff=53760"/>
		<updated>2025-11-13T22:33:54Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* IHC */ +GATA-3&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The '''seminal vesicles''', abbreviated '''SV''', are a pair of organs closely associated with the [[prostate gland]] that add fluid to the ejaculate. They are seen attached to [[radical prostatectomy]] specimens.&lt;br /&gt;
&lt;br /&gt;
=Normal seminal vesicles=&lt;br /&gt;
==General==&lt;br /&gt;
*Seen in radical prostatectomies and occasionally in core biopsies.&lt;br /&gt;
*Very rarely a site of a [[primary seminal vesicle carcinoma|primary cancer]].&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Worm-like paired organs.&lt;br /&gt;
*Empty into the ejaculatory ducts (as does the [[vas deferens]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Gray1153.png | Relationship between the SVs, ejaculatory ducts and [[vas deferens]].&lt;br /&gt;
Image:Gray1152.png | Relationship between the SVs, prostate and bladder.&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
*Fern-like architecture - epithelial component clustered closely, looks like it connects.&lt;br /&gt;
**Epithelium surrounded by a thick layer of muscle (&amp;gt;10 cells across ~80 microns).&lt;br /&gt;
*Lipofuscin (coarse cytoplasmic yellow granules approximately 1-2 micrometers) - '''key feature'''. &lt;br /&gt;
*Nucleoli - common.&lt;br /&gt;
*Nuclear inclusions - common.&amp;lt;ref&amp;gt;URL: [http://surgpathcriteria.stanford.edu/prostate/adenocarcinoma/benign-vs-carcinoma.html http://surgpathcriteria.stanford.edu/prostate/adenocarcinoma/benign-vs-carcinoma.html]. Accessed on: 10 January 2013.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Notes:&lt;br /&gt;
*The ''ejaculatory ducts'' have the same epithelium as the seminal vesicles.&amp;lt;ref name=pmid12657938&amp;gt;{{cite journal |author=Leroy X, Ballereau C, Villers A, ''et al.'' |title=MUC6 is a marker of seminal vesicle-ejaculatory duct epithelium and is useful for the differential diagnosis with prostate adenocarcinoma |journal=Am. J. Surg. Pathol. |volume=27 |issue=4 |pages=519–21 |year=2003 |month=April |pmid=12657938 |doi= |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Seminal_vesicle_low_mag.jpg | SV - showing fern-like architecture. (WC/Nephron)&lt;br /&gt;
Image:Seminal_vesicle_high_mag.jpg | SV - looking vaguely like to prostate adenocarcinoma. (WC/Nephron)&lt;br /&gt;
Image:Seminal_vesicle_intermed_mag.jpg | SV - looks a bit like prostate but lumina too big. (WC/Nephron)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
www:&lt;br /&gt;
*[http://dspace.udel.edu:8080/dspace/bitstream/19716/2016/1/cmrsvlm3.GIF SV (udel.edu)].&lt;br /&gt;
&lt;br /&gt;
==IHC==&lt;br /&gt;
*[[PSA]] -ve.&amp;lt;ref name=pmid22895132&amp;gt;{{Cite journal  | last1 = Itami | first1 = Y. | last2 = Nagai | first2 = Y. | last3 = Kobayashi | first3 = Y. | last4 = Shimizu | first4 = N. | last5 = Yamamoto | first5 = Y. | last6 = Minami | first6 = T. | last7 = Hayashi | first7 = T. | last8 = Nozawa | first8 = M. | last9 = Yoshimura | first9 = K. | title = [A case of prostatic cancer with a low PSA level accompanied with cystic formation requiring differentiation from adenocarcinoma of the seminal vesicle]. | journal = Hinyokika Kiyo | volume = 58 | issue = 7 | pages = 349-53 | month = Jul | year = 2012 | doi =  | PMID = 22895132 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[CK7]] +ve.&amp;lt;ref name=pmid19468449&amp;gt;{{Cite journal  | last1 = Tarján | first1 = M. | last2 = Ottlecz | first2 = I. | last3 = Tot | first3 = T. | title = Primary adenocarcinoma of the seminal vesicle. | journal = Indian J Urol | volume = 25 | issue = 1 | pages = 143-5 | month = Jan | year = 2009 | doi = 10.4103/0970-1591.45557 | PMID = 19468449 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=pmid22076175&amp;gt;{{Cite journal  | last1 = Terada | first1 = T. | title = Monstrous epithelial cell clusters in the seminal vesicle. | journal = Int J Clin Exp Pathol | volume = 4 | issue = 7 | pages = 727-30 | month =  | year = 2011 | doi =  | PMID = 22076175 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[CK20]] -ve.&amp;lt;ref name=pmid19468449/&amp;gt;&lt;br /&gt;
*[[p63]] +ve.&amp;lt;ref name=pmid22076175/&amp;gt;&lt;br /&gt;
*[[CK34betaE12]] -ve.&amp;lt;ref name=pmid22076175/&amp;gt;&lt;br /&gt;
*[[AMACR]] -ve.&amp;lt;ref name=pmid22076175/&amp;gt;&lt;br /&gt;
*[[GATA-3]] +ve.&amp;lt;ref name=pmid28461097&amp;gt;{{cite journal |authors=Ortiz-Rey JA, Chantada-de la Fuente D, Peteiro-Cancelo MÁ, Gómez-de María C, San Miguel-Fraile MP |title=Usefulness of GATA-3 as a marker of seminal epithelium in prostate biopsies |journal=Actas Urol Esp |volume=41 |issue=9 |pages=577–583 |date=November 2017 |pmid=28461097 |doi=10.1016/j.acuro.2017.03.004 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
B. PROSTATE, RIGHT MEDIAL SUPERIOR, BIOPSY:&lt;br /&gt;
- BENIGN PROSTATE TISSUE.&lt;br /&gt;
- BENIGN SEMINAL VESICLE/EJACULATORY DUCT.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=Pathology=&lt;br /&gt;
==Primary seminal vesicle carcinoma==&lt;br /&gt;
{{Main|Primary seminal vesicle carcinoma}}&lt;br /&gt;
&lt;br /&gt;
==Amyloid in the seminal vesicles==&lt;br /&gt;
{{Main|Amyloid in the seminal vesicles}}&lt;br /&gt;
&lt;br /&gt;
=Benign=&lt;br /&gt;
==Stromal lipofuscinosis of the seminal vesicle==&lt;br /&gt;
{{Main|Stromal lipofuscinosis of the seminal vesicle}}&lt;br /&gt;
&lt;br /&gt;
=See also=&lt;br /&gt;
*[[Prostate gland]].&lt;br /&gt;
*[[Prostate cancer staging]].&lt;br /&gt;
*[[Primary seminal vesicle carcinoma]].&lt;br /&gt;
&lt;br /&gt;
=References=&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Genitourinary pathology]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Talk:Small_cell_carcinoma&amp;diff=53759</id>
		<title>Talk:Small cell carcinoma</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Talk:Small_cell_carcinoma&amp;diff=53759"/>
		<updated>2025-11-13T18:08:37Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* Keratin negative small cell carcinoma */ new section&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Keratin negative small cell carcinoma ==&lt;br /&gt;
&lt;br /&gt;
There is a paper that says it exists: https://pmc.ncbi.nlm.nih.gov/articles/PMC3282443 https://pubmed.ncbi.nlm.nih.gov/22355493/&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Paraganglioma&amp;diff=53758</id>
		<title>Paraganglioma</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Paraganglioma&amp;diff=53758"/>
		<updated>2025-11-12T18:48:55Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* IHC */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ Infobox diagnosis&lt;br /&gt;
| Name       = {{PAGENAME}}&lt;br /&gt;
| Image      = Paraganglioma_-_very_high_mag.jpg&lt;br /&gt;
| Width      =&lt;br /&gt;
| Caption    = Paraganglioma. [[H&amp;amp;E stain]].&lt;br /&gt;
| Synonyms   =&lt;br /&gt;
| Micro      = Zellballen (nests of cells), fibrovascular septae, salt-and-pepper nuclei, +/-hemorrhage (very common)&lt;br /&gt;
| Subtypes   =&lt;br /&gt;
| LMDDx      = [[neuroendocrine tumour]], [[pheochromocytoma]] (paraganglioma of the [[adrenal gland]]), [[gangliocytic paraganglioma]]&lt;br /&gt;
| Stains     = &lt;br /&gt;
| IHC        = chromogranin +ve, synaptophysin +ve, CD56 +ve&lt;br /&gt;
| EM         =&lt;br /&gt;
| Molecular  =&lt;br /&gt;
| IF         =&lt;br /&gt;
| Gross      = dusky colour&lt;br /&gt;
| Grossing   =&lt;br /&gt;
| Site       = abdomen (adrenal gland paraganglioma = pheochromocytoma), head and neck (carotid body tumour)&lt;br /&gt;
| Assdx      =&lt;br /&gt;
| Syndromes  = [[von Hippel Lindau]], hereditary paragangliomatosis, [[neurofibromatosis]] type 1 (von Recklinghausen disease), [[MEN 2A]], [[MEN 2B]], [[Carney-Stratakis syndrome]], [[Carney triad]] &lt;br /&gt;
| Clinicalhx =&lt;br /&gt;
| Signs      =&lt;br /&gt;
| Symptoms   =&lt;br /&gt;
| Prevalence = uncommon&lt;br /&gt;
| Bloodwork  =&lt;br /&gt;
| Rads       =&lt;br /&gt;
| Endoscopy  =&lt;br /&gt;
| Prognosis  = usually good, rarely malignant&lt;br /&gt;
| Other      =&lt;br /&gt;
| ClinDDx    =&lt;br /&gt;
| Tx         =&lt;br /&gt;
}}&lt;br /&gt;
'''Paraganglioma''' is a rare tumour arising from the paraganglion.  A paraganglioma arising in the [[adrenal gland]] is known as a [[pheochromocytoma]].&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*Definition: tumour of paraganglion. &lt;br /&gt;
**Can be sympathetic or parasympathetic.&lt;br /&gt;
**Locations of paraganglia&lt;br /&gt;
***Paravertebral (retroperitoneal)&lt;br /&gt;
***Near the large blood vessels of the head and neck and base of skull&lt;br /&gt;
***Scattered in other tissues&lt;br /&gt;
*Most common paraganglioma = [[pheochromocytoma]].&amp;lt;ref name=Ref_EP_327&amp;gt;{{Ref EP|327}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Sites relate to locations of paraganglia&lt;br /&gt;
****Head &amp;amp; neck most common - neck, ear, carotid body, base of skull&lt;br /&gt;
****Retroperitoneal/abdomen&lt;br /&gt;
****Bladder&lt;br /&gt;
&lt;br /&gt;
Special site names&lt;br /&gt;
*Carotid body tumour = paraganglioma of carotid body - very vascular - right near a major artery.  Don't stick a needle in it.&lt;br /&gt;
*Glomus tympanicum tumor = paraganglioma of the middle ear - pulsitile tintinitis and conductive hearing loss.&lt;br /&gt;
*Pheochromocytoma - basically a 'paraganglioma' in the adrenal medulla&lt;br /&gt;
&lt;br /&gt;
===Epidemiology===&lt;br /&gt;
*Rare.&lt;br /&gt;
*Rarely malignant.&lt;br /&gt;
&lt;br /&gt;
Familial syndromes associated with paragangliomas:&amp;lt;ref name=Ref_EP328&amp;gt;{{Ref EP|328}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[von Hippel Lindau]].&lt;br /&gt;
*Hereditary paragangliomatosis.&lt;br /&gt;
*[[Neurofibromatosis]] type 1 (von Recklinghausen disease).&lt;br /&gt;
*[[MEN 2A]].&lt;br /&gt;
*[[MEN 2B]].&lt;br /&gt;
*[[Carney-Stratakis syndrome]] - [[GIST]]s and paraganglioma.&amp;lt;ref&amp;gt;{{Cite journal  | last1 = Blay | first1 = JY. | last2 = Blomqvist | first2 = C. | last3 = Bonvalot | first3 = S. | last4 = Boukovinas | first4 = I. | last5 = Casali | first5 = PG. | last6 = De Alava | first6 = E. | last7 = Dei Tos | first7 = AP. | last8 = Dirksen | first8 = U. | last9 = Duffaud | first9 = F. | title = Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | journal = Ann Oncol | volume = 23 Suppl 7 | issue =  | pages = vii49-55 | month = Oct | year = 2012 | doi = 10.1093/annonc/mds252 | PMID = 22997454 | url = http://annonc.oxfordjournals.org/content/23/suppl_7/vii49.full }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Succinate dehydrogenase|SDH]] mutation associated (SDHB, SDHC and SDHD).&amp;lt;ref name=pmid24523625&amp;gt;{{Cite journal  | last1 = Lefebvre | first1 = M. | last2 = Foulkes | first2 = WD. | title = Pheochromocytoma and paraganglioma syndromes: genetics and management update. | journal = Curr Oncol | volume = 21 | issue = 1 | pages = e8-e17 | month = Feb | year = 2014 | doi = 10.3747/co.21.1579 | PMID = 24523625 }}&amp;lt;/ref&amp;gt; &lt;br /&gt;
*[[Hereditary leiomyomatosis and renal cell carcinoma syndrome]].&amp;lt;ref name=pmid39705504&amp;gt;{{cite journal |authors=Orrego JJ, Chorny JA |title=Hereditary leiomyomatosis and renal cell cancer (HLRCC), pheochromocytoma (PCC)/paraganglioma (PGL) and germline fumarate hydratase (FH) variants |journal=Endocrinol Diabetes Metab Case Rep |volume=2024 |issue=4 |pages= |date=October 2024 |pmid=39705504 |pmc=11737469 |doi=10.1530/EDM-24-0073 |url=}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=pmid36773955&amp;gt;{{cite journal |authors=Zavoshi S, Lu E, Boutros PC, Zhang L, Harari A, Hatchell KE, Nielsen SM, Esplin ED, Ouyang K, Nykamp K, Wilde B, Christofk H, Shuch B |title=Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma |journal=Urology |volume=176 |issue= |pages=106–114 |date=June 2023 |pmid=36773955 |doi=10.1016/j.urology.2022.11.053 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Other associations - not proven to be genetic:&lt;br /&gt;
*[[Carney triad]].&lt;br /&gt;
&lt;br /&gt;
===Clinical===&lt;br /&gt;
*10% bilateral, multiple, familial, pediatric and malignant.&amp;lt;ref name=Ref_EP327&amp;gt;{{Ref EP|327}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
**''Not'' quite true... more than 10% are familial - see ''[[pheochromocytoma]]'' article.&lt;br /&gt;
&lt;br /&gt;
==Gross==&lt;br /&gt;
*Dusky colour.&lt;br /&gt;
&lt;br /&gt;
Note:&lt;br /&gt;
*''Pheo'' (in [[pheochromocytoma]]) is ''dusky''; ''chromo'' is ''colour''.&lt;br /&gt;
&lt;br /&gt;
Image:&lt;br /&gt;
*[http://commons.wikimedia.org/wiki/File:Mediastinal_paraganglioma.jpg Mediastinal paraganglioma (WC/AFIP)].&lt;br /&gt;
&lt;br /&gt;
==Microscopic==&lt;br /&gt;
Features:&amp;lt;ref&amp;gt;{{Ref EP|329-332}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Zellballen - nests of cells - '''key low power feature'''.&lt;br /&gt;
**Zellballen is &amp;quot;cell balls&amp;quot; in German.&lt;br /&gt;
*Fibrovascular septae and sustentacular cells (structural support cell).&lt;br /&gt;
*Finely granular cytoplasm (salt-and-pepper nuclei).&lt;br /&gt;
*+/-Hemorrhage - very common.&lt;br /&gt;
&lt;br /&gt;
DDx:&lt;br /&gt;
*[[Neuroendocrine tumour]] - nests surrounded by stroma/do not touch.&lt;br /&gt;
*[[Pheochromocytoma]] - paraganglioma of the [[adrenal gland]].&lt;br /&gt;
*[[Gangliocytic paraganglioma]] - has schwannian component and ganglion cells, usu. [[duodenum]].&lt;br /&gt;
&lt;br /&gt;
===Images===&lt;br /&gt;
Carotid body tumour:&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Carotid_body_tumour_2_intermed_mag.jpg | Paraganglioma - intermed. mag. (WC)&lt;br /&gt;
Image:Carotid_body_tumour_2_high_mag.jpg | Paraganglioma - high mag. (WC)&lt;br /&gt;
Image:Neck Paraganglioma HP CTR (2).jpg|Neck - Paraganglioma - nice Zeballen (SKB)&lt;br /&gt;
Image:Neck Paraganglioma CarotidBody MP PA.JPG|Neck Paraganglioma - Carotid Body Tumor (SKB)&lt;br /&gt;
Image:Neck Paraganglioma CarotidBody HP PA.JPG|Neck - Paraganglioma - Carotid Body Tumor (SKB)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
Duodenal paraganglioma - uncommon location:&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Paraganglioma_-_low_mag.jpg | Paraganglioma - low mag. (WC)&lt;br /&gt;
Image:Paraganglioma_-_very_high_mag.jpg | Paraganglioma - very high mag. (WC)&lt;br /&gt;
Image:Paraganglioma_-_chromo_-_intermed_mag.jpg | Paraganglioma - chromogranin A - intermed. mag. (WC)&lt;br /&gt;
Image:Paraganglioma_-_s100_-_very_high_mag.jpg | Paraganglioma - S100 - very high mag. (WC)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
Retroperitoneal paraganglioma&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Retroperitoneum Paraganglioma 2 MP PA.JPG|Retroperitoneum - Paraganglioma - Prominent vascular component (SKB)&lt;br /&gt;
Image:Retroperitoneum Paraganglioma 2 HP PA.JPG|Retroperitoneum - Paraganglioma   (SKB)&lt;br /&gt;
Image:Retroperitoneum Paraganglioma HP PA.JPG|Retroperitoneum - Paraganglioma - florid atypia  (SKB)&lt;br /&gt;
Image:Retroperitoneum Paraganglioma MP CTR.jpg|Retroperitoneum - Paraganglioma - large nests (SKB)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
Ear paraganglioma &amp;quot;Glomus Tympanicum&amp;quot;&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Ear Paraganglioma GlomusTympanicumTumor MP PA.JPG|Ear - Paraganglioma - Glomus Tympanicum Tumor (SKB)&lt;br /&gt;
Image:Ear Paraganglioma GlomusTympanicumTumor HP 2 PA.JPG|Ear - Paraganglioma - Glomus Tympanicum Tumor  (SKB)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
Bladder&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Bladder Paraganglioma PA DSCN4717.JPG|Bladder - Paraganglioma - Presented as micturation syncope (SKB)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
Other:&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:Pheochromocytoma_high_mag.jpg | Pheochromocytoma - high mag. (WC)&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
www:&lt;br /&gt;
*[http://path.upmc.edu/cases/case523.html Paraganglioma with gangliocytic differentiation - several images (upmc.edu)].&lt;br /&gt;
&lt;br /&gt;
==IHC==&lt;br /&gt;
Features:&amp;lt;ref name=Ref_EP335&amp;gt;{{Ref EP|335}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Chromogranin +ve.&lt;br /&gt;
*Synaptophysin +ve.&lt;br /&gt;
*S100 +ve/-ve (+ve in sustentacular cells, not tumor cells)&lt;br /&gt;
*Cytokeratin -ve.&lt;br /&gt;
*[[EMA]] -ve.&lt;br /&gt;
**+ve in [[renal cell carcinoma|RCC]].&lt;br /&gt;
*ATRX normal/loss.&lt;br /&gt;
**Loss of staining a poor prognosticator in pheochromocytoma/paraganglioma.&amp;lt;ref name=pmid40652840&amp;gt;{{cite journal |authors=Wang LL, Wei XJ, Zhang QC, Li F, Chen GY |title=Analysis of clinicopathological and immunohistochemical features of pheochromocytoma/paraganglioma |journal=Ann Diagn Pathol |volume=79 |issue= |pages=152525 |date=December 2025 |pmid=40652840 |doi=10.1016/j.anndiagpath.2025.152525 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Testing for heritable tumours:&lt;br /&gt;
*SDHB (SDHx alterations).&lt;br /&gt;
*FH (loss in HLRCC).&lt;br /&gt;
*2SC (positive in HLRCC).&lt;br /&gt;
*CAIX (+ve in VHL-related).&lt;br /&gt;
*Alpha-inhibin (+ve in VHL-related and SHDx alterations).&lt;br /&gt;
&lt;br /&gt;
==EM==&lt;br /&gt;
Features:&amp;lt;ref name=em_stuff&amp;gt;URL: [http://path.upmc.edu/cases/case408.html http://path.upmc.edu/cases/case408.html]. Accessed on: 16 January 2012.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Neurosecretory granules.&lt;br /&gt;
**Electron dense core.&lt;br /&gt;
**Typically perinuclear location.&lt;br /&gt;
&lt;br /&gt;
Image:&lt;br /&gt;
*[http://path.upmc.edu/cases/case408/images/fig14.jpg Neurosecretory granules (upmc.edu)].&amp;lt;ref name=em_stuff&amp;gt;URL: [http://path.upmc.edu/cases/case408.html http://path.upmc.edu/cases/case408.html]. Accessed on: 16 January 2012.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Sign out==&lt;br /&gt;
&amp;lt;pre&amp;gt;&lt;br /&gt;
SOFT TISSUE, LEFT/RIGHT CAROTID BODY, EXCISION:&lt;br /&gt;
- PARAGANGLIOMA (SIZE IN CM).&lt;br /&gt;
- NEGATIVE RESECTION MARGIN.&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Adrenal gland]].&lt;br /&gt;
*[[Head and neck pathology]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Weird stuff]]&lt;br /&gt;
[[Category:Diagnosis]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Bladder_cancer_staging&amp;diff=53757</id>
		<title>Bladder cancer staging</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Bladder_cancer_staging&amp;diff=53757"/>
		<updated>2025-11-11T16:04:46Z</updated>

		<summary type="html">&lt;p&gt;Michael: /* TNM staging system */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image:Diagram showing the T stages of bladder cancer CRUK 372.svg|thumb|right|180px|Schematic showing the T stages in bladder cancer. (WC/CRUK)]] &lt;br /&gt;
The article deals with '''bladder cancer staging'''.  A general discussion about staging is found in ''[[cancer staging]]''.&lt;br /&gt;
&lt;br /&gt;
==General==&lt;br /&gt;
*TNM staging the most commonly used.&lt;br /&gt;
*[[Urachal carcinoma]] has its own staging system - see ''[[Sheldon staging system]]''.&amp;lt;ref name=pmid22901574&amp;gt;{{Cite journal  | last1 = Bruins | first1 = HM. | last2 = Visser | first2 = O. | last3 = Ploeg | first3 = M. | last4 = Hulsbergen-van de Kaa | first4 = CA. | last5 = Kiemeney | first5 = LA. | last6 = Witjes | first6 = JA. | title = The clinical epidemiology of urachal carcinoma: results of a large, population based study. | journal = J Urol | volume = 188 | issue = 4 | pages = 1102-7 | month = Oct | year = 2012 | doi = 10.1016/j.juro.2012.06.020 | PMID = 22901574 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==TNM staging system==&lt;br /&gt;
===Tumour===&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot; &lt;br /&gt;
! T stage&lt;br /&gt;
! Criteria&lt;br /&gt;
|-&lt;br /&gt;
| Ta&lt;br /&gt;
| non-invasive papillary carcinoma&lt;br /&gt;
|-&lt;br /&gt;
| Tis&lt;br /&gt;
| [[urothelial carcinoma in situ|carcinoma in situ]]&lt;br /&gt;
|-&lt;br /&gt;
| T1&lt;br /&gt;
| lamina propria invasion&lt;br /&gt;
|-&lt;br /&gt;
| T2&lt;br /&gt;
| muscularis propria invasion&lt;br /&gt;
|-&lt;br /&gt;
| T3a&lt;br /&gt;
| microscopic extravesicular invasion&lt;br /&gt;
|-&lt;br /&gt;
| T3b&lt;br /&gt;
| macroscopic extravesicular invasion&lt;br /&gt;
|-&lt;br /&gt;
| T4a&lt;br /&gt;
| extension into the uterus, vagina or prostate&lt;br /&gt;
|-&lt;br /&gt;
| T4b&lt;br /&gt;
| extension into the abdominal wall or pelvic wall&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Notes:&lt;br /&gt;
*The most important distinction is between T1 and T2. This is dealt with in the ''[[muscularis propria invasion in the urinary bladder]]'' article.&lt;br /&gt;
**T2 is typically managed with a [[radical cystectomy]] or [[radical cystoprostatectomy]].&lt;br /&gt;
*Upstaging based on cystectomy/cytoprostatectomy pathology common - range 20-80%.&amp;lt;ref name=pmid22321341&amp;gt;{{Cite journal  | last1 = Turker | first1 = P. | last2 = Bostrom | first2 = PJ. | last3 = Wroclawski | first3 = ML. | last4 = van Rhijn | first4 = B. | last5 = Kortekangas | first5 = H. | last6 = Kuk | first6 = C. | last7 = Mirtti | first7 = T. | last8 = Fleshner | first8 = NE. | last9 = Jewett | first9 = MA. | title = Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome. | journal = BJU Int | volume = 110 | issue = 6 | pages = 804-11 | month = Sep | year = 2012 | doi = 10.1111/j.1464-410X.2012.10939.x | PMID = 22321341 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Not all fat is perivesicular. Fat within the bladder wall (submucosa) is well-described.&amp;lt;ref name=pmid19820494&amp;gt;{{cite journal |authors=Thickman D |title=Fat within the wall of the urinary bladder: computed tomographic appearance |journal=J Comput Assist Tomogr |volume=33 |issue=5 |pages=695–7 |date=2009 |pmid=19820494 |doi=10.1097/RCT.0b013e31818d8de6 |url=}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=pmid23142003&amp;gt;{{cite journal |authors=Kriegshauser JS, Conley CR, Hentz JG |title=Bladder wall fat on computed tomography with pathologic correlation |journal=Clin Imaging |volume=37 |issue=3 |pages=509–13 |date=2013 |pmid=23142003 |doi=10.1016/j.clinimag.2012.10.001 |url=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Nodes===&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot; &lt;br /&gt;
! N stage&lt;br /&gt;
! Criteria&lt;br /&gt;
|-&lt;br /&gt;
| N1&lt;br /&gt;
| one regional [[lymph node metastasis]]&lt;br /&gt;
|-&lt;br /&gt;
| N2&lt;br /&gt;
| more than one regional lymph node metastasis&lt;br /&gt;
|-&lt;br /&gt;
| N3&lt;br /&gt;
| metastasis to the common iliac lymph nodes&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Urothelium]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
*[http://www.cancer.net/cancer-types/bladder-cancer/stages-and-grades Bladder cancer staging (cancer.net)].&lt;br /&gt;
&lt;br /&gt;
[[Category:Genitourinary pathology]]&lt;br /&gt;
[[Category:Cancer staging]]&lt;/div&gt;</summary>
		<author><name>Michael</name></author>
	</entry>
</feed>